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1 Discovery of artemisinin as anti-malaria compound 
Artemisia annua L. also named Sweet wormwood or Sweet Annie (Figure 1), belongs to the 
family of Asteraceae and is native to Asia. As the name indicates, this plant has an annual 
cycle. Greenish or yellowish flowers appear in August or September and are induced by a 
short-day photoperiod. It is a single-stemmed shrub with an aromatic smell that can grow over 
2 m high and has fern-like leaves.  
As early as 168 B.C., Artemisia annua was used in Chinese medicine for the treatment of 
hemorrhoids [1]. The first recommendation to use A. annua to cure fevers with sweating and 
jaundice, symptoms resembling malaria, dates from 150-219 A.D. in a text entitled On Cold 
Damage (Shang Han Lun) and written by Zhang Ji [1]. In 1596, the Chinese materia medica 
described the use of A. annua to treat malaria [1]. 
 
Figure 1: Morphology of Artemisia annua L. with its most active anti-malarial 
compound.  
A: Picture of A. annua L. in the botanical garden of Ghent University; B: Detail of a leaf from 
A. annua; C: Molecular structure of artemisinin. 
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Malaria was more deadly for the soldiers during the Vietnam war than armed conflicts [3], 
therefore Vietnam asked the Chinese government for help to find anti-malaria treatments. A 
systematic screening of the Chinese materia medica was set up [2] and extracts from A. annua 
were one of the first substances tested but initially no anti-malarial activity was found [3]. 
This was due to the use of traditional methods of boiling and high-temperature extraction 
which damage the active ingredient. An extraction at lower temperature with ether revealed 
100% inhibition of mouse malaria [4]. The active compound artemisinin was isolated and 
characterized by the Qinghaosu Antimalarial Coordinating Research Group (1979) as a 
sesquiterpene with endoperoxide bridge (Figure 1) [4]. Artemisinin production was reported 
in Artemisia annua, Artemisia apiacea and Artemisia lancea [6, 7]. 
2 Malaria 
2.1 General facts 
Roughly half of the world’s population is at risk of malaria and the World Health 
Organization (WHO) estimated 216 million episodes in 2010 [5]. Despite the fact that malaria 
is preventable and curable, the WHO assesses that malaria was responsible for approximately 
655,000 deaths in 2010 [5]. Areas at risk for malaria transmission are shown in Figure 2. 
Malaria is caused by an infection with parasites from the genus Plasmodium.  
Five species of the genus Plasmodium infect humans: P. falciparum, P. vivax, P. ovale, P. 
malariae and P. knowlesi. The most deadly species is P. falciparum which is predominant in 
Africa [5]. P. vivax is the most widespread species that counts for 80% of the infections in 
Southeast Asia and 70% of the infections in America [7]. This species can form dormant 
hypnozoite forms in the liver [7]. P. malariae infections are observed in all major malaria-
endemic regions [6] and P. ovale is mainly present in Sub-Saharan Africa but occurs also in 
the western Pacific and the Asian mainland [7]. P. malariae and P. ovale are relatively mild 
infections [6]. P. knowlesi is a malaria parasite in monkeys which is increasingly associated 
with human infections in Southeast Asia [8]. This species can cause severe malaria 
comparable with falciparum malaria [8]. 
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Figure 2: Areas at risk of malaria. 
(http://gamapserver.who.int/mapLibrary/Files/Maps/Global_Malaria_2010.png) 
2.2 Infection cycle and diagnosis 
Plasmodium parasites are transmitted by mosquitoes from the genus Anopheles. Before the 
mosquito starts consuming her blood meal, saliva is injected as anticoagulant and Plasmodium 
sporozoites -motile and infective stages of the parasite- can be introduced (Figure 3) [9]. 
Malaria further develops in an exo-erythrocytic and erythrocytic (red blood cell) phase. The 
exo-erythrocytic phase starts with sporozoite migration to the liver to invade hepatocytes, a 
differentiation and asexual multiplication to make exo-erythrocytic schizonts containing 
merozoites. This phase is asymptomatically and takes 8-30 days [9]. Some malaria species 
can remain dormant in the liver for extended periods and cause relapses weeks or months later 
[10].  
When merozoites are released in the bloodstream, they invade the erythrocytes (red blood 
cells) and develop through different stages. The first stage is the immature trophozoit with a 
characteristic ring structure (Figure 4) and mature trophozoit stage in which the parasite is 
highly metabolic active [9]. In the next stage, asexual division forms erythrocytic schizonts 
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containing merozoites [9]. These merozoites break out synchronously every 1-3 days and 
invade new erythrocytes. This event is linked to a wave of fever. After asexual amplification, 
a small proportion of the merozoites will differentiate into ♂ micro- and ♀ macro-
gametocytes [9].  
 
Figure 3: Infection cycle of Plasmodium falciparum [11].  
Three developmental stages of P. falciparum can be distinguished: sporozoite-formation in 
the mosquito, an exo-erythrocytic phase in the liver and an erythrocytic phase in humans. 
If these gametocytes are ingested from the blood stream by a female mosquito, micro- and 
macro-gametocytes will form a zygote in the mosquito gut. The zygote develops into an 
ookinete which can penetrate the gut and an oocyst is formed in the gut-wall of the mosquito. 
After 8-15 days, sporozoites are formed and they migrate to the salivary glands of the 
mosquito [10]. 
Accurate clinical diagnosis of malaria is challenging as the first symptoms of malaria are 
nonspecific and common to many diseases e.g. fatigue, headache, vomiting, chills and muscle 
and joint pains [12]. In a further stage: fever, chills, perspiration, anorexia, vomiting and 
worsening malaise are observed [12]. If not treated, particularly in P. falciparum or P. 
knowlesi infections, this can lead to severe malaria. In P. falciparum infections, parasite-
infected erythrocytes accumulate and sequestrate in various organs such as brain, heart, lung 
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and kidney [9]. Severe malaria is complex and characterized by one or more of the following 
symptoms: coma in the case of cerebral malaria, metabolic acidosis, severe anaemia, 
hypoglycaemia, acute renal failure or acute pulmonary oedema [12]. Without appropriate 
treatment, severe malaria is fatal. 
 
Figure 4: Light microscopy view of malaria parasites in blood. 
A trophozoit- and schizont-stage of P. vivax are detected in red blood cells 
(http://www.itg.be/itg/distancelearning/lecturenotesvandenendene/imagehtml/ppages/kabisa_1522.htm). 
Since it is difficult to base the diagnosis of malaria on the symptoms alone, clinical suspicion 
of malaria should be confirmed by the detection of parasites. Two methods routinely used are 
light microscopy and rapid diagnostic tests (RDTs). With light microscopy, blood samples are 
screened on parasite presence (Figure 4) while with RDT parasite-specific antigens or 
enzymes are detected. Which method is recommended depends on local circumstances.  
For light microscopy, a well-trained and skilled staff is required as well as a power source. An 
advantage is that with light microscopy the amount of parasites in the blood can be quantified 
and that the response to treatments can be assessed [12]. Additionally, it can lead to the 
identification of other causes of disease.  
RDTs are more expensive but easier to use outside health facilities because no special 
equipment is needed and the tests are relatively simple to perform and interpret [12]. A 
disadvantage is that the specificity and sensitivity of RDTs can vary due to storage conditions 
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such as temperature and humidity. It is also difficult to distinguish new infections from 
effectively treated infections as some antigens can persist in the blood for a few weeks after 
treatment [13].  
Nucleic acid-based tests (NATs) e.g. PCR are also used and can detect lower infections-levels 
than light microscopy and RDTs [13]. 
2.3 Anti-malarial compounds 
Medicines useful for prophylaxis (prevention) are chloroquine, doxycycline, mefloquine and 
proguanil with atovaquone [14]. Chloroquine (e.g. Nivaquine) is used in regions were only P. 
vivax, P. ovale and P. malariae are causing infections since chloroquine resistance in P. 
falciparum is widespread [12]. Doxycycline is effective against malaria but must be 
administered daily [12] and during 4 weeks after returning home. Mefloquine (e.g. Lariam) is 
effective against all forms of malaria but can cause serious neuropsychiatric disturbances in 
approximately 1 out of 10 000 travellers [12]. Proguanil in combination with atovaquone 
(Malarone) is as efficient as mefloquine but with less side effects [14]. This medicine inhibits 
also pre-erythrocytic development in the liver [12]. It has to be noted that prophylactic 
medicines are not active against dormant liver stages of P. vivax and P. ovale [12]. 
Artemisinin has a half-life in the order of one hour [12] and is therefore not suited for 
prophylaxis of malaria.  
To treat malaria infections, artemisinin-derivatives are not recommended as monotherapy 
since their half-life is too short. Therefore, artemisinin-derivatives are combined with slowly 
eliminated anti-malaria compounds. Another advantage of using a combination therapy with 
different modes of action is to delay the emergence of resistance against artemisinin. Five 
combinations with artemisinin-derivatives are recommended by the WHO: lumefantrine, 
amodiaquine, mefloquine, sulfadoxine-pyrimethamine and piperaquine [5]. 
Pure artemisinin is poorly soluble in water and oil [15] but can be administered orally. Oral 
administration is not suited for patients with severe malaria since extreme vomiting occurs. 
Therefore, artemisinin-derivatives are synthesized which are more soluble in water e.g. 
artesunate or in oil e.g. arteether or artemether (Figure 5) [16]. These compounds are in vitro 
more potent against Plasmodium parasites than artemisinin itself [17]. In vivo: artesunate, 
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arteether and artemether are converted into a number of metabolites with antimalarial activity 
such as dihydroartemisinin [18]. 
 
Figure 5: Artemisinin derivatives.  
A: artemisinin, B: dihydroartemisinin, C: artemether, D: arteether, E: artesunate. 
The WHO recommends that uncomplicated P. falciparum infections are treated with 
artemisinin-based-combination therapy (ACT) [12]. For severe malaria, the treatment should 
be started with parenteral artesunate and followed by an oral ACT. To cure patients from P. 
vivax, the preferred treatment is chloroquine in areas where there is no resistance for 
chloroquine; otherwise ACT should be used [12]. Because P. vivax has developed resistance 
to sulfadoxine-pyrimethamine, other ACTs are recommended [12]. P. ovale and P. malariae 
infections are preferably treated with chloroquine [12]. 
2.4 Targets for artemisinin 
For the anti-malarial activity of artemisinin(-derivatives), several modes of action have been 
proposed but these are still under debate [19]. A schematic overview is given in Figure 6. 
A first hypothesis is related to hemoglobin metabolism. Plasmodium parasites degrade 
hemoglobin present in the erythrocytes and in this reaction, amino acids are released which 
are used for parasite protein synthesis. In addition to amino acids, free heme is released which 
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is toxic for the parasite. The cleavage of the artemisinin endoperoxide bond produces free 
radicals which alkylate heme molecules. This interferes with the crystallization of heme into 
the non toxic haemozoin [19, 20]. Another proposed reaction model is that artemisinin can 
alkylate proteins [20]. 
 
Figure 6: Overview of proposed modes of action and resistance against artemisinins 
[20]. Putative modes of action are coloured in orange, resistance mechanisms in yellow. 
Artemisinin (Art) is activated into radicals. Activated artemisinins might block heme 
detoxification, block the Ca
2+
 storage in the ER by interfering with PfATPase6, alkylate 
proteins or cause membrane depolarization. Proteins with mutations (red dots) can increase 
(arrow) or decrease (inhibition line) susceptibility to artemisins. 
Another reaction model proposes the inhibition of sarco/endoplasmic reticulum Ca
2+
 ATPase 
(SERCAs) [20]. The function of SERCA is to reduce free calcium in the cytosol and to 
concentrate it into membrane bound stores. It is known that SERCAs in mammalians are 
inhibited by the sesquiterpene lactone thapsigargin which lacks an endoperoxide bridge [19]. 
Since artemisinin has a sesquiterpene lactone structure too, it was reasoned that artemisinin 
might act on SERCAs. Only one enzyme in P. falciparum is orthologous to SERCA: 
PfATPase6 [19]. This target is present in the endoplasmic reticulum of the parasite and not in 
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the food vacuole [19]. It is reported that PfATPase6 is indeed inhibited by artemisinin and 
that this supposedly can mediate parasite death [20]. 
Interference with mitochondrial functions is also suggested. The electron transport chain of 
malaria parasites is proposed to directly activate artemisinin which leads to an accumulation 
of reactive oxygen species [21]. In Plasmodium berghei but not in mammal cells, reactive 
oxygen species induce mitochondrial membrane depolarization and ultimately parasite death 
[20]. This membrane depolarization is endoperoxide bridge dependent since this effect was 
not observed with deoxyartemisinin [21]. In addition to this, artemisinin is suspected to cause 
damage of the parasite membrane [19]. 
2.5 Artemisinin resistance 
Despite diverse action mechanisms proposed for artemisinin and its derivatives, resistance is 
emerging. Resistance is mainly reported in specific regions in Asia. In Laos, resistance is not 
yet observed as the half life of parasite decline after a treatment with artemisinin is only 2 
hours [22]. In contrast with this, the half life of parasite decline is 6 hours at the Thai-
Cambodian border [22]. This confirms previous reports [23] of artemisinin resistance at the 
Thai-Cambodian border. In western Thailand, artemisinin resistance has recently emerged 
(half life of 3 hours) [22]. At the Thai-Cambodian border, artemisinins have been used as 
monotherapy for more than 30 years [24] whether in western Thailand (Thai-Burumese 
border), artemisinin derivatives have been used almost exclusively in combination with 
mefloquine [24]. 
A gene associated with reduced artemisinin efficacy is pfmdr1 which encodes an ATP-
binding cassette transporter. This transporter is present on the membrane of the digestive 
vacuole of the parasite. As illustrated in Figure 6, there are indications that this transporter 
pumps drugs from the cytoplasm of the parasite to the food vacuole [25]. In vitro, it was 
shown that pfmdr1 gene amplification is correlated with reduced susceptibility to artemisinin-
derivatives and higher recrudescence after treatment with artesunate-mefloquine [23]. 
Removal of drug pressure can result in deamplification of pfmdr1 and reduced resistance [23].  
As illustrated in Figure 6, artemisinin can inhibit PfaTPase6. Therefore, it is not surprising 
that mutations observed in PfaTPase6 in vitro correlate with an increased mean IC50 for 
artemether [26]. Cheeseman et al. identified 33 genome regions associated with artemisinin 
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resistance. From these regions, 10 were known anti-malarial resistance genes but pfmdr1 and 
pfatpase6 were not amongst them. This shows that the mechanism of artemisinin resistance is 
still under debate [22].  
A mechanism by which P. falciparum might survive artemisinin treatment is by arresting its 
development at the ring stage (Figure 6). If drug pressure is removed, the parasite can resume 
its normal cell cycle [27]. There are indications that the parasite might enter the quiescent 
stage by reducing the rate of hemoglobin degradation [23, 28] which can explain why ring-
stage parasites can survive short-lasting drug exposure and why high recrudescence is 
reported after artemisinin monotherapy [23]. 
Despite the emerging artemisinin resistance, the WHO underlines that the clinical efficacy of 
ACTs is not yet substantially reduced. Along the Thai-Cambodian border, the cure rate for 
patients treated with a combination of mefloquine and artesunate was above 90% [29]. 
However, it is important to closely monitor the spread of resistance. 
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1 Artemisinin supply 
A high supply of artemisinin at a low price is needed to cure patients from malaria. Chemical 
synthesis of artemisinin is very complicated and expensive [30] and therefore not cost-
effective. In A. annua, the concentration of artemisinin is only 0.01-0.8% of dry weight [11]. 
Because of this, artemisinin production is enhanced by crossing high-producing plants [31]. 
Another strategy to increase artemisinin production is synthesis of artemisinic acid in 
engineered yeast and subsequent (photo)chemical conversion to artemisinin [32, 33]. Direct 
synthesis of artemisinin in yeast is only possible if the artemisinin biosynthesis pathway is 
completely unravelled. This chapter will discuss the general biosynthesis of terpenes and 
focus on the biosynthesis of artemisinin itself.  
2 Terpenoids 
2.1 Structure and function 
Artemisinin belongs to the group of terpenoid metabolites. Terpenoids (isoprenoids) were 
named after turpentine [34], the first compound isolated from this group. Another name 
frequently used is terpene. Originally, the name terpene was used to refer to molecules 
assembled from five-carbon units based on the isopentane skeleton (Figure 7) and terpenoid 
or isoprenoid to refer to the entire class of terpenes as well as terpenes that were chemically 
modified but nowadays, the words terpenes and terpenoids are used interchangeably [35]. 
Terpenoids are the largest class of all known plant metabolites and includes more than 40 000 
structures [36]. Based on their function, terpenoids are classified as primary- or secondary- 
metabolites.  
Primary metabolites are essential for growth, development and general metabolism of plants. 
An example of such terpenoids are carotenoids [35, 37] which are important in 
photosynthesis. The phytol side chain of chlorophyll is another terpenoid [37] that enables the 
chlorophyll to be anchored in the membrane. Gibberellins are terpenoid phytohormones [38] 
involved in plant growth and development. [35, 37, 38].  
In contrast, secondary metabolites, also called natural products, are not essential for plant 
growth but they influence interactions between plants and its environment. Bad-tasting or 
toxic metabolites can protect plants against herbivores and good-smelling volatiles attract 
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pollinators. Secondary plant terpenoids are industrially relevant in pharmaceutics, flavour, 
fragrances and pesticides [36]: artemisinin and paclitaxel (Taxol) [35] are well known 
pharmaceutical terpenoids and menthol [35] is widely used in flavour and fragrance industry. 
Besides terpenoids, secondary metabolites comprise molecules from the alkaloids, 
phenylpropanoids and phenols [34]. 
 
Figure 7: General scheme of plant terpenoid biosynthesis (adapted from [36]).  
Isopentenyl pyrophosphate (IPP) and its isomer dimethylallyl pyrophosphate (DMAPP) are 
the building blocks for terpenes. DMAPP, geranyl diphosphate (GDP), farnesyl diphosphate 
(FDP) and geranylgeranyl diphosphate (GGDP) are precursors for hemi-, mono-, sesqui- and 
diterpenes. Two FDP molecules linked will form triterpenes and the association of two GGDP 
molecules leads to tetraterpenes. 
Despite the structural diversity of terpenoids, as illustrated in Figure 7, isopentenyl 
pyrophosphate (IPP) and its isomer, dimethylallyl pyrophosphate (DMAPP) are the C5-
building blocks of all terpenoids. Terpenoid classification is based on the number of C5-units 
in their structure. Hemiterpenoids contain only one C5-unit whereas molecules assembled 
from two C5-units are called monoterpenoids. In sesquiterpenes such as artemisinin 
(C15H22O5), three building blocks are linked and di- and triterpenes contain respectively 4- and 
6- C5-units. Two pathways are involved in the production of IPP: the mevalonate (MVA) 
pathway and the 2-C-methyl-D-erythritol 4-phosphate (MEP) pathway. 
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2.2 Biosynthesis of isoprene units 
The mevalonate (MVA) pathway is present in all eukaryotes and some Gram-positive 
prokaryotes [35]. A schematic overview of the MVA pathway is shown in (Figure 8). This 
pathway is expressed in the cytosol and starts with the condensation of 3 molecules acetyl-
CoA by acetyl-CoA acetyltransferase (AACT) and 3-hydroxy-3-methyl-glutaryl-CoA 
synthase (HMGS) to HMG-CoA. Subsequently, HMG-CoA is reduced by HMG-CoA 
reductase (HMGR) to mevalonic acid. HMGR is the key regulatory step from the mevalonate 
pathway [39, 40]. It has been shown that this step also limits artemisinin biosynthesis [40, 
41]. Mevalonate is converted by mevalonate kinase (MVK) to mevalonic acid-5-phosphate 
and further by phosphomevalonate kinase (PMK) to mevalonic acid-5-diphosphate. Finally, 
mevalonic acid-5-diphosphate is converted by diphosphomevalonate decarboxylase (PMD) to 
IPP which can be isomerized to DMAPP by isopentenyl diphosphate isomerase (IDI).  
The MVA pathway was the only known source of terpenoids before 1993 [42]. Rohmer et al. 
showed with isotope-labelling studies that there is an alternative pathway which does not 
originate from acetyl-CoA [42]. An alternative 2-C-methyl-D-erythritol 4-phosphate (MEP) 
or deoxyxylulose-5-phosphate pathway was discovered that is generally found in many 
prokaryotes, apicomplexa parasites and photosynthetic eukaryotes [43]. Plants have thus both 
MVA and MEP pathways [39]. Despite the prokaryotic origin of the MEP pathway, all genes 
coding for enzymes of this pathway are encoded in the nucleus [43] but the biosynthetic 
pathway itself is located in plastids [37].  
The enzyme 1-deoxy-D-xylulose-5-phosphate synthase (DXS) combines pyruvate and 
glyceraldehyde-3-phosphate to 1-deoxy-D-xylulose-5-phosphate (DXP) (Figure 8). The next 
step is the conversion of 1-deoxy-D-xylulose-5-phosphate into 2-C-methyl-D-erythritol 4-
phosphate by DXP-reductoisomerase (DXR) and this is subsequently converted by 2-C-
methyl-D-erythritol-4-phosphate cytidylyltransferase (MCT) to 4-diphosphocytidyl-2-C-
methyl-D-erythritol. This metabolite is phosphorylated by 4-cytidine 5’-diphospho-2-C-
methyl-D-erythritol kinase (CMK) and 4-diphosphocytidyl-2-C-methyl-D-erythritol 2-
phosphate is formed which is cyclised by 2-C-methyl-D-erythritol-2,4-cyclodiphosphate 
synthase (MCS) to form 2C-methyl-D-erythritol 2,4-cyclodiphosphate. This is converted by 
hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate synthase (HDS) and hydroxy-2-methyl-2-(E)-
butenyl 4-diphosphate reductase (HDR) to IPP and DMAPP in a 5:1 ratio [35].  
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Figure 8: Schematic overview of MVA and MEP pathways.  
The MVA pathway starts with acetyl-CoA to synthesize IPP. The MEP pathway uses as input 
pyruvate and glyceraldehyde-3-phosphate to form IPP and DMAPP. Rate limiting enzymes 
are labelled in red. 
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It is well established that DXS plays a role in regulation of the MEP pathway [43]. In addition 
to this, experimental evidence suggests that DXR and HDR are also rate-limiting in this 
pathway but their regulatory role appears to vary among plants and in different conditions 
[43]. Both MVA and MEP pathway are involved in artemisinin production [44] but the MVA 
pathway is the main contributor [41]. 
Farnesyl diphosphate synthase (FDS) catalyzes the condensation of two units of IPP and one 
of DMAPP to form farnesyl diphosphate, the precursor for all sesquiterpenoid molecules such 
as artemisinin [45]. The artemisinin biosynthesis pathway will be reviewed in the next 
paragraphs. 
3 Artemisinin production 
3.1 Trichomes and localization of artemisinin biosynthesis 
The first important breakthrough to unravel the biosynthetic pathway of artemisinin was the 
discovery that the biosynthesis is localized in the glandular trichomes [46]. Trichomes, named 
after the Greek word for hair, are small outgrowths of epidermal origin on the surfaces of 
leaves and other organs of many plants. As illustrated in Figure 9, they range in size, shape 
and number of cells. Well known are the long trichomes that cover the seeds of cotton plants 
(Figure 9 B) and that are used in the textile industry. Other trichomes on leave surfaces 
release the characteristic smell from basil, mint or thyme.  
Based on secretory capacity, trichomes are grouped in two categories: non-glandular and 
glandular [47]. Both types as shown in Figure 9 C are present on leaves, stems and 
inflorescences of A. annua. Non-glandular trichomes from A. annua count five cells in a T-
shape. The T-top is formed by an elongated cell [48]. Filamentous or non-glandular trichomes 
are assumed to form a physical barrier by steric hindrance of herbivores [49]. In numerous 
plant species, a negative correlation is observed between trichome density, insect feeding and 
oviposition [49, 50]. Furthermore, leaf hairs can serve as a reflector to decrease the light 
absorbed by leaves and reduce the heat load [51, 52], or impact water retention [53]. Non-
glandular trichomes are mainly described for taxonomic and phylogenetic purposes [54-58] 
but little is known about their production of secondary metabolites [59].  
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Figure 9: Morphological diversity of plant trichomes. 
Pictures illustrate the diversity of plant trichomes in and amongst species. A: short gleaming 
glandular trichomes and long filamentous trichomes on flower pedicel of Solanum 
lycopersicum (Tomato), B: long white trichomes on the seeds of cotton, C: peltate glandular 
and T-shaped filamentous trichomes on the surface of A. annua (scale bar not available but 
glandular trichomes are approximately 37µm in size) D: long glandular trichome from 
Medicago sativa (Alfalfa), E: non-glandular trichome from Arabidopsis (Mouse-ear cress), F: 
procumbent trichome in Medicago truncatula (barrelclover), G: glandular trichome from 
Humulus lupulus (Hop), H: glandular trichomes on a female bract of Cannabis sativa 
(Marijuana), I: non-glandular trichomes on Medicago truncatula, J: glandular trichomes on 
Solanum lycopersicum (C-J: SEM pictures; D-J: scale bar = 100 µm). 
(A: http://digitalbotanicgarden.blogspot.be/2011_12_01_archive.html, B: http://www.biologie.uni-
hamburg.de/b-online/library/webb/BOT311/BOT311-00/anthophyta_significant_life_cycl.htm, C: 
http://www.biorenewables.org/about-us/feedstock-developmentunit/microsoft-powerpoint-photos-for-phil-ian-
compatibility-mode/, D-J: [60]) 
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This is in contrast with glandular trichomes which are well characterized as production sites 
for a variety of secondary metabolites. These metabolites form a first-line defence at the 
surface of the plant through their capacity to entrap, deter or poison pathogens and herbivores 
[61]. Besides this, they can attract pollinators or avoid water loss [60]. Several compounds 
produced by glandular trichomes are commercially interesting for example menthol [62], 
cannabinoids [63, 64] and essential hop oils used in beer brewing [65].  
Glandular trichomes from A. annua have a peltate morphology (shield shape) with 5 cell pairs 
arranged in two rows (biseriate): stalk cells, basal cells and 3 pairs of secretory cells (Figure 
10). Secretory cells are bordered by a cuticula which separates from the cell walls and forms a 
sub-cuticular sac. In mature glandular trichomes, the cuticula splits and releases its content 
[66]. The sub-cuticular space is probably a storage compartment for phytotoxic secondary 
metabolites to avoid cell exposure to high levels of autoallelopathic compounds.  
 
Figure 10: Morphology of a glandular trichome from A. annua. 
Light microscopy picture of a glandular trichome from A. annua with on top a pair of white 
apical cells and two pairs of green sub-apical cells surrounded by a sub-cuticular cavity (cells 
at the basis of the trichome are partially removed). 
As artemisinin is toxic to A. annua itself [67], this compound might be produced in the 
secretory cells and stored in the sub-cuticular space of glandular trichomes. This hypothesis 
was tested with a biotype of A. annua with only filamentous trichomes that arose 
spontaneously among field-cultivated plants. Duke et al., compared this biotype to a normal 
biotype with both filamentous and glandular trichomes. Only in the presence of glandular 
trichomes, artemisinin was detected [46]. In addition to this, a 5-s dip in chloroform causes 
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collapse of the sub-cuticular sac from glandular trichomes and extracted 97% of the 
artemisinin from leaf tissue [46]. These results indicate that artemisinin is produced in 
glandular trichomes. In the next sections, the biosynthesis of artemisinin is discussed. 
 
Figure 11: Leaf surface of A. annua. 
Cryo-SEM of Artemisia annua leaf surface adapted from Duke et al. [46], glandular 
trichomes are marked as GT, filamentous trichomes as FT. A: Leaf surface of glanded biotype 
(scale bar = 100 µm); B: Leaf surface of glandless biotype (scale bar = 100 µm); C: Glandular 
trichome (scale bar = 10 µm); D: Glandular trichome after 5-s dip in chloroform (scale bar = 
10 µm). 
3.2 Known artemisinin biosynthesis enzymes 
Step by step, the biosynthesis pathway of artemisinin is elucidated (Figure 12). The first step 
is the cyclization of farnesyl diphosphate to amorpha-4,11-diene. Amorpha-4,11-diene 
synthase (ADS), the enzyme responsible for this conversion was characterized by 
Bouwmeester et al. [68].  
Other breakthroughs in unravelling the artemisinin biosynthesis, were the result of an 
expressed sequence tag (EST) approach [69]. Three EST libraries were constructed: glandular 
trichome, flower bud and glandular trichome-minus-flower-bud subtracted library. Genes 
were identified that are preferentially expressed in glandular trichomes. As was suggested that 
in the following step(s) of the artemisinin biosynthesis an enzyme of the cytochrome P450 
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family is involved [68, 70], ESTs corresponding to cytochromes from this family were 
investigated. This lead to the characterization of CYP71AV1 as enzyme that converts 
amorpha-4,11-diene via alcohol and aldehyde intermediates to artemisinic acid [32, 69]. 
Additionally, CYP71AV1 is able to oxidize dihydroartemisinic alcohol to dihydroartemisinic 
aldehyde but the rate is 50% slower than for artemisinic alcohol [71]. This enzyme was also 
investigated for its ability to oxidize dihydroartemisinic aldehyde to dihydroartemisinic acid 
but no net activity was detected [71].  
 
Figure 12: Biosynthetic pathway of artemisinin. 
The biosynthesis of artemisinin is initialized by the formation of amorpha-4,11-diene which is 
subsequently converted to alcohol, aldehyde and acid forms. Double bound reduction leads to 
dihydroartemisinic forms. Dihydroartemisinic acid is proposed as precursor for artemisinin 
biosynthesis.  
In the EST libraries, a transcript highly expressed in glandular trichomes popped out as a 
candidate aldehyde dehydrogenase. This enzyme was named aldehyde dehydrogenase 1 
(ALDH1) and in vitro it was shown to oxidize the substrates artemisinic aldehyde and 
dihydroartemisinic aldehyde to their acid forms [71].  
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To convert artemisinic- to dihydroartemisinic-compounds, the double bond is reduced. In an 
effort to find the enzyme catalyzing this reaction, extracts of A. annua were investigated. With 
partial protein purification, mass spectrometry and EST analysis, Zhang et al. found an 
enzyme that has an artemisinic aldehyde Δ 11(13) double bond reductase activity [72]. The 
corresponding gene Dbr2 (double bond reductase 2) was found to be more expressed in 
glandular trichomes. Purified recombinant Dbr2 from Escherichia coli interacted with 
artemisinic aldehyde and formed dihydroartemisinic aldehyde. No double bond reductase 
activity was detected with arteannuin B, artemisinic acid or artemisinic alcohol [72].  
An enzyme was characterized that can reduce dihydroartemisinic aldehyde to 
dihydroartemisinic alcohol: RED1 [73]. This enzyme may have a negative impact on 
artemisinin production. Olofsson et al. reported however that RED1 does not appear to have a 
significant influence on artemisinin biosynthesis since it is only partially localized in the 
trichomes and has a relative low turnover potential [74]. 
An enzyme proposed to oxidize artemisinic alcohol to artemisinic aldehyde is ADH1. A 
patent is filed for this gene (United States Patent Application 20110162097) but no article is 
published yet.  
In yeast, an experiment was performed with co-expression of farnesyl diphosphate synthase, 
amorpha-4,11-diene synthase, CYP71AV1, cytochrome P450 reductase and DBR2. This 
strain was capable of synthesizing dihydroartemisinic acid [72]. It is noteworthy that 
dihydroartemisinic acid was accumulated even without co-expression of ALDH1.  
3.3 Artemisinin biosynthesis from dihydroartemisinic acid 
Dihydroartemisinic acid is proposed as precursor of artemisinin [75]. In vitro, 
dihydroartemisinic acid can autooxidize slowly and spontaneously to artemisinin and other 
products reported in A. annua [76]. This occurs in an organic solution (CHCl3). As illustrated 
in Figure 13, the reaction mechanism involves 4 steps: initial reaction with molecular oxygen 
to yield a tertiary allylic hydroperoxide, Hock cleavage, oxygenation of this product and 
cyclization to the 1,2,4-trioxane system of artemisinin. Conversion was facilitated in open 
vessels and no transformations were observed when solutions were kept in the dark [76].  
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Figure 13: In vitro autooxidation of dihydroartemisinic acid to artemisinin [76]. 
Reaction mechanism for the autooxidation of dihydroartemisinic acid (2) to artemisinin (1) in 
an organic CHCl3 solution. Intermediates are tertiary allylic hydroperoxide (3), enolic 
intermediate (4) and vicinal hydroperoxyl-aldehyde (5). 
To investigate whether dihydroartemisinic acid is in vivo also converted to artemisinin, 
labelled dihydroartemisinic acid has been fed via the root to intact A. annua plants [75]. This 
approach was chosen since preparation of cell-free extracts causes exposure to the atmosphere 
and can lead to artificial spontaneous oxygenations. As plants incised just above the root 
showed a similar distribution of dihydroartemisinic acid, the root is not a physiological barrier 
for dihydroartemisinic acid uptake [75]. 
In A. annua, close parallels were observed with the spontaneous in vitro autoxidation of 
dihydroartemisinic acid to artemisinin as e.g. labelled allylic hydroperoxide intermediates 
were detected. In spite of this, spontaneous autooxidations of dihydroartemisinic acid in 
organic solutions were completed only after several weeks whereas this takes just a few days 
in A. annua [75]. A possible explanation for this is that due to the presence of photosensitizers 
(under the form of pigments), the relative abundance of singlet oxygen (
1
O2) is high [75]. 
Singlet oxygen is generally considered to be the reactive species in autooxidation [75]. 
For the 16 metabolites with an incorporated label, the proportion was estimated in which 
labels were included. This was 70% with exception for the metabolites artemisinin and 
arteannuin H. From these compounds, only 5-15% incorporated a label [75].  
In vitro, no spontaneous oxidation of dihydroartemisinic acid to artemisinin was observed in 
aqueous medium, therefore Brown and Sy proposed that this reaction occurs only in a 
predominant lipophilic environment such as glandular trichomes [75]. In lipophilic solutions, 
hydroperoxide intermediates were more stable [75]. These lipophilic compartments were 
probably the last to be accessed after root feeding and this might explain the relatively low 
label incorporation. This raised the question whether the 14 other metabolites with 70% label 
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incorporation were synthesized in the more accessible aqueous compartments. In aqueous 
solutions, dihydroartemisinic acid was mainly converted to seco-cadinane or dihydro-epi-
deoxyarteannuin B [75]. In vivo, approximately 70% of these products incorporated a label 
during the feeding experiment. For the other metabolites, more detailed studies are needed to 
see if they are products of spontaneous autooxidations in an aqueous environment [75]. 
The main argument of the authors against enzyme involvement was a feeding experiment with 
live plants and plants that were dried. They assume that if only 30% of the initial plant weight 
was present, the intracellular environment was sufficiently dehydrated to inhibit enzymatic 
processes. Labelled artemisinin levels were too low to compare the live and dead groups but 
in both groups, a similar isotope concentration of tertiary allylic hydroperoxide was detected 
[75]. As this is an intermediate of the in vitro chemical conversion (see compound 3 in Figure 
13) to artemisinin, this indicated also a chemical conversion from dihydroartemisinic acid to 
artemisinin in vivo. However, this did not prove that chemical conversion in vivo is the only 
or major pathway that leads to artemisinin. Since only 5-15% of labelled artemisinin was 
detected, it is possible that the conversions described in this article represent a minor 
alternative pathway [75] but that the major conversion to artemisinin was catalyzed by 
enzymes which were difficultly reached by root feeding of labelled compounds. 
4 Increased artemisinin production 
4.1 Increased artemisinin production in A. annua 
The cultivation of A. annua is labour-intensive, plants are grown six months and harvested 
just before flowering [77] as plants in reproductive phase contain more artemisinin in 
comparison with vegetative plants which contain more dihydroartemisinic acid [78]. Dried 
leaves and inflorescences are extracted with organic solvents such as hexane and petroleum 
ether. Each hectare yields around 5 kg artemisinin from 1000 kg dry leaves [77]. The 
conversion to artemisinin-derivatives such as artesunate and artemether results in 
approximately 3 kg [77]. To have enough for 216 million adult artemisinin-based-
combination (ACT) treatments; 37,000 hectares of A. annua plantations are needed. In 2006, 
around 25,000 hectares of A. annua were grown or under construction [77]. 
To increase the production of artemisinin in Artemisia annua, high-producing cultivars were 
obtained by selection and breeding of high-yielding plants. Mediplant developed a cultivar 
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called “Artemis” containing up to 1.4% artemisinin (on dry weight of leaves) by crossing two 
clones with high artemisinin content [79]. In a field trial with this cultivar, approximately 
3000 kg of dried leaves were produced per hectare which yields 38 kg of artemisinin [79]. In 
the CNAP Artemisia Research Project, a huge breeding program was set up to produce new 
hybrids. Their starting material was the Artemis cultivar as well as several natural populations 
of A. annua. Additionally artificial variation was induced with ethylmethane sulfonate to find 
beneficial mutations. Genes and markers were identified for fast-track breeding and a 
quantitative trait loci map was composed [31]. Artemisinin production in A. annua plants can 
be augmented by increasing the total leaf biomass per hectare, by increasing the density of 
glandular trichomes and by producing more artemisinin in each glandular trichome.  
Another possibility to increase the production in A. annua is to use genetic modification to 
overexpress enzymes that limit artemisinin biosynthesis. Since HMGR limits artemisinin 
biosynthesis, Acquil et al. transformed A. annua plants with HMGR from Catharanthus 
roseus. These transgenic lines showed up to 22% increase in artemisinin content [40]. MVA 
and MEP pathways synthesize IPP and DMAPP units and these are converted by farnesyl 
diphosphate synthase (FDS) to farnesyl diphosphate. Chen et al. transformed A. annua plants 
with FDS of Gossypium arboreum and in these overexpressed plants, 2-3 times higher 
artemisinin levels were detected [80].  
Farnesyl diphosphate is not only the precursor for artemisinin synthesis but also for the 
biosynthesis of sterols and other sesquiterpenes such as germacrene A and β-caryophyllene 
[81]. Therefore, overexpression of ADS which guides farnesyl diphosphate to the artemisinin 
biosynthesis pathway resulted in approximately 2-fold elevated artemisinin levels [82].  
Yang et al. followed an alternative strategy by downregulating the competing sterol pathway 
[83]. Antisense squalene synthase was expressed in A. annua to suppress the expression of 
endogenous squalene synthase and this induced overexpression of ADS, CYP71AV1 and 
cytochrome P450 reductase [83]. Although downregulation of squalene synthase did not 
proportionally increase artemisinin content. Suppression of squalene synthase may narrow the 
route to squalene but does not certainly guide to extra artemisinin [83]. However, treatment of 
A. annua seedlings with the squalene synthase inhibitor miconazole did significantly increase 
artemisinin concentrations [84]. An RNA silencing method was used by Chen et al. to 
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downregulate expression of β-caryophyllene in A. annua and this resulted in 55% increase of 
artemisinin [81].  
4.2 Increase artemisinin production in heterologous organisms 
Total chemical synthesis of artemisinin is very complex and not cost-effective [30]. 
Therefore, artemisinin supply in A. annua plants is complemented by semi-synthetic 
production. Semi-synthetic is used as designation to indicate biologically produced precursors 
which are further chemically converted to the molecule of interest. Total biosynthesis of 
artemisinin in bacteria or yeast is still impracticable as the artemisinin biosynthesis pathway is 
not completely elucidated. With this semi-synthetic system, a more stable artemisinin supply 
is assured and more farmland is available for food production.  
First attempts were made in engineering Escherichia coli. E. coli contains the MEP pathway 
but lacks the MVA pathway to produce IPP. Strains were engineered to express the MVA 
pathway from yeast and additionally ADS [85]. This worked well but, it was very difficult to 
express membrane-bound cytochrome P450s such as CYP71AV1 due to the absence of an 
endoplasmic reticulum in E. coli [84, 86, 87].  
Saccharomyces cerevisiae has an endoplasmic reticulum and produced higher yields of 
artemisinic acid, therefore it became the preferred system for semi-synthetic production of 
artemisinin [32, 87]. In yeast, overexpression of the MVA rate-limiting enzyme (a truncated 
form) HMGR increased the production of amorpha-4,11-diene five-fold [32]. Additionally, 
amorpha-4,11-diene production was elevated two-fold by downregulating the competing 
squalene synthase. ADS, CYP71AV1 and cytochrome P450 oxidoreductase were expressed in 
yeast and the resulting yeast strain produced 4.5% compared to 1.9% artemisinic acid per dry 
weight in A. annua plants and this in only 4-5 days instead of 6 months [32]. Thereafter, 
artemisinic acid was chemically converted to artemisinin. A semi-synthetic production system 
for artemisinin was developed by Amyris and commercialized by Sanofi-Aventis. At their 
website, Sanofi announces their goal is to produce 40 tons of artemisinin in 2013. 
Lévesque and Seeberger developed a continuous flow system to convert dihydroartemisinic 
acid, derived from artemisinic acid to artemisinin [33]. Intermediates must not be isolated and 
purified prior to flow chemistry in thin tubes wrapped around a light source. Reaction steps 
were similar as in Figure 13. After initial reduction of artemisinic acid to dihydroartemisinic 
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acid, this compound was mixed with oxygen and tetraphenylporphyrin as photosensitizer into 
a tube and photooxidized to form a tertiary allylic hydroperoxide. Trifluroacetic acid is added 
which cleaves a carbon ring, this ring reacts with molecular oxygen and the molecule is 
further condensated to form artemisinin. Dihydroartemisinic acid was converted to 
artemisinin in 4.5 minutes with a yield of 39% [33]. 
Recently, Westfall et al. overexpressed in addition to HMGR, all other enzymes of the MVA 
pathway in yeast. This increased the production of artemisinic acid 2-fold. Despite this 
increase, artemisinic acid was 10-fold lower than amorpha-4,11-diene production [88]. 
Therefore, the authors developed a method for chemical conversion of amorpha-4,11-diene to 
dihydroartemisinic acid. However it would be advantageous to produce artemisinic acid in 
yeast in levels similar to amorpha-4,11-diene as the chemical conversion to artemisinin is 
easier [88]. For ACTs, artemisinin is converted to its derivatives artesunate, arteether or 
artemether. 
4.3 Aims and objectives 
Straightaway production of artemisinin in yeast would be enabled if enzymes are discovered 
which convert dihydroartemisinic acid to artemisinin. Therefore, the main aim of this PhD 
project was to search for candidate genes involved in the last step(s) of the artemisinin 
biosynthesis. The workflow of this PhD project is summarized in Figure 14. 
The quest was focussed on the transcriptome level of two types of trichomes on A. annua. 
With 2
nd
 generation sequencing, a comparison was made between glandular trichomes which 
produce artemisinin and filamentous trichomes which do not produce artemisinin. For the 
latter, little was known about their production of other secondary metabolites. Therefore, the 
comparison of glandular and filamentous trichomes provided both biologically relevant 
information on specific secondary metabolite production in filamentous trichomes (additional 
aim of this project) and genes upregulated in glandular trichomes and less expressed in 
filamentous trichomes which might have a function in artemisinin biosynthesis. Another 
approach to find candidate genes for artemisinin biosynthesis was to elicitate A. annua plants 
with jasmonic acid since jasmonic acid treatment was shown to increase artemisinin 
production [89]. Glandular trichomes from plants treated with and without jasmonic acid were 
compared and candidate genes should have been upregulated after jasmonic acid treatment. 
Results of these experiments are reported in Part III Chapter I.  
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Figure 14: Workflow of this PhD project. 
In Part III, Chapter 1: glandular and filamentous trichomes were collected and analyzed at the 
transcript level. In Part III, Chapter 2: apical and sub-apical cells from glandular trichomes 
were collected and analyzed at the transcriptome and metabolite level. Steps marked with * 
were optimized in Part II Chapters 2 and 3. 
The last experiment designed to find candidate genes, was based on an article from Olsson et 
al. [90] which claimed that artemisinin production is specifically localized in the apical 
secretory cells from glandular trichomes. Therefore, two types of secretory cells: apical and 
sub-apical cells, from the glandular trichomes were compared to discover new candidates. 
These results are discussed in Part III Chapter II.  
In Part II Chapter II and III, technical optimizations were made to find the best experimental 
setup to collect and prepare transcriptome material for 2
nd
 generation sequencing. 
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To enhance the artemisinin supply, it would be beneficial if direct production of artemisinin in 
yeast is enabled. Due to gaps in our knowledge of the biosynthesis pathway, this was not yet 
possible. Therefore, the aim of this project was to discover new candidate genes which can 
close this gap. This research project was mainly focussed on trichomes from A. annua. As it 
was known that plants with both glandular and filamentous trichomes contain artemisinin and 
plants with only filamentous trichomes do not, it is clear that artemisinin biosynthesis takes 
place in glandular trichomes. Therefore, a comparison of filamentous and glandular trichomes 
can generate a list of candidates. As proteome analysis on small samples such as trichomes is 
difficult, the decision was made to work on the transcriptome level. New 2
nd
 generation high-
throughput sequencing platforms offer the opportunity to perform whole transcriptome 
analysis. In Chapter I, the basis of these sequencing technologies will be explained and an 
overview is given of several commercial platforms. As the Illumina HiSeq2000 was used in 
this project, most attention will be given to discuss the workflow of this system. To obtain 
good results with 2
nd
 generation sequencing, the quality of the input RNA material is 
important. Procedures to collect good quality RNA were optimized as reported in Chapter II. 
In Chapter III, it was investigated whether the commercial Illumina protocol introduces bias if 
barcodes were used for multiplexing several samples. 
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With 2nd generation sequencing, also called next generation sequencing, millions of DNA or 
RNA fragments can be sequenced in parallel. This enables for example the comparison of the 
whole transcriptome in glandular and filamentous trichomes to find candidate genes for 
artemisinin production. At the genome level, it also facilitates for example genetic association 
studies to link genomic regions of A. annua cultivars with traits such as biomass production, 
density of trichomes and artemisinin production in each trichome [2]. In 2005, 454 
sequencing (Roche Applied Science, Basel, Switzerland) was the first 2
nd
 generation 
sequencing technology that became commercially available [3], followed by other platforms: 
Illumina or Solexa (Illumina, San Diego, California, USA), SOLiD and Ion Torrent (Life 
Technologies, Paisly, UK).  
 
Figure 1: Clonal amplification for second generation sequencing [4].  
A: Emulsion PCR in 454, SOLiD and Ion Torrent platforms. B: Bridge PCR in Illumina 
platform. 
Although the sequencing biochemistry of these platforms is quite diverse, they are based on a 
similar concept. Depending on the platform, the maximum read length is between 100 and 
1000 nucleotides and to obtain fragments with appropriate lengths, the starting material is 
randomly fragmented. To overcome detection problems during sequencing of single 
molecules, fragments are clonally amplified in vitro by bridge PCR or emulsion PCR as 
shown in Figure 1. In the case of bridge amplification, adaptors are ligated to the DNA 
fragments which bind to spatially isolated oligonucleotides attached on a flow cell. Around 
each DNA sequence, a cluster is formed with clonally amplified fragments (see Figure 1). 
Library preparation by bridge amplification is explained on page 51. This technology is 
adopted in the Illumina platform. In 454 sequencing, SOLiD and Ion Torrent, emulsion PCR 
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is performed. Adaptors are ligated to the DNA fragments. Within an oil phase, adaptors of 
each DNA molecule bind to a bead in an aqueous droplet (see Figure 1). Ideally, each droplet 
contains exactly one bead and only one DNA molecule. This aqueous droplet forms a mini-
reactor and isolates the clonally amplified fragments. For sequencing, each clonal-group is 
spatially isolated on a plate (SOLiD) or in wells (454 and Ion Torrent) which enables 
sequencing in parallel. In SOLiD, fragments are sequenced by ligation whereas in the other 
platforms they are sequenced by synthesis. In the next paragraph, the sequencing 
biochemistry of these 2
nd
 generation sequencing technologies is explained and advantages or 
disadvantages of the systems are given. 
1 Comparison of sequencing platforms 
The sequencing technology used in the 454 systems is called pyrosequencing. The basic 
principle is illustrated in Figure 2. All four types of nucleotides are sequentially added and 
incorporation of a complementary nucleotide releases pyrophosphate. In the presence of ATP 
sulfurylase, pyrophosphate reacts with adenosine 5’ phosphosulfate (APS) and ATP is formed 
[5]. The amount of ATP correlates with the number of incorporated nucleotides. Luciferase 
converts ATP and luciferin to oxy luciferin and visible light is generated. Apyrase degrades 
unincorporated nucleotides and subsequently another nucleotide is added [5]. Instead of 
dATP, dATPαS is used because this is not recognised by luciferase [5]. The main advantages 
of 454 sequencing is the long read length up to 1000 bp with the GS FLX Titanium XL+ 
system (http://454.com/products/gs-flx-system/index.asp). Its speed is an additional advantage 
since it takes only 10 hours to complete the sequencing itself [3]. Another advantage is that 
library construction can be automated and emulsion PCR semi-automated which reduces 
manpower costs but on the other hand reagents are costly: $12.56 per million bases [3]. 
However, an important disadvantage is that sequencing of homopolymers longer than 6 bp 
results in high error rates as it becomes very difficult to distinguish the light emitted by 
incorporation of e.g. 7 or 8 nucleotides [3]. 
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Figure 2: Pyrosequencing chemistry in 454 sequencing. 
Incorporation of a nucleotide generates the formation of oxy luciferin and light. 
(http://454.com/products/technology.asp) 
Illumina sequencing is like 454 sequencing based on sequencing-by-synthesis but instead of 
pyroluminescence, it uses fluorescence. Each nucleotide is modified with a reversible chain 
terminator and labelled with a distinct fluorescent dye. Because of this, all 4 nucleotides can 
be added at once. After incorporation of 1 nucleotide in each strand, the fluorescent dye and 
chain terminator group are removed and the following nucleotide can be incorporated. In 
comparison with the older Illumina GA series, HiSeq2000 (available since 2010) gives 2- to 
5-fold more data output. The enhanced output is reached by imaging the top and bottom 
surface of the flow cell. Speed is increased in the new system by simultaneous detection of 
four bases by using 4 cameras instead of one and imaging by line scanning mode instead of 
area imaging [6]. Run time is between 3 and 10 days, depending on the read length required 
and single and or paired-end option chosen. In comparison with 454 sequencing, SOLiD and 
Ion Torrent PGM, Illumina HiSeq2000 generates the largest data output (600 Gb/run) at the 
cheapest reagent cost: $ 0.02 per million bases [3]. Bias observed in Illumina systems are 
increased coverage of regions with < 47% GC and most frequently A to C conversions [6]. 
Illumina is most prone to errors after GC-rich motifs or long homopolymers > 20 bases but 
total error rates (< 0.4%) are lower than in Ion Torrent and PacBio [7]. For our transcriptome 
analysis, Illumina HiSeq2000 sequencing was used. The procedure for Illumina sequencing 
will be explained in more detail in paragraph 2 Illumina sequencing. 
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Figure 3: SOLiD sequencing [8]. 
Figure showing the colour-space coding from the first two nucleotides from the octamers. 
From A-D: starting from primer n, the first ligation cycle is finished; E: primer n-1 starts the 
second sequencing cycle out of 5. 
SOLiD is the abbreviation for Sequencing by Oligo Ligation Detection [3]. The sequencing 
reaction by this system is complicated but the generated data is very accurate as the sequence 
of each nucleotide is deduced from two hybridizations. The principle of this technique is 
shown in Figure 3. At first, a primer (n) is annealed to the complementary template. In the 
next step, octamers are added with four fluorescent labels. Each fluorescent label is a colour-
code for the combination of the first 2 nucleotides in its octamer. As shown in the colour-
spacing code in Figure 3, the red label incorporated after the primer displays the possible 
combinations: AT, CG, GC or TA and codes for 4 out of 16 possible di-nucleotide 
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combinations. Nucleotides 3 to 8 of the octamer are not specific. After ligation, the octamer is 
cleaved between nucleotide 5 and 6 and the tail is removed. Subsequently another octamer is 
ligated to determine nucleotide 6 and 7 of the template and so on. At the end of this ligation 
cycle, no information is available from the in between sequences and the exact sequence of 
nucleotides 1 and 2 can still be one out of 4 possibilities as mentioned above (AT, CG, GC or 
TA). In order to attain this information, the ligation cycle is shifted by primer (n-1), one 
nucleotide away from the site where the first primer (n) annealed as shown in Figure 3 E. 
Adenosine hybridizes with the 3’ end from the adaptor and the blue label shows that the next 
nucleotide is also adenosine. Therefore, the combination with the red label in Figure 3 A was 
AT. Each fragment is sequenced in five cycles, starting from primer n until primer n-4. 
SOLiD 5500xl has read lengths of only 85 bp which is its major shortcoming [3]. 
Ion Torrent PGM (Personal Genome Machine) was launched at the end of 2010 and is based 
on sequencing by synthesis and detection with semi-conductor technology [3]. An advantage 
of this technology is that no modified nucleotides (e.g. fluorescently labelled) nor expensive 
imaging technologies are needed [9]. During sequencing, the four nucleotides are sequentially 
introduced and if they are incorporated by DNA polymerase, hydrogen ions are released. 
Proportional to the number of nucleotides added, these hydrogen ions produce a shift in pH. 
Instead of scanning the whole chip, the semi-conductor detects protons directly and this 
speeds up the sequencing to a run time of 2 hours [9]. The read length is 200 bp [7]. A 
limitation of the system is the unreliable detection of the number of bases in homopolymers 
longer than 8 nucleotides [7]. IonTorrent PGM gives a low coverage in AT-rich regions and 
this bias is probably induced during amplification [7]. In the beginning of 2012, the Ion 
Proton sequencer (Life Technologies) was released. This system is based on the same 
principles but with a higher throughput (up to 10 Gb) than the Ion Torrent PGM (up to 1 Gb). 
The 2
nd
 generation sequencing platforms are based on clonal amplification of fragments since 
more fragments facilitate the detection of the sequencing signal. Despite this advantage, PCR 
amplification may introduce base sequencing errors or favour certain sequences over others, 
changing the relative abundance of DNA fragments [10]. This problem could be overcome by 
the introduction of very sensitive detectors enabling the sequencing of single DNA molecules. 
Sequencing of single DNA molecules is called 3
rd
 generation sequencing.  
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In April 2011, a commercial 3
rd
 generation sequencing system was released by Pacific 
Biosciences (Menlo Park, California, USA). PacBio RS enables single molecule real time 
sequencing (SMRT). This technology is based on two key inventions: zero-mode waveguides 
and nucleotides with a different phospho-linked fluorescent dye. The sequencing is executed 
in zero-mode waveguides, small nanophotonic visualisation chambers with a detection 
volume of 20x10
-21
 litres as shown in Figure 4 A [11]. In each chamber, a DNA polymerase 
with DNA strand are attached to the bottom. Nucleotides are diffusing in and out the detection 
chamber and during incorporation by DNA polymerase, the phosphate bond is cleaved and 
the fluorophore is held in place for tens of milliseconds (see Figure 4 B). This is much longer 
than the diffusion time of the non-incorporated nucleotides [11]. After fluorophore release, it 
rapidly diffuses out of the chamber and another nucleotide is incorporated. In this way, wash 
steps between the incorporation of each nucleotide are skipped which reduces the reagent 
costs and speeds up the process. Run times are approximately 2 hours [7]. PacBio has 
significantly higher (13%) error rates than Illumina (0.4%) and IonTorrent (1.78%) but errors 
were distributed evenly over the chromosome [7]. Another disadvantage for some 
applications is that PacBio needs input amounts of approximately 1 µg whereas 100 ng is 
enough for the other systems [7]. PacBio can be beneficial in de novo sequencing as the read 
lengths are substantially longer (1500 bp) and detection of alternative splicing can be 
facilitated [7]. The PacBio platform gives almost even coverage on GC and AT-rich regions 
[7].  
 
Figure 4: PacBio sequencing system [11]. 
Schematic representation of the PacBio sequencing system, A: nanophotonic visualisation 
chamber with DNA and DNA polymerase bound to the bottom, B: Incorporation of 
fluorescently labelled nucleotides gives a pulse of light. 
Oxford Nanopore Technologies intended to release new 3
rd
 generation sequencing platforms 
at the end of 2012: GridION and MinION. The MinION is a disposable sequencing device 
with the size of an USB memory stick and an expected price of less than $900. GridIOn is a 
Chapter I: Introduction to 2nd generation sequencing Part II 
 
51 
 
high-throughput device with an output in the order of 10 Gb in 24 hours. More up-to date 
information can be found on: http://www.nanoporetech.com/news/. 
2 Illumina sequencing 
The Illumina system was used during this PhD project and will therefore be explained in more 
detail. The workflow comprises 3 steps: library preparation (Figure 5), cluster generation 
(Figure 6) and sequencing (Figure 7). To prepare the library, the ends of fragmented DNA are 
made blunt as shown in Figure 5. The 5’ end is phosphorylated and the 3’ end adenylated to 
enable the ligation of adaptors with a T-overhang. To both ends of the DNA fragment, a 
forked adaptor is ligated.  
 
Figure 5: Illumina library preparation.  
The ends of fragmented DNA are made blunt, 5’ ends are phosphorylated and 3’ ends 
adenylated. Forked adapters with a thymine-overhang are ligated and fragments with adapters 
at both ends are enriched by PCR amplification. 
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As illustrated in Figure 5, this adaptor structure ensures exponential amplification of 
fragments with an adaptor ligated to both ends since fragments without adaptors ligated or 
with one adaptor are not exponentially amplified. Adaptors and PCR primers incorporate 
sequences with 2 specific functions: enable hybridization to oligonucleotides on the flow cell 
and binding of the sequencing primer. It is possible to pool several samples in one flow cell. 
To do this, a specific sequence is added as barcode. In the Illumina library preparation 
protocols, this barcode is added just before or during PCR amplification. Adding an extra 
sequence during PCR amplification might create amplification bias. To investigate the 
influence of this, a new post amplification ligation-mediated barcoding protocol was 
developed and tested [12] and this will be discussed in Chapter III. 
 
Figure 6: Cluster generation for Illumina sequencing.  
Hybridization of template fragments to adapters attached to the flow cell, bridge amplification 
and removal of reverse strands. Finally, 3’ ends are blocked and sequencing primers are 
annealed.  
(http://www.illumina.com/documents/products/datasheets/datasheet_cbot.pdf) 
The cluster generation for Illumina is fully automated on the cBOT machine. As shown in 
Figure 6 A and B, library fragments are denatured and hybridized to oligonucleotides attached 
to the flow cell. These oligonucleotides act as a primer to start the synthesis of a new 
molecule that is covalently bound to the flow cell. The original template is washed away after 
denaturation with formamide (Figure 6 D) and the new molecule flips over and hybridizes 
with adjacent primers to form a bridge (Figure 6 E). Subsequently a second strand is 
synthesized and this forms a double stranded bridge (Figure 6 F). After denaturation, two 
copies of covalently bound single stranded templates are present (Figure 6 G). These are 
further amplified by bridge formation (Figure 6 H). At the end of the amplification, reverse 
strands are cleaved and removed (Figure 6 I and J). This results in a big cluster with only 
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forward strands. After blocking the 3’ end, the sequencing primer is annealed and the flow 
cell is ready for sequencing (Figure 6 K). 
The fragments are sequenced with reversible-terminated dNTP’s labelled with different 
fluorescent dyes (see Figure 7). In each sequencing cycle all four dNTPs are presented to the 
flow cell but only one dNTP is incorporated per template. Fluorescent signals of each cluster 
are imaged and the terminator sequence with fluorescent dye is removed. 
 
Figure 7: Illumina sequencing with fluorescently labelled nucleotides. 
In each cycle, one dNTP with fluorescent label is incorporated in each cluster. Clusters are 
imaged and images from subsequent cycles are combined to determine the sequence of each 
fragment. 
(http://www.illumina.com/documents/products/brochures/brochure_genome_analyzer.pdf) 
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To find candidate genes involved in the biosynthesis of artemisinin, glandular trichomes 
which produce artemisinin were compared at the transcriptome level with filamentous 
trichomes that do not synthesize artemisinin. As there were indications in literature that 
artemisinin is only synthesized in the apical cells on top of the glandular trichomes and not in 
the sub-apical cells [13], these cells were also compared. To sequence the transcriptome, 
RNASeq was performed on Illumina HiSeq2000. 
To harvest the target sample-types as pure as possible and diminish the risk of contamination 
from other tissues, a microscope-guided collection technique was used. This technique is 
explained in Paragraph 1.1. Sample collection with laser capture microdissection is labour 
intensive and RNASeq is still an expensive technique which requires high quality input 
material. Because of this, attention was paid to optimize the collection and RNA extraction. 
As it was impossible to collect enough RNA with laser microdissection and laser pressure 
catapulting, an amplification step was introduced prior to RNASeq. An overview of these 
optimizations is given in this Chapter. Optimizations of the library preparation for RNASeq 
will be discussed in Chapter III. 
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1 Introduction and methods 
1.1 Laser capture microdissection 
For harvesting specific cells or tissues, a cutting laser is coupled with a microscope and a 
computer interface. The technique is called laser capture microdissection. Laser capture 
microdissection is a two-step process. In the first step named laser microdissection, the target 
is separated from surrounding tissues. For this, the laser is focused on the tissue, a trajectory is 
drawn with the computer (green in Figure 8 A) and the laser cuts while following this line 
(Figure 8 B). The second step is to collect the target sample as illustrated in Figure 8 (C-D) 
and for this, several technologies exist. 
 
Figure 8: Laser microdissection and laser pressure catapulting with P.A.L.M. 
MicroLaser technology.  
Pictures illustrating the operating procedure to collect tissue with laser microdissection and 
laser pressure catapulting, A: the area of interest is lined out, B: this trajectory is cut by laser 
microdissection, C: the target tissue is catapulted upwards by laser pressure catapulting, D: 
laser micro-dissected membrane catapulted out of liquid.  
(A-C: https://www.zeiss.com/C1256D18002CC306/0/D502284E9F21E27DC12574410058EBD0/$file/49-
0010_e.pdf, D: Image of Prof. A. Vogel, Lübeck, Germany 
https://www.zeiss.com/C1256D18002CC306/0/D502284E9F21E27DC12574410058EBD0/$file/49-0010_e.pdf) 
Two technologies are widely used: Arcturus (Life Technologies) and P.A.L.M. MicroLaser 
(Zeiss and P.A.L.M. Microlaser Technologies, München, Germany) as shown in Figure 9. 
The system of Arcturus places a cap with a thermoplastic film on the tissue sample and by IR-
activation, a specific region of the film is selected to form a bridge between the cap and tissue. 
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The film adheres to target cells and these 
cells are removed by lifting the cap 
(Figure 9 C-D). The P.A.L.M system 
isolates target cells by catapulting them 
with one laser pulse into the cap of a tube 
filled with fluid (Figure 9 G-H). The cap is 
positioned 1-3 mm above the slide. The 
catapulting strategy avoids sample contact 
and this is in contrast with the Arcturus 
system which uses adhesive films to tear 
away the target cells. Because of this, the 
Arcturus strategy is associated with a 
greater risk of contamination with non-
target material. The narrower focusing 
width of the UV-A laser used in P.A.L.M. 
(0.5 µm) enables more precise cutting 
than IR-lasers (7.5 µm) [14]. There were 
some concerns over the impact of UV-A 
light on nucleic acids but recent studies 
showed that this is not harming or changing nucleic acids and other cellular macromolecules 
[15]. Therefore, laser capture microdissection can be applied to prepare samples for genomics, 
transcriptomics, proteomics and metabolomics studies [16].  
Olsson et al. developed a protocol to use laser capture microdissection on glandular trichomes 
from A. annua [13] as shown in Figure 10. Instead of leaves, flower heads (Figure 11 C and 
D) were used since glandular trichomes protrude on the surface of floret buds (see Figure 11 
B) and are sunken in the leaves (see Figure 11 A). Plant material was fixated under vacuum in 
formaldehyde and flower heads were chopped with a razor blade on a glass slide with 
formaldehyde. Thereafter, the P.A.L.M. MicroLaser technology fitted with a Robo-Mover to 
position the collection tube was used in combination with a microscope from Zeiss. In Figure 
10, glandular trichomes were catapulted in the cap of a tube. For RNA extraction, cells were 
collected in 30µl of lysis buffer with β–mercaptoethanol from the Absolutely Nanoprep kit 
(Stratagene, La Jolla, CA, USA).  
Figure 9: Mechanism of tissue capture with 
Arcturus and P.A.L.M. [1]. 
Arcturus captures samples on a transfer film 
whereas P.A.L.M. catapults samples in fluid.  
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Figure 10: Glandular trichomes collected with P.A.L.M. 
Picture of glandular trichomes from A. annua captured by laser pressure catapulting in the cap 
of a 500 µl tube. 
 
Figure 11: Glandular and filamentous trichomes from Artemisia annua. 
Electron microscopy pictures of A. annua with glandular (GT) and filamentous (FT) 
trichomes. A: adaxial leaf surface with glandular trichomes sunken in the epidermis and 
filamentous trichomes; B: floret bud with protruding glandular trichomes; C: flower head 
(capitulum) with basal a lot of filamentous trichomes; D: floret buds in the involucrum of a 
flower head. 
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1.2 RNA extraction 
After the collection of laser captured samples in lysis buffer with β-mercaptoethanol, RNA 
was extracted. The Absolutely RNA Nanoprep kit was chosen as this kit is optimized to 
extract RNA from extremely small numbers of cells (1-10
4
 cells). Another advantage of this 
kit was that the big reaction volume in which the samples were collected, was easily reduced 
by pooling all the collection tubes on one filter. A DNase digestion was performed to remove 
DNA contamination and RNA was recovered in only 10µl.  
To perform laser capture microdissection and RNA extraction, some factors were tested to 
estimate their influence on the final RNA quality such as the influence of fixation, the period 
of time that collected cells were kept in lysis buffer during sampling, the compatibility of lysis 
buffer with plant material from A. annua and the temperature at which the RNA was 
extracted. The amount of laser captured cells was too low to determine the RNA quality. Due 
to this, RNA preparation was optimized with more plant material. If possible for optimizing 
the procedure, the RNeasy Plant Mini Kit (Qiagen, Hilden, Germany) was used since this kit 
was better suited for bigger amounts of input material (in the range of 50 mg). These results 
were extrapolated to the laser captured samples. 
Nanoprep and RNeasy RNA extraction kits are based on the same principles. To denature 
RNase enzymes, β-mercaptoethanol is added. The lysis buffer contains chaotropic salts which 
destabilize hydrogen bonds, Van der Waals forces and hydrophobic interactions. Also other 
proteins are denatured and the water shell from the negatively charged backbone of the 
nucleic acids is removed. This enables the binding of (ribo)-nucleic acids to a positively 
charged silica-filter [17, 18]. This binding can be improved with addition of ethanol [19] or 
sulfolane [20]. After washing, ribonucleic acids are eluted from the silica column with water 
or an elution buffer. 
1.3 RNA quality control 
The quality or integrity of RNA samples can be determined on a microfluidics-based 
electrophoresis system. Using such a sensitive system, it is easier to interpret the quality of the 
RNA than with normal gel electrophoresis. The two most frequently used systems are the 
Agilent bioanalyzer and the Experion system from Bio-Rad. In both systems, electrophoresis 
is performed on a chip with microchannels (Figure 12 A).  
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Figure 12: Experion electrophoresis. 
RNA quality determination with Experion, A: Experion RNA StdSens electrophoresis chip. 
B: electropherograms from RNA samples with their corresponding RQI score. X-axis: 
migration time in seconds, Y-axis: fluorescent intensity. 
(adapted from http://www.bio-rad.com/webroot/web/pdf/lsr/literature/Bulletin_5452B.pdf) 
The RNA quality is assessed by an algorithm that calculates a quality score: RNA integrity 
number (RIN) (Agilent) or RNA quality indicator (RQI) score (Bio-Rad). As illustrated in 
Figure 12 B, scores are between 10 (highly intact RNA) and 1 (highly degraded RNA). To 
calculate these scores, several electrophoretic regions are taken into account as well as 18S 
and 28S peaks. The 18S and 28S rRNA are cleavage products from a common transcription 
unit. That means that exactly the same numbers of 18S and 28S molecules are present in each 
cell. In intact RNA, the peak intensity of 28S/18S has a ratio of two since the 28S fragment is 
approximately twice as long as 18S. Twice as many bases will bind twice as many dye 
molecules and this will lead to an increased signal detected during electrophoresis. For 
samples with a good quality, the RQI score is based on the ratio of 28S/18S whereas for 
samples with a quality that is less good, preferably the 18S and pre-18S regions are used. 
Instead of 28S, this ribosomal subunit is called 25S in plants. Each sample is loaded with a 
lower alignment marker as indicated in Figure 12 B. According to the Experion manual, at 
least 100 pg/µl of Total RNA is needed for quality determination with the Experion HighSens 
kit but preliminary tests in this project were not able to detect RNA from 150 laser captured 
glandular trichomes with Experion. Therefore, tests for optimizing the RNA quality were up-
scaled with more material. 
1.4 RNA amplification 
For sequencing with Illumina, at least 0.1 µg of total RNA is needed as input (Illumina 
TruSeq RNA Sample Preparation Guide). Since it was technically impossible to collect that 
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amount of RNA from laser captured trichome samples and apical as well as sub-apical cells, 
RNA was amplified. For amplification of RNA, several commercial kits are available and the 
choice was made to use a linear amplification kit since sequence-dependent bias and length-
dependent bias may be amplified exponentially in the other kits [21]. Furthermore, highly 
variable amplification of low abundant transcripts might occur [21]. Another factor taken into 
consideration for selecting an amplification kit was the type of primers applied for 
amplification. Most kits use only oligo dT primers that bind on the 3’ polyA tail of mRNA 
transcripts. The Ovation RNA-Seq system (NuGen, AC Bemmel, The Netherlands) uses oligo 
dT-based primers and random primers. With the use of random primers, it remains possible to 
sequence the 5’ end if RNA shows signs of degradation. Because of the random primers and 
the linear amplification, the Ovation RNA-Seq system was chosen to amplify RNA from the 
laser captured trichome samples. A schematic overview of the Ovation RNASeq amplification 
protocol is given in Figure 13. 
Input amounts of total RNA are preferably in the range of 500 pg to 100 ng and serve as 
template for first strand cDNA synthesis. For cDNA synthesis, chimeric primers are used. 
These primers have a DNA part which is an oligo dT or a random hexamer and an additional 
RNA fraction which does not hybridize across the transcripts but introduces a unique RNA 
sequence at the 5’ end of the cDNA. 
Within the cDNA/mRNA complex, fragmentation of the mRNA transcript occurs. This 
creates priming sites for DNA polymerase to synthesize a second strand DNA molecule. The 
newly synthesized strand contains an additional part complementary to the RNA sequence of 
the chimeric primers which creates a unique DNA/RNA heteroduplex at one end. This 
heteroduplex plays a key role during amplification. 
RNaseH cleaves RNA in the DNA/RNA heteroduplex and makes the DNA part of the 
heteroduplex accessible for annealing a SPIA primer with RNA portion and replication is 
initiated by DNA polymerase. This forms the basis for single primer isothermal amplification 
(SPIA). The RNA sequence included in the newly synthesized strand is cleaved by RNaseH, 
another SPIA primer can bind and DNA polymerase can synthesize a new strand. With 500 
pg total RNA starting material, an average amplification of 800-fold is observed. The 
amplification process is completed with a post-SPIA modification. In this step, the amplified 
Chapter II:  Optimizations for RNA preparation Part II 
 
65 
 
SPIA product is converted to double stranded cDNA appropriate for Illumina library 
preparation.  
 
Figure 13: Ovation RNASeq amplification protocol (Nugen). 
Starting from template RNA, cDNA is synthesized which contains an RNA/DNA 
heteroduplex. RNAseH cleaves the RNA portion and single primer isothermal amplification is 
performed. After amplification, SPIA product is converted to ds cDNA. 
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2 Optimization results and discussion 
2.1 RNA quality 
2.1.1 Optimization of sample preparation for laser capture microdissection 
Olsson et al. developed a protocol with formaldehyde fixation of the plant material for laser 
capture microdissection (see page 61) [13]. To test the influence of formaldehyde fixation on 
the RNA quality, 70 mg of plant material was fixated on ice for 3 to 4 hours under vacuum 
with a 4% formaldehyde phosphate buffered saline solution. Another 70 mg of plant material 
was not fixated. RNA from both samples was extracted with the RNeasy Plant Mini Kit with 
RLT lysis buffer. The quality from these samples was analysed on an Agilent Pico chip. In the 
electropherogram of the non-fixated sample (10-fold diluted), ribosomal peaks 5.8S, 18S and 
25S were clearly visible as well as additional peaks from the chloroplast rRNA. A RIN 
quality score of 8.7 was assigned whereas the fixated sample had a quality score of 2.5 and as 
shown in Figure 14, 18S and 25S were not detected in the undiluted fixated sample. 
 
Figure 14: RNA extraction from fixated and non-fixated plant material. 
Agilent traces showing the difference in quality of RNA extracted from A: fixated and B: 
non-fixated leaf material from A. annua. RNA from non-fixated material was 10-fold diluted. 
Scale on X-axis is length in nucleotides and Y-axis is expressed in fluorescent units. 
With formaldehyde fixation, RNA yield and quality was clearly deteriorated. The preparation 
procedure of tissues for laser microdissection balanced between morphological preservation 
and the recovery of molecules from the fixated tissue. Formaldehyde fixation cross-linked the 
cytoplasm and facilitated laser microdissection. This fixation made cells more rigid and 
during laser microdissection, cells were forced to separate as shown in Figure 15. Without 
fixation, cells were less robust and the risk of cutting through the cell walls increased. 
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Figure 15: Laser capture microdissection of fixated tissue from A. annua. 
Separation and isolation of apical cells from a glandular trichome from A. annua with 
P.A.L.M., A: laser microdissection diverges apical and sub-apical cells (arrow) of a 
formaldehyde fixated glandular trichome, B: apical and sub-apical cell are further separated 
(arrow) and C: apical cell is removed by laser pressure catapulting and the isolation of the 2
nd
 
apical cell is started (arrow). 
The adverse effect of formaldehyde fixation on RNA quality was later also reported by 
Olofsson et al. [22]. They overcame this problem by using the following protocol: on a RNA 
free microscope slide, a closed flower head was cut in a drop of cold buffer with 25 mM 
MOPSO (pH6.3) (Sigma-Aldrich, Steinheim, Germany), 200 mM sorbitol (Alfa Aesar, 
Karlsruhe, Germany), 10 mM sucrose (Acros, Geel, Belgium), 5 mM thiourea (Sigma-
Aldrich), 2 mM DTT (Fluka, Sigma-Aldrich), 5 mM MgCl2 (Sigma-Aldrich) and 0.5 mM 
sodium-phosphate (Acros) [22]. For capturing apical and sub-apical cells, both cell types must 
be separated very precisely as shown in Figure 15. With the unfixed protocol from Olofsson 
et al. [22], laser microdissection to separate apical and sub-apical cells was difficult to 
perform and leakage occurred. Therefore, one experiment for RNASeq was performed with 
and another without fixation to collect apical and sub-apical cells. 
To collect whole glandular and filamentous trichomes, fixation was less an issue. If trichomes 
were attached to a big piece of tissue, one laser shot was used to catapult a trichome. This was 
not the case if trichomes were attached to a small piece of tissue since the whole tissue would 
be catapulted upwards. In that case, trichomes were separated from the rest of the tissue by 
transecting the cells that connect the trichome to the floret or involucrum. Subsequently, one 
laser pulse catapulted the trichome into the collection cap. Therefore, fixation was not needed 
to collect glandular and filamentous trichomes. 
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2.1.2 Compatibility of Nanoprep lysis buffer with A. annua 
As described in the RNeasy Plant Mini Kit, some secondary metabolites in plant tissues can 
cause solidification of the sample, making extraction of RNA impossible. Therefore, the 
compatibility of the Nanoprep lysis buffer with plant material from A. annua was tested. Plant 
material (72 mg) of A. annua leaves was lysed in Nanoprep lysis buffer, homogenized on a 
QIAshredder column and further extracted with the RNeasy Plant Mini extraction kit. The 
extracted RNA had an RQI score of 9.9 and a 25S/18S ratio of 1.98 was automatically 
assigned. However it should be noted that this ratio was influenced by the genomic DNA 
present around the 25S peak but no visual degradation was observed (see Figure 16). 
Therefore, it was concluded that the lysis buffer of the Nanoprep kit is well suited for 
extraction of RNA from A. annua.  
 
Figure 16: RNA extracted from A. annua with lysis buffer of the Nanoprep extraction 
kit. 
Experion electropherogram from RNA extracted with Nanoprep lysis buffer. Ribosomal peaks 
are clearly visible. Y-axis: fluorescent intensity, scale of X-axis is migration time in seconds 
and other indications on X-axis are corrected peak areas. 
2.1.3 Optimization of RNA extraction temperature 
It was also tested at which temperature the RNA extraction with the Nanoprep kit is 
performed optimally since this information was not given in the manual. In a similar RNA 
extraction kit: RNeasy Plant Mini Kit, the manual recommends to work not colder than room 
temperature whereas working on ice is better to preserve RNA quality. Therefore, the 
Nanoprep kit was tested both at room temperature and on ice. For each test, two flower heads 
were crushed with a mortar in liquid nitrogen, homogenized on a QIAshredder column and 
the Nanoprep protocol was executed. For the test at room temperature, centrifuge was set at 
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20°C whereas for extraction on ice, centrifuge temperature was 4°C and samples were kept on 
ice during handling. Samples prepared on ice had a good RQI score of 8.6 whereas to RNA 
extracted at room temperature a moderate RQI score of 4.6 was assigned as shown in Table 1. 
Electrophoretic traces are shown in Figure 17. 
Figure 17: RNA extraction with the Nanoprep kit on ice and at room temperature. 
Experion electropherogram from RNA extracted with Nanoprep lysis buffer A: on ice and B: 
at room temperature. RNA extracted at room temperature was more degraded. Y-axis: 
fluorescent intensity, scale of X-axis is migration time in seconds and other indications on X-
axis are corrected peak areas. 
 
Table 1: The influence on RNA quality of samples extracted with the Nanoprep kit on 
ice and at room temperature. 
Experion result table in which RNA extracted on ice and room temperature were compared. 
The total RNA area and therefore also the RNA concentration in the electropherogram was 
slightly higher in the sample on ice. Ratios of rRNA were similar in both samples, Experion 
reports eukaryotic ribosomal ratios standard as 28S:18S but in plants the 28S is called 25S. 
RQI score is higher with extraction on ice. 
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2.1.4 Collection time for laser capture microdissection 
With laser capture microdissection, samples were catapulted directly in Nanoprep lysis buffer 
with β-mercaptoethanol at room temperature. It was more convenient to collect several 
trichomes in one collection tube. To simulate the influence of collecting samples in one cap 
for 2 hours, plant material from A. annua was directly extracted, incubated for 10 minutes or 
incubated for 2 hours in Nanoprep lysis buffer with β-mercaptoethanol at room temperature. 
Samples were subsequently extracted with the RNeasy Plant Mini Kit. In all tests, the RNA 
quality was good and no deterioration of RNA quality was observed after incubating the 
samples in lysis buffer with β-mercaptoethanol at room temperature for 2 hours (Figure 18).  
 
Figure 18: Incubation time in collection buffer and RNA quality. 
Agilent electropherograms of A: direct RNA extraction with RNeasy Plant Mini Kit (RIN 
score: 8), B: 10 minutes incubation in lysis buffer and β-mercaptoethanol at room temperature 
before RNA extraction (RIN score: 7.6) and C: 2 hours incubation in lysis buffer and β-
mercaptoethanol at room temperature before RNA extraction (RIN score: 7.8). Y-axis: 
fluorescent intensity, X-axis scale is migration time in seconds. 
2.2 RNA quantification from laser captured trichomes 
For the Ovation RNA-Seq amplification kit, it is best to have at least 500 pg RNA as input 
material. To estimate the yield from laser captured trichomes, glandular and filamentous 
trichomes were captured, extracted with the Nanoprep kit and the RNA amount was 
quantified with Quant-iT RiboGreen (Life Technologies).  
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To accelerate the collection of filamentous trichomes, not all stalk cells were included for 
each collected trichome. Extraction of 300 filamentous trichomes yielded approximately 600 
pg RNA in 10 µl. For the Ovation RNA-Seq amplification kit, only 5 µl can be used which 
means that 1 pg input for amplification was obtained for each filamentous trichome. 
Therefore, preferably more than 500 filamentous trichomes were collected.  
From glandular trichomes, 150 trichomes were captured with at least 6 intact secretory cells. 
This yielded approximately 2150 pg of RNA in 10 µl elution buffer, which was for 
amplification 1075 pg or around 7 pg of RNA per glandular trichome. This means that at least 
72 glandular trichomes had to be collected to obtain the recommended input amount of 500 
pg. 
Yields from glandular trichomes were extrapolated to estimate the number of apical and sub-
apical cells needed. The amount of cells collected from 150 glandular trichomes was 
approximately 1040. This gave a yield of around 2 pg for each collected cell and 1 pg input 
for amplification. To obtain 500 pg, at least 500 apical or sub-apical cells needed to be 
collected but collecting this amount of cells was very laborious. As the technical support from 
Nugen recommended to go not below 300 pg of input material, it was decided to collect at 
least 300 cells and to have a two independent collection experiments. 
3 Conclusions 
From these optimization experiments, the conclusion was drawn that preferably non-fixated 
material is used for laser capture microdissection. During laser capture microdissection, 
samples can be collected for 2 hours in the same collection tube. The Nanoprep RNA 
extraction kit is suited to extract RNA from plant material of A. annua but it is better to 
perform the extraction procedure on ice. At least 72 glandular trichomes were collected for 
amplification whereas from filamentous trichomes around 500 were collected to have enough 
RNA. From apical as well as sub-apical cells, at least 300 cells were collected. 
 

 73 
 
 
Chapter III Quantitative bias in Illumina TruSeq 
and a Novel Post Amplification Barcoding Strategy 
for Multiplexed DNA and Small RNA Deep 
Sequencing [12] 
 
 
Filip Van Nieuwerburgh1, Sandra Soetaert1, Katie 
Podshivalova2, Eileen Ay-Lin Wang2, Lana Schaffer3, 
Dieter Deforce1, Daniel R. Salomon2, Steven R. Head3, Phillip 
Ordoukhanian3 
1
 Laboratory of Pharmaceutical Biotechnology, Ghent University, Ghent, Belgium,  
2
 Department of Molecular and Experimental Medicine, The Scripps Research Institute, 
La Jolla, California, United States of America,  
3
 Next Generation Sequencing Core, The Scripps Research Institute, La Jolla, California, 
United States of America 
 

Chapter III: Novel Post Amplification Barcoding Strategy for 
Multiplexed Deep Sequencing 
Part II 
 
75 
 
With Ovation RNA-Seq amplification, RNA was converted to DNA for six sample-types 
collected with laser capture microdissection: glandular trichomes, glandular trichomes treated 
with the plant hormone jasmonic acid, filamentous trichomes, filamentous trichomes treated 
with jasmonic acid and apical as well as sub-apical cells from glandular trichomes. From each 
sample-type, 3 samples were sequenced. Sequencing these 18 samples in 3 lanes on an 
Illumina flow cell was enabled by tagging them with a unique barcode during the library 
preparation step.  
In the TruSeq DNA library preparation protocol (Illumina), the barcode is introduced before 
the PCR step. During PCR amplification, several types and causes of bias can occur such as 
lower amplification of AT-rich regions [23], less efficient amplification of longer fragments 
[24] and formation of heteroduplexes in the annealing step in samples with a diverse 
population of nucleic acids [25]. Because of this, it is worth to investigate if the introduction 
of a unique barcode before PCR can cause sequence-dependent bias as this might influence 
the differential expression analysis. 
A new barcoding protocol was developed which ligates barcodes after the PCR step, called 
Post Amplification Ligation Mediated (PALM) barcoding. Both PALM and TruSeq barcoding 
protocols were essayed on the same pool of reference DNA generated by converting 
Saccharomyces cerevisiae mRNA into double stranded DNA and results were compared. A 
similar PALM protocol was developed for miRNA. 
After optimization on reference DNA, the PALM barcoding strategy was used in Part III for 
library preparation of samples from A. annua. 
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1 Introduction 
Taking advantage of the increasing throughput achieved by second generation sequencing 
technologies, multiplexing several samples in one analysis can increase experimental 
throughput while reducing time and cost. 
Several strategies have been described for barcoding sequencing libraries [26-30]. Vigneault 
et al. [29] published a miRNA barcoding protocol using ligation of 3' pre-adenylated 
barcoded adapter oligonucleotides as the first step of sequencing library preparation. 
Buermans et al. [30] published a miRNA sequencing protocol, introducing a barcode during 
PCR. Illumina recently released the TruSeq kits for multiplexed high-throughput sequencing. 
The Illumina TruSeq small RNA protocol introduces the barcode during the PCR step using 
differentially barcoded primers, while the TruSeq DNA (or messenger RNA converted to 
double stranded DNA) protocol introduces the barcode before the PCR step by ligation of 
differentially barcoded double stranded adaptors. All published methods place the barcodes 
within the adapters, downstream or within the PCR primer binding site or introduce the 
barcode during PCR. However, it is well established that multi-template PCR amplification 
can result in a sequence-dependent amplification bias, as some DNA species are amplified 
more efficiently than others [23, 24, 31, 32]. For this reason, introducing barcodes near a 
priming site might result in a barcode-specific quantitative bias. To our knowledge, no 
previous publication has provided in-depth data measuring PCR amplification bias resulting 
from the use of barcodes. 
Our initial attempts to adapt previous barcoding strategies to multiplexed sequencing of small 
RNA used index sequences placed at the distal end of the 5' adapter in the Illumina small 
RNA library protocol. Despite a number of iterations of the design we consistently failed to 
avoid PCR amplification bias when identical samples with different barcodes were compared. 
Therefore, we designed a new strategy in which we ligate both the 3' and 5' adapters, perform 
the RT-PCR step and then ligate the barcode after the library PCR amplification, as the last 
step of the library preparation. We have called this strategy Post Amplification Ligation 
Mediated (PALM) barcoding. In the present study, we compared the de-multiplexed 
quantitative results of 12 differentially PALM barcoded miRNA samples, 12 TruSeq 
barcoded miRNA samples and 4 miRNA samples barcoded using our above-mentioned pre-
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PCR barcoding strategy from the Human Brain Reference RNA (Ambion). Each pool was 
sequenced in a single lane on an Illumina GAIIx. 
Parallel to PALM barcoding for small RNA, we also developed a PALM barcoding protocol 
for DNA samples or messenger RNA (mRNA) converted to double stranded DNA (dsDNA). 
The main difference compared to the PALM barcoding for small RNA, is the fact that double 
stranded adapters instead of single stranded adaptors need to be ligated before PCR. In the 
present study, we compared the de-multiplexed quantitative results of 12 differentially PALM 
barcoded DNA samples and 12 TruSeq barcoded DNA samples. Reference DNA was 
generated by converting Saccharomyces cerevisiae mRNA into double stranded DNA. Each 
pool was sequenced in a single lane on an Illumina HiSeq 2000. 
2 Methods 
2.1 PALM small RNA barcoding 
The PALM miRNA barcoding protocol is similar to the Illumina Small RNA v1.5 Sample 
Preparation Guide. This protocol was modified to achieve a higher yield after the PCR 
amplification step using higher reaction volumes for the RT-PCR step. No extra cycles were 
added to the PCR reaction. The adapters used in the protocol were modified to allow for 
PALM barcoding and Illumina index sequencing with the Illumina multiplexing index read 
sequencing primer. The complete protocol, including the adapter sequences, is available in 
section 5.3. Figure S1 shows a typical Invitrogen 4% E-gel of a Human Brain Reference RNA 
(Ambion) library after PCR amplification and before barcode ligation. Figure 19 shows the 
necessary oligonucleotide components for PALM and how they are consecutively added to 
the miRNA sample. The key difference with respect to the current Illumina small RNA library 
protocol is the addition of the barcode to the library by ligation after PCR amplification. After 
ligation of the barcode, no further purification of the library is required. The library is 
quantified using analysis of area under the peaks with a BioAnalyzer 2100 (Agilent) to 
determine the correct loading concentration for subsequent sequencing. 
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Figure 19: Comparative schematic of small RNA barcoding methods. 
The three methods start with ligation of a 3' and 5' RNA adapter to generate a substrate for 
RT-PCR. In the pre-PCR barcoding method, the barcode is incorporated in the 5' adapter. In 
the TruSeq method, the barcode is incorporated in one of the RT-PCR primers. In the PALM 
barcoding method, the amplified RT-PCR product is A-tailed and ligated to a T-tailed 
barcoded adapter. 
2.2 Pre-PCR barcoding of small RNA 
The pre-PCR miRNA barcoding protocol is also similar to the Illumina Small RNA v1.5. 
Sample Preparation Guide. The adapters used in the protocol were modified to include a 
barcode and to allow for Illumina index sequencing with the Illumina multiplexing index read 
sequencing primer. The complete protocol, including the adapter sequences, is available in 
section 5.3. 
2.3 Preparation of dsDNA from S. cerevisiae mRNA 
Starting with poly A+ enriched RNA from S. cerevisiae (Clontech 636312), dsDNA was 
prepared with the NEBNext mRNA Sample Prep Reagent Set 1 (New England Biolabs 
E6100). During this procedure, RNA was fragmented with a fragmentation buffer and 
subsequently purified with the Qiagen RNeasy Minelute kit. After second strand cDNA 
synthesis, the dsDNA was purified with a Zymo DNA Clean and concentrator-5. 
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2.4 PALM DNA barcoding 
The PALM DNA barcoding protocol is similar to the Illumina Genomic DNA Sample 
Preparation Guide. The adapters used in the protocol were modified to allow for PALM 
barcoding and Illumina index sequencing with the Illumina multiplexing index read 
sequencing primer. The complete protocol, including the adapter sequences, is available in 
section 5.3. The main difference compared to the current Illumina Genomic DNA library 
protocol is the addition of the barcode to the library by ligation after PCR amplification. After 
ligation of the barcode, no further purification of the library is required. The library is 
quantified using analysis of area under the peaks with a BioAnalyzer 2100 (Agilent) to 
determine the correct loading concentration for subsequent sequencing. 
2.5 miRNA sequencing and data analysis 
The pooled PALM and pre-PCR miRNA libraries were each sequenced in one lane on an 
Illumina Genome Analyzer IIx sequencer (40 bp single reads), using version 4 of cluster 
generation and sequencing kits. Sequencing of the pooled TruSeq miRNA libraries was done 
in one lane on an Illumina HiSeq 2000 sequencer (40 bp single reads), using version 4 of 
cluster generation and sequencing kits. Raw sequences were obtained from the Illumina GA 
Pipeline software CASAVA v1.7. The PALM barcoded sequences were demultiplexed using 
the Illumina pipeline and the pre-PCR barcodes using scripts written for this purpose. The 
pre-PCR barcodes cannot be demultiplexed using CASAVA because the pre-PCR barcode is 
not obtained with a separate read like the PALM and TruSeq barcode. The scripts allow for no 
mismatches in the barcode. Each barcode set was analyzed for small RNA using the Illumina 
pipeline add-on Flicker v2.7. Flicker trims the adaptor sequence from each read and does 
iterative alignment to the genome and to the miRNA database (miRBase v16) using the 
ELAND alignment strategy. The iterative alignment generates statistics of the number of 
reads aligning to the different classes of miRNA, as well as to individual miRNAs. 
2.6 DNA/mRNA sequencing and data analysis 
The pooled S. cerevisiae mRNA libraries were sequenced in one lane on an Illumina HiSeq 
2000 sequencer (40 bp single reads), using version 4 of cluster generation and sequencing 
kits. The Illumina GA Pipeline software CASAVA v1.7. was used to obtain the reads and to 
demultiplex the PALM and TruSeq barcoded sequences. Each barcode read set was aligned 
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and annotated with CASAVA v1.7 using the S. cerevisiae S228C genome downloaded from 
the UCSC Genome website and the S. cerevisiae GTF exon and splice site annotation file 
downloaded from the Ensembl website. Reads that aligned to each exon and splice junction 
site were summed per gene. 
2.7 TruSeq small RNA and DNA barcoding and sequencing 
For the TruSeq sample preparation, the Illumina TruSeq Small RNA Sample Prep Kit (RS-
200–0012) and the Illumina TruSeq DNA Sample Prep Kit (FC-121–1001) were used. 
3 Results 
3.1 Yields and quantification of libraries 
The PALM barcode ligation step produces several DNA products but only the main product, 
library products with the barcode adapters ligated to both ends, are able to form clusters and 
generate sequencing data. For miRNA libraries, this product has a size of approximately 170 
bp. For mRNA/DNA libraries this product has a size that is 102 bp longer than the size 
selected product before the PCR step. The other DNA products present in the library cannot 
form clusters or be sequenced: residual barcode adapters (~32 bp) can bind to the Illumina 
flow cell with one end, but will not produce clusters because bridge amplification only occurs 
when both ends of the DNA strand bind to the flow cell. Barcode-adapter dimers (~64 bp), 
can bind to the flow cell, but will not produce sequence because they lack a sequencing 
primer hybridization site. For this reason, no gel purification step is needed after the PALM 
barcode ligation step. When no final gel purification step is performed, quantification of the 
total quantity of DNA present in the library after barcode ligation would over-estimate the 
available material for optimal cluster generation and sequencing. Therefore, it is good practice 
to quantify the amounts of the desired products using an Agilent High Sensitivity DNA chip 
or an analogous gel- and microfluidics-based system to correctly load the flow cell. 
For miRNA PALM barcoding, we optimized the yield of the Illumina small RNA library 
preparation protocol (version 1.5) for PALM barcoding by using higher reaction volumes for 
the RT-PCR step. No extra cycles were added to the PCR reaction. Starting from 1 µg of 
Human Brain Reference total RNA, the protocol yields 11.14±1.5 ng of gel purified PCR 
product. The PALM barcoding step worked well starting with between 2 and 20 ng of gel-
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purified, PCR-amplified miRNA library. After PALM barcoding and AMPure XP bead 
purification, the final yield (in ng) of library with barcodes ligated to both ends, is 
approximately the same as the amount of PCR-amplified miRNA library used to start the 
PALM barcoding reaction. 
The mRNA/DNA PALM barcoding protocol is based on the Illumina Genomic DNA Sample 
Preparation Guide. Starting from 5 ng of dsDNA, the PALM protocol yields ~200 ng PCR-
amplified library (15 cycles) of which 100 ng was used in the PALM barcoding step. This 
generated >100 ng of library with barcodes ligated to both ends. 
3.2 Deep Sequencing Results of Human Brain Reference RNA 
We performed multiplexed miRNA deep sequencing on Human Brain Reference RNA using 
libraries prepared with three different protocols: PALM barcoded (12 barcodes), pre-PCR 
barcoded (4 barcodes) and TruSeq barcoded (12 barcodes). Sequencing of the brain RNA 
yielded 23,685,700 Illumina GAIIx pass-filter reads for the PALM barcoded pool, 24,171,696 
Illumina GAIIx reads for the pre-PCR barcoded pool and 35,495,446 Illumina HiSeq 2000 
reads for the TruSeq pool. Of the pass-filter reads from the PALM, pre-PCR and TruSeq 
barcoded libraries, 88%, 92% and 97% contained the barcode sequence respectively. 
Representation of the differentially barcoded libraries within the flow cell lanes was uniform 
and more than 50% of all the sequences mapped to mature miRNAs (Table S1). 
3.3 Deep Sequencing Results of S. cerevisiae mRNA 
We performed multiplexed mRNA deep sequencing on S. cerevisiae reference mRNA using 
libraries prepared with two different protocols: PALM barcoded (12 barcodes) and TruSeq 
barcoded (12 barcodes). Sequencing yielded 104,277,310 Illumina HiSeq 2000 pass-filter 
reads for the PALM barcoded pool and 115,419,701 Illumina HiSeq 2000 pass-filter reads for 
the TruSeq pool. Of the pass-filter reads from the PALM and TruSeq barcoded libraries, 94% 
and 97% contained the barcode sequence respectively. Representation of the differentially 
barcoded libraries within the flow cell lanes was uniform and more than 60% of all the 
sequences mapped to exons and splice junction sites (Table S2). 
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Figure 20: miRNA digital expression levels of all detected human brain reference sample 
miRNAs. 
(a) in the pre-PCR barcoded library 1 versus their expression in the 3 other pre-PCR barcoded 
libraries, (b) in the PALM barcoded library 1 versus their expression in the 11 other PALM 
barcoded libraries, (c) in the TruSeq barcoded library 1 versus their expression in the 11 other 
TruSeq barcoded libraries. 
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3.4 Evaluation of bias for miRNA barcoding 
We calculated the expression of each miRNA as its number of read counts normalized by the 
total number of reads for each library. The scatter plots in Figure 20 shows a side-by-side 
comparison of the miRNA expression profiles of the human brain reference libraries, 
barcoded using either the pre-PCR (A), PALM barcoding protocol (B) and the TruSeq 
barcoding protocol (C). This comparison reveals a very low variability in the miRNA 
expression profiles of the PALM and TruSeq barcoded samples but not for the pre-PCR 
barcoded samples, which is confirmed using a linear regression analysis on the miRNA with 
at least 10 counts (Table S1) for one of the barcodes: Barcode 1 against the other barcodes 
gives an R
2
 = 0.8197±0.1217 for pre-PCR vs. R
2
 = 0.9930±0.0022 for PALM vs. R
2
 = 
0.9977±0.0016 for TruSeq (See Table S3 for details). The bias introduced by the pre-PCR 
barcoding protocol precludes quantitative comparison of multiple samples using this strategy 
for multiplexing. 
3.5 Evaluation of bias for mRNA/dsDNA barcoding 
 
Figure 21: mRNA digital expression levels of all detected S. cerevisiae reference sample 
mRNAs. 
A: in the PALM barcoded library 1 versus their expression in the 11 other PALM barcoded 
libraries, B: in the TruSeq barcoded library 1 versus their expression in the 11 other TruSeq 
barcoded. 
We calculated the expression of each mRNA as its number of read counts normalized by the 
total number of reads for each library. The scatter plots in Figure 21 shows a side-by-side 
comparison of the mRNA expression profiles of the S. cerevisiae libraries, barcoded using 
either the PALM barcoding protocol (A) and the TruSeq barcoding protocol (B). This 
comparison reveals a very low variability in the mRNA expression profiles of the PALM and 
TruSeq barcoded samples, which is confirmed using a linear regression analysis on the 
mRNA with at least 10 counts (Table S2) for one of the barcodes: Barcode 1 against the other 
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barcodes gives an R
2
 = 0.9991±0.0005 for PALM vs. TruSeq R
2
 = 0.9996±0.0003 for TruSeq 
(See Table S3 for details). 
4 Discussion 
The constantly increasing throughput of next generation sequencers opens the possibility for 
multiplexed sequencing of samples. For example, sequencing one miRNA sample in one flow 
cell lane on an Illumina GAIIx generates an order of magnitude more read data than required: 
there are currently only 1037 known human miRNAs, representing a maximum of 25 kb of 
reference sequence [33]. Current Illumina technology provides >50 million reads from 1 flow 
cell lane. Thus, even multiplexing 12 different miRNA samples in one lane results in >2 
million reads per sample. This coverage is still enough to accurately quantify all but the low 
abundant miRNA present in these samples. 
A commonly used technique for multiplexing samples for deep sequencing is to incorporate a 
known, sample-specific nucleotide sequence in the DNA fragments during library preparation 
[26-30]. This sample-specific sequence (barcode) is sequenced together with the rest of the 
fragment. PCR amplification of a pool of DNA molecules with different nucleotide 
compositions, especially near priming sites, can however result in quantitative bias because 
some DNA species are amplified more efficiently than others [23, 24, 31, 32]. As we have 
shown here, introducing a barcode before the PCR step can result in a barcode-specific 
quantitative bias. Nonetheless, the currently published methods and commercial kits (i.e. 
Nugen and Bioo Scientific) introduce the barcode in the library before or during PCR-based 
library amplification. Unfortunately, none of these methods are provided with a quantitative 
analysis of the bias resulting from the use of barcodes. Thus, we reasoned that introduction of 
the barcode after library amplification would address this limitation by simply avoiding the 
problem and developed the PALM protocol. Illumina only recently introduced the TruSeq 
multiplexed sample preparation kits. The Illumina TruSeq small RNA strategy introduces the 
barcode during the PCR step using differentially barcoded primers, while the TruSeq DNA 
(or messenger RNA converted to double stranded DNA) strategy introduces the barcode 
before the PCR step by ligation of differentially barcoded adaptors. At the time of this 
publication, we are unaware of any published data demonstrating the impact of the TruSeq 
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protocols on the bias created by the combination of barcoding and PCR. For this reason, we 
compared the PALM barcoding strategy with the TruSeq barcoding strategy. 
Our results describe a detailed quantitative analysis of PCR and barcoding bias obtained using 
the PALM and the TruSeq barcoding protocol. The PALM protocol demonstrates a robust and 
efficient multiplexing method for miRNA and mRNA expression profiling that is free of 
barcode-induced PCR bias. In contrast, our results for the same miRNA samples profiled with 
our pre-PCR barcoding protocol demonstrate significant barcode-specific bias. This bias is 
quite extreme, as the digital expression of the same miRNAs shows up to 100-fold differences 
in read counts for the top 200 most abundantly expressed miRNAs. Both the TruSeq miRNA 
and mRNA/dsDNA barcoding protocols show no bias. In the TruSeq miRNA protocol, the 
strategy of introducing the barcode during the PCR step using differentially barcoded primers 
does not result in bias. The TruSeq protocol for mRNA/dsDNA which introduces the barcode 
before the PCR step, surprisingly also produces results with no bias. It is unclear why our pre-
PCR protocol for small RNA produces biased results, while the TruSeq protocol for 
mRNA/dsDNA produces unbiased results. Compared to our pre-PCR small RNA protocol 
which places the barcode only 3 bp away from the miRNA insert, the TruSeq mRNA/dsDNA 
protocol places the barcode 34 bp away from the mRNA/dsDNA. Another difference is that 
the mRNA/dsDNA protocol contains no reverse transcriptase step after bacoding and works 
with a typical insert size of 250 bp, instead of the miRNA insert size of approx. 22 bp. 
Because of this, the barcode sequence might have less impact on the quantitative results after 
PCR. 
There are multiple sources of bias that can be introduced during sample purification and 
library preparation including ligation bias, secondary structures, PCR-bias created by 
amplification of differentially barcoded miRNAs and amplification bias introduced on the 
surface of the flow cell [34-36]. The important point in the context of the present work is that 
PALM and TruSeq barcoding, in contrast to the pre-PCR barcoding protocol we used, gives 
consistent and reproducible results allowing multiplexing and meaningful comparisons of 
differential miRNA and mRNA expression without the need for technical replicates with 
different barcodes. In addition, PALM is a transparent and adaptable alternative to 
commercial strategies with a limited number of barcodes. It allows the user to modify the 
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protocol and provides the flexibility to synthesize as many barcodes as needed in order to 
keep up with the ever-growing sequencing throughput. 
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5 Supporting information  
5.1 Supplementary figures 
 
Figure S1: E-gel of a library after PCR amplification and before barcode ligation.  
Typical Invitrogen 4% E-gel with 50 bp ladder of a Human Brain Reference RNA (Ambion) 
library after PCR amplification and before barcode ligation. The PCR product that needs to be 
purified from the gel is the band next to the 100 bp marker (second ladder band starting from 
the bottom of the picture). The bands closely above this PCR product should not be excised 
from the gel: doing so lowers the percentage of mature miRNA sequences in the sequencing 
results. 
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5.2 Supplementary tables 
Table S1: : Human Brain RNA sequence quality statistics. 
 Number of reads (mean ± st. dev) 
 
 
Dd 
% (mean ± st. dev) 
 12 PALM barcodes   
Total reads with barcodes 20,598,984  
Ave reads per barcoded sample 
 
1,716,582 ± 372,711 
 
 
Unaligned – too short 
 
 303,765 ± 126,807 17.58 ± 5.35 
Unaligned – no match 
 
123,341 ± 24,814 7.22 ± 0.53 
Aligned - mature 904,344 ± 207,458 52.69 ± 4.74 
Identified miRNA 491 ± 19  
miRNA with >10 counts 325  
4 pre-PCR barcodes   
Total reads with barcodes 22,149,582  
Ave reads per barcoded sample 
 
5,537,396 ± 1,209,422  
Unaligned – too short 
 
359,639 ± 136,311 6.49 ±2.46 
Unaligned – no match 
 
261,967 ± 82,974 4.73 ±1.50 
Aligned - mature 3,359,695 ± 698,009 60.67 ± 12.61 
Identified miRNA 594 ± 4  
miRNA with >10 counts 434  
12 TruSeq barcodes   
Total reads with barcodes 
 
34,590,185 
 
 
 
Ave reads per barcoded sample 
 
2,882,515 ± 386,221  
Unaligned – too short 
 
63,515 ± 9,874 2.2 ± 0.34 
Unaligned – no match 
 
470,410 ± 56,970 16.32 ± 1.98 
Aligned - mature 1,563,981 ± 211692 54.26 ± 7.34 
Identified miRNA 581 ± 14  
miRNA with >10 counts 402  
Alignment statistics were generated by Flicker version 2.7. The pool of 12 PALM barcodes and the 
pool of 4 Pre-PCR barcodes were each sequenced in one Illumina GAIIx flow cell lane. The pool of 12 
TruSeq barcodes was sequenced in one Illumina HiSeq 2000 lane. The table also shows the number 
of identified miRNA in each barcoded sample and the number of miRNA with at least 10 counts in at 
least one of the barcoded samples. 
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Table S2: S. cerevisiae mRNA sequence quality statistics. 
 Number of reads 
(mean ± st. dev) 
 
 
dd 
% (mean ± st. dev) 
 
12 PALM barcodes   
Total reads with barcodes 98,108,551  
Ave reads per barcoded sample 
 
8,175,712 ± 2,018,971  
Aligned  
 
5,287,979 ± 1,315,639 0,64 ± 0,16 
Unaligned 2,887,734 ± 703,653 0,35 ± 0,09 
Identified mRNA 6482 ± 24  
miRNA with >10 counts 6208  
12 TruSeq barcodes   
Total reads with barcodes 112,036,259  
Ave reads per barcoded sample 
 
9,336,354 ± 1,405,129  
Aligned  
 
6,120,073 ± 929,944 0,66 ± 0,10 
Unaligned 3,216,282 ± 477,117 0,34 ± 0,05 
Identified mRNA 6496 ± 14  
miRNA with >10 counts 6230  
Alignment statistics were generated with CASAVA v1.7. The pool of 12 PALM barcodes and the 
pool of 12 TruSeq barcodes were each sequenced in one Illumina HiSeq 2000 lane. The table also 
shows the number of identified mRNA for each barcoded sample and the number of miRNA with at 
least 10 counts in at least one of the barcoded samples. 
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Table S3: Matrix of correlations between differentially barcoded samples. 
Only miRNA and mRNA with at least 10 counts in at least one of the barcoded samples were considered. 
miRNA: Pre-PCR barcoding 
        
 
BC 1 BC 2 BC 3 BC 4 
        BC 1 1,0000 0,7334 0,7677 0,7774 
        BC 2 0,7334 1,0000 0,8859 0,9363 
        BC 3 0,7677 0,8859 1,0000 0,9479 
        BC 4 0,7774 0,9363 0,9479 1,0000 
        miRNA: PALM barcoding 
        
 
BC 1 BC 2 BC 3 BC 4 BC 5 BC 6 BC 7 BC 8 BC 9 BC 10 BC 11 BC 12
BC 1 1,0000 0,9923 0,9920 0,9919 0,9928 0,9924 0,9919 0,9929 0,9930 0,9929 0,9921 0,9922 
BC 2 0,9923 1,0000 0,9982 0,9986 0,9993 0,9995 0,9976 0,9994 0,9989 0,9983 0,9990 0,9968 
BC 3 0,9920 0,9982 1,0000 0,9975 0,9995 0,9988 0,9992 0,9989 0,9997 0,9992 0,9983 0,9986 
BC 4 0,9919 0,9986 0,9975 1,0000 0,9981 0,9990 0,9984 0,9986 0,9986 0,9989 0,9994 0,9982 
BC 5 0,9928 0,9993 0,9995 0,9981 1,0000 0,9995 0,9988 0,9996 0,9996 0,9989 0,9989 0,9978 
BC 6 0,9924 0,9995 0,9988 0,9990 0,9995 1,0000 0,9990 0,9999 0,9992 0,9986 0,9997 0,9975 
BC 7 0,9919 0,9976 0,9992 0,9984 0,9988 0,9990 1,0000 0,9990 0,9993 0,9992 0,9992 0,9991 
BC 8 0,9929 0,9994 0,9989 0,9986 0,9996 0,9999 0,9990 1,0000 0,9993 0,9986 0,9996 0,9975 
BC 9 0,9930 0,9989 0,9997 0,9986 0,9996 0,9992 0,9993 0,9993 1,0000 0,9998 0,9990 0,9991 
BC 10 0,9929 0,9983 0,9992 0,9989 0,9989 0,9986 0,9992 0,9986 0,9998 1,0000 0,9988 0,9997 
BC 11 0,9921 0,9990 0,9983 0,9994 0,9989 0,9997 0,9992 0,9996 0,9990 0,9988 1,0000 0,9980 
BC 12 0,9922 0,9968 0,9986 0,9982 0,9978 0,9975 0,9991 0,9975 0,9991 0,9997 0,9980 1,0000 
miRNA: TruSeq barcoding 
        
 
BC 1 BC 2 BC 3 BC 4 BC 5 BC 6 BC 7 BC 8 BC 9 BC 10 BC 11 BC 12
BC 1 1,0000 0,9988 0,9955 0,9977 0,9988 0,9991 0,9944 0,9975 0,9972 0,9970 0,9990 0,9976 
BC 2 0,9988 1,0000 0,9971 0,9987 0,9996 0,9995 0,9963 0,9982 0,9991 0,9984 0,9995 0,9993 
BC 3 0,9955 0,9971 1,0000 0,9956 0,9983 0,9984 0,9996 0,9992 0,9992 0,9995 0,9975 0,9984 
BC 4 0,9977 0,9987 0,9956 1,0000 0,9980 0,9982 0,9957 0,9970 0,9972 0,9976 0,9983 0,9986 
BC 5 0,9988 0,9996 0,9983 0,9980 1,0000 0,9998 0,9972 0,9990 0,9995 0,9989 0,9992 0,9994 
BC 6 0,9991 0,9995 0,9984 0,9982 0,9998 1,0000 0,9977 0,9994 0,9993 0,9991 0,9996 0,9993 
BC 7 0,9944 0,9963 0,9996 0,9957 0,9972 0,9977 1,0000 0,9988 0,9984 0,9992 0,9969 0,9980 
BC 8 0,9975 0,9982 0,9992 0,9970 0,9990 0,9994 0,9988 1,0000 0,9990 0,9995 0,9989 0,9991 
BC 9 0,9972 0,9991 0,9992 0,9972 0,9995 0,9993 0,9984 0,9990 1,0000 0,9994 0,9988 0,9994 
BC 10 0,9970 0,9984 0,9995 0,9976 0,9989 0,9991 0,9992 0,9995 0,9994 1,0000 0,9988 0,9991 
BC 11 0,9990 0,9995 0,9975 0,9983 0,9992 0,9996 0,9969 0,9989 0,9988 0,9988 1,0000 0,9990 
BC 12 0,9976 0,9993 0,9984 0,9986 0,9994 0,9993 0,9980 0,9991 0,9994 0,9991 0,9990 1,0000 
mRNA / dsDNA: PALM barcoding 
         
 
BC 1 BC 2 BC 3 BC 4 BC 5 BC 6 BC 7 BC 8 BC 9 BC 10 BC 11 BC 12
BC 1 1,0000 0,9982 0,9995 0,9985 0,9991 0,9989 0,9994 0,9985 0,9993 0,9996 0,9989 0,9988 
BC 2 0,9982 1,0000 0,9978 0,9995 0,9994 0,9995 0,9969 0,9997 0,9992 0,9991 0,9955 0,9995 
BC 3 0,9995 0,9978 1,0000 0,9987 0,9989 0,9983 0,9988 0,9981 0,9988 0,9993 0,9991 0,9986 
BC 4 0,9985 0,9995 0,9987 1,0000 0,9996 0,9993 0,9971 0,9995 0,9991 0,9993 0,9965 0,9996 
BC 5 0,9991 0,9994 0,9989 0,9996 1,0000 0,9996 0,9981 0,9995 0,9995 0,9997 0,9973 0,9996 
BC 6 0,9989 0,9995 0,9983 0,9993 0,9996 1,0000 0,9981 0,9996 0,9997 0,9995 0,9966 0,9996 
BC 7 0,9994 0,9969 0,9988 0,9971 0,9981 0,9981 1,0000 0,9975 0,9987 0,9988 0,9991 0,9978 
BC 8 0,9985 0,9997 0,9981 0,9995 0,9995 0,9996 0,9975 1,0000 0,9993 0,9992 0,9961 0,9996 
BC 9 0,9993 0,9992 0,9988 0,9991 0,9995 0,9997 0,9987 0,9993 1,0000 0,9997 0,9974 0,9994 
BC 10 0,9996 0,9991 0,9993 0,9993 0,9997 0,9995 0,9988 0,9992 0,9997 1,0000 0,9981 0,9995 
BC 11 0,9989 0,9955 0,9991 0,9965 0,9973 0,9966 0,9991 0,9961 0,9974 0,9981 1,0000 0,9968 
BC 12 0,9988 0,9995 0,9986 0,9996 0,9996 0,9996 0,9978 0,9996 0,9994 0,9995 0,9968 1,0000 
mRNA / dsDNA: TruSeq barcoding 
         
 
BC 1 BC 2 BC 3 BC 4 BC 5 BC 6 BC 7 BC 8 BC 9 BC 10 BC 11 BC 12
BC 1 1,0000 0,9994 0,9989 0,9998 0,9997 0,9996 0,9991 0,9994 0,9997 0,9997 0,9997 0,9996 
BC 2 0,9994 1,0000 0,9994 0,9992 0,9991 0,9996 0,9989 0,9992 0,9992 0,9993 0,9990 0,9994 
BC 3 0,9989 0,9994 1,0000 0,9985 0,9983 0,9989 0,9981 0,9981 0,9985 0,9993 0,9987 0,9994 
BC 4 0,9998 0,9992 0,9985 1,0000 0,9998 0,9996 0,9991 0,9995 0,9998 0,9994 0,9995 0,9993 
BC 5 0,9997 0,9991 0,9983 0,9998 1,0000 0,9996 0,9992 0,9995 0,9998 0,9992 0,9993 0,9991 
BC 6 0,9996 0,9996 0,9989 0,9996 0,9996 1,0000 0,9990 0,9995 0,9996 0,9993 0,9991 0,9992 
BC 7 0,9991 0,9989 0,9981 0,9991 0,9992 0,9990 1,0000 0,9994 0,9991 0,9987 0,9988 0,9988 
BC 8 0,9994 0,9992 0,9981 0,9995 0,9995 0,9995 0,9994 1,0000 0,9995 0,9989 0,9991 0,9989 
BC 9 0,9997 0,9992 0,9985 0,9998 0,9998 0,9996 0,9991 0,9995 1,0000 0,9994 0,9994 0,9993 
BC 10 0,9997 0,9993 0,9993 0,9994 0,9992 0,9993 0,9987 0,9989 0,9994 1,0000 0,9996 0,9998 
BC 11 0,9997 0,9990 0,9987 0,9995 0,9993 0,9991 0,9988 0,9991 0,9994 0,9996 1,0000 0,9996 
BC 12 0,9996 0,9994 0,9994 0,9993 0,9991 0,9992 0,9988 0,9989 0,9993 0,9998 0,9996 1,0000 
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5.3 Supplementary Materials and Methods (Text S1) 
5.3.1 PALM Barcoding of small RNA 
Materials: All oligonucleotides were ordered HPLC 
purified from Integrated DNA Technologies Inc. (IDT). 
Enzymes were obtained from Invitrogen, Life 
Technologies, Inc., New England Biolabs, and 
Enzymatics Inc.  
 PALM Adapters 
5X PALM miRNA 3′adapter (10 µM) 
 5′ rApp-AGATCGGAAGAGCACACGTCT(C3spacer) 
PALM miRNA 5′adapter    (5 µM) 
 5′ GUUCAGAGUUCUACAGUCCGACGAUC 
 5X PALM Reverse Transcription primer 
5X PALM RT primer (100 µM) 
 5′ GTGACTGGAGTTCAGACGTGTGCTCTTCCGA 
 PALM PCR primers 
PALM miRNA PCR primer 1 (25 µM) 
 5′ AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA 
PALM miRNA PCR primer 2 (25 µM) 
 5′ P-GTGACTGGAGTTCAGACGTGTGCTCTTCCGA 
 PALM Barcodes (50 µM final 
concentration in annealed solution 
50mM NaCl/10mM Tris pH 7.5) 
barcode 1-P  5′  P-G-ATCACG-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 1-T  5′ CAAGCAGAAGACGGCATACGAGATCGTGATC*T 
barcode 2-P  5′ P-G-CGATGT-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 2-T  5′ CAAGCAGAAGACGGCATACGAGATACATCGC*T 
barcode 3-P  5′ P-G-TTAGGC-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 3-T  5′ CAAGCAGAAGACGGCATACGAGATGCCTAAC*T 
barcode 4-P  5′ P-G-TGACCA-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 4-T  5′ CAAGCAGAAGACGGCATACGAGATTGGTCAC*T 
barcode 5-P  5′ P-G-ACAGTG-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 5-T  5′ CAAGCAGAAGACGGCATACGAGATCACTGTC*T 
barcode 6-P  5′ P-G-GCCAAT-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 6-T  5′ CAAGCAGAAGACGGCATACGAGATATTGGCC*T 
barcode 7-P  5′ P-G-CAGATC-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 7-T  5′ CAAGCAGAAGACGGCATACGAGATGATCTGC*T 
barcode 8-P  5′ P-G-ACTTGA-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 8-T  5′ CAAGCAGAAGACGGCATACGAGATTCAAGTC*T 
barcode 9-P  5′ P-G-GATCAG-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 9-T  5′ CAAGCAGAAGACGGCATACGAGATCTGATCC*T 
barcode 10-P 5′ P-G-TAGCTT-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 10-T 5′ CAAGCAGAAGACGGCATACGAGATAAGCTAC*T 
barcode 11-P 5′ P-G-GGCTAC-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 11-T 5′ CAAGCAGAAGACGGCATACGAGATGTAGCCC*T 
barcode 12-P 5′ P-G-CTTGTA-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 12-T 5′ CAAGCAGAAGACGGCATACGAGATTACAAGC*T 
(P = 5′phosphate, 3AmMO = 3′amine, and * 
= phosphorothioate linkage) 
 
 
 T4 RNA Ligase 2, truncated; T4 RNA Ligase; 
Finnzymes 2X Phusion HF master mix; and Taq 
DNA polymerase (New England Biolabs)  
 RNaseOUT, SuperScript™ II Reverse 
Transcriptase, Qubit Fluorometer, dsDNA High 
Sensitivity assay, Magnetic Particle Concentrator, 
E-Gel EX 4% Agarose Gel, TrackIt 50 bp ladder, 
and 10 mM ATP (Invitrogen, Life Technologies, 
Inc.) 
 Agarose Dissolving Buffer (ADB) and DNA 
Clean and concentrator -5 and -25 kits (Zymo 
Research Co.) 
 T4 DNA Ligase (Rapid), using 2X Rapid 
Ligation Buffer (Enzymatics, Inc.)  
 Molecular Biology Grade, DNase- and RNase-
free MgCl2 (Sigma-Aldrich, Co.)  
 2100 Bioanalyzer and High Sensitivity DNA kit 
(Agilent Technologies)  
 Agencourt AMPure XP magnetic beads 
(Beckman Coulter, Inc.) 
 Dark Reader® transilluminator (Clare Chemical 
Research, Inc.) 
 
Methods: 
1) Ligation of 3′- and 5′- adapters to total RNA 
1 µg of total RNA sample was added to 10 pmol 
of PALM miRNA 3′ adapter in a final volume of 
6 µL. The mixture was incubated at 70°C for 2 
minutes, and then transferred to ice. 
Subsequently, the following reagents were added 
to the mixture: 1 μL 10X T4 RNA Ligase 2 
truncated reaction buffer; 0.8 μL 100 mM 
MgCl2; 1.5 μL T4 RNA Ligase 2 truncated; and 
0.5 μL RNaseOUT, and the reaction was 
incubated at 22°C for 1 hour. Just prior to this 
reaction finishing, the PALM miRNA 5′ adapter 
was denatured by heating it at 70°C for 2 minutes 
and transferring it to ice. Then, the following 
reagents were added to the reaction mixture: 1 μL 
of 10 mM ATP; 1 μL PALM miRNA 5′ Adapter; 
and 1 μL T4 RNA Ligase. The reaction was 
incubated at 20°C for 1 hour and then transferred 
to ice. 
 
2) Reverse transcription of adapter ligated 
products. 
12 μL of the above RNA Ligation reaction was 
then taken and added directly to 60 pmol of 
PALM RT primer in a final volume of 15 μL. The 
mixture was then heated to 70°C for 2 minutes, 
and then transferred to ice. In a separate, 
nuclease-free PCR tube the following reagents 
were premixed: 6 μL 5X First Strand Buffer; 1.5 
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μL 12.5 mM dNTP mix; 3 μL 100 mM DTT; and 
1.5 μL RNaseOUT. The 15 μL of Ligation 
products and PALM RT primer were then 
combined with the 12 μL of reagents in the PCR 
tube. The mixture was heated to 48°C for 3 
minutes, and then 3 μL SuperScript™ II was 
added. The reaction was then incubated at 44°C 
for 1 hour, and then transferred to ice. 
3) PCR Amplification. 
In a separate microfuge tube the following 
reagents were combined and placed on ice: 50 μL 
2X phusion master mix; 2 uL PALM miRNA 
PCR primer 1; 2 uL PALM miRNA PCR primer 
2; 16 μL nuclease-free purified water. This 
mixture of reagents was then added to the 30 μL 
from the reverse transcription reaction in a PCR 
tube. The mixture was then placed in a 
thermocycler using the following program: 1 
initial hold, 98ºC, 30 seconds; cycled 12 times, 
98ºC, 10 seconds; 60ºC, 30 seconds; and 72ºC, 15 
seconds; 1 final hold, 72ºC, 10 minutes. 
After the PCR reaction was complete, the PCR 
products were purified using a Zymo-25 DNA 
column clean up protocol and eluted from the 
column in 38.5 µL nuclease-free purified water. 
4) 3′ A-tailing of PCR products. 
The eluted PCR products were mixed with 5 µl 
10X Taq buffer, 5 μL 10 mM dATP and 1.5 µL 
Taq polymerase. The reaction was then incubated 
at 72°C for 30 minutes. The A-tailed PCR 
products were then isolated from the reaction 
using a Zymo-25 DNA column clean up protocol 
and eluted from the column in 60 µL nuclease-
free purified water. 
5) Purification of PCR products. 
The desired PCR products were purified by 
loading onto a 4% Agarose E-gel, 20 μL per lane 
(3 lanes per sample). 5 μL of TrackIT 50bp 
Ladder was loaded into a single lane and used as 
a DNA size marker. The gel was electrophoresed 
for approximately 30 minutes, until the desired 
bands (at approximately 100bp ± 10bp, see 
Supplementary Figure 1), were at the bottom of 
the gel. The gel was imaged using a Dark 
Reader® Transilluminator and the desired bands 
were excised using a clean razor blade. 
Approximately, 4 volumes of ADB buffer were 
added to the gel pieces and the mixture was 
incubated for 5-10 minutes at 37 ºC, while mixing 
several times during the period. PCR products 
were isolated from the mixture using a Zymo-5 
DNA column clean up protocol. The desired PCR 
products were eluted from the column with 21 μL 
nuclease-free, purified water. 1 µL of the eluted 
DNA products was used for quantification with a 
Qubit Fluorometer. 
6) Ligation of PALM barcodes to PCR products. 
The amount of material going into ligation 
reaction varied but worked well at 2-20 ng. The 
eluted PCR products were mixed with 25 pmol of 
annealed PALM barcode in a final volume of 20 
μL and added to 25 μL of 2X Rapid Ligation 
buffer with 5 μL T4 DNA Ligase (Rapid) and 
incubated at 20°C for 30 minutes. 1 µl of 0.5 M 
EDTA was added to stop the ligation reaction. 
7) AMPure XP magnetic bead isolation of DNA 
products.  
After the ligation reaction, 90 μl of AMPure XP 
beads was added, mixed, and allowed to incubate 
at room temperature for 5 minutes. Using a 
Magnetic Particle Concentrator (MPC), the beads 
were pelleted against the wall of the tube. The 
tube will remained in the MCP during all 
subsequent wash steps. The supernatant was 
removed, and the beads were washed twice with 
500 μL of 70% ethanol (allowed to sit for 1 
minute each time during wash). The AMPure XP 
beads were allowed to air dry for approximately 5 
minutes. Then the tube was removed from the 
MPC and 30 μL of TE was added and vortexed to 
re-suspend the beads. After a 2 minute wait step, 
the tube was placed back in the MPC to pellet the 
beads against the wall of the tube and the eluate 
was removed and transferred to a fresh microfuge 
tube. 
8) Agilent High Sensitivity DNA chip analysis 
and Illumina flow cell loading. 
1 µl of the eluted DNA library was run on an 
Agilent High Sensitivity DNA chip to determine 
size and concentration of the desired barcoded 
products (at approximately 145bp and 180bp). 
The concentration of the desired products was 
determined from the Agilent 2100 Bioanalyzer 
electropherogram and used to prepare an 
equimolar pool of 9 pM solution for cluster 
generation on an Illumina flow cell. 
5.3.2 Pre-PCR Barcoding of small 
RNA 
Materials: All oligonucleotides were ordered HPLC 
purified from Integrated DNA Technologies Inc. 
(IDT). Enzymes were obtained from Invitrogen, Life 
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Technologies, Inc., New England Biolabs, and 
Enzymatics Inc. 
 Adapters 
5X miRNA 3′adapter (10 µM) 
 5′ rApp-ATCTCGTATGCCGTCTTCTGCTTG(ddC) 
miRNA 5′adapter    (5 µM) 
 5′ GUUCAGAGUUCUACAGUCCGACGAUC 
Note: Bases in red are the barcode 
sequences. The 4 barcodes used in 
this study were: 
BC1 5′ GUUCAGAGUUCUACAGUCCGACGAUC GACG AUC 
BC2 5′ GUUCAGAGUUCUACAGUCCGACGAUC AAGA AUC 
BC3 5′ GUUCAGAGUUCUACAGUCCGACGAUC ACUC AUC 
BC4 5′ GUUCAGAGUUCUACAGUCCGACGAUC CGCA AUC 
 5X Reverse Transcription primer 
5X miRNA RT primer (100 µM) 
 5′ CAAGCAGAAGACGGCATACGA 
 PCR primers 
miRNA PCR primer 1 (25 µM) 
 5′ CAAGCAGAAGACGGCATACGA 
miRNA PCR primer 2 (25 µM)  
 5′ 
AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA 
 T4 RNA Ligase 2, truncated; T4 RNA Ligase; and 
Finnzymes 2X Phusion HF master mix (New 
England Biolabs)  
 RNaseOUT, SuperScript™ II Reverse Transcriptase, 
Qubit Fluorometer, dsDNA High Sensitivity assay, 
Magnetic Particle Concentrator, E-Gel EX 4% 
Agarose Gel, TrackIt 50 bp ladder and 10 mM ATP 
(Invitrogen, Life Technologies, Inc.) 
 Agarose Dissolving Buffer (ADB) and DNA Clean 
and concentrator -5 and -25 kits (Zymo Research 
Co.) 
 Molecular Biology Grade, DNase- and RNase-free 
MgCl2 (Sigma-Aldrich, Co.)  
 2100 Bioanalyzer and High Sensitivity DNA kit 
(Agilent Technologies)  
 Agencourt AMPure XP magnetic beads (Beckman 
Coulter, Inc.) 
 Dark Reader® transilluminator (Clare Chemical 
Research, Inc.) 
 
Methods: 
1) Ligation of 3′- and 5′- adapters to total RNA 
1 µg of total RNA sample was added to 10 pmol 
of miRNA 3′ adapter in a final volume of 6 µL. 
The mixture was incubated at 70°C for 2 minutes, 
and then transferred to ice. Subsequently, the 
following reagents were added to the mixture: 1 
μL 10X T4 RNA Ligase 2 truncated reaction 
buffer; 0.8 μL 100 mM MgCl2; 1.5 μL T4 RNA 
Ligase 2 truncated; and 0.5 μL RNaseOUT, and 
the reaction was incubated at 22°C for 1 hour. Just 
prior to this reaction finishing, the miRNA 5′ 
adapter was denatured by heating it at 70°C for 2 
minutes and transferring it to ice. Then, the 
following reagents were added to the reaction 
mixture: 1 μL of 10 mM ATP; 1 μL miRNA 5′ 
Adapter; and 1 μL T4 RNA Ligase. The reaction 
was incubated at 20°C for 1 hour and then 
transferred to ice. 
2) Reverse transcription of adapter ligated 
products. 
8 μL of the above RNA Ligation reaction was 
added directly to 40 pmol of miRNA RT primer in 
a final volume of 10 μL. The mixture was heated 
to 70°C for 2 minutes and then transferred to ice. 
In a separate, nuclease-free PCR tube the 
following reagents were premixed: 4 μL 5X First 
Strand Buffer; 1 μL 12.5 mM dNTP mix; 2 μL 100 
mM DTT; and 1 μL RNaseOUT. The 10 μL of 
ligation products and miRNA RT primer were then 
combined with the 8 μL of reagents in the PCR 
tube. The mixture was heated to 48°C for 3 
minutes and then 2 μL SuperScript™ II was 
added. The reaction was then incubated at 44°C 
for 1 hour and then transferred to ice. 
3) PCR Amplification. 
In a separate microfuge tube the following 
reagents were combined and placed on ice: 25 μL 
2X phusion master mix; 1 uL miRNA PCR 
primer 1; 1 uL miRNA PCR primer 2 and 3 μL 
nuclease-free purified water. This mixture of 
reagents was then added to the 20 μL from the 
reverse transcription reaction in the PCR tube. 
The mixture was then placed in a thermocycler 
using the following program: 1 initial hold, 98ºC, 
30 seconds; cycled 12 times, 98ºC, 10 seconds; 
60ºC, 30 seconds; and 72ºC, 15 seconds; 1 final 
hold, 72ºC, 10 minutes.  
The PCR products were then isolated from the 
reaction using a Zymo-25 DNA column clean up 
protocol and eluted from the column in 60 µL 
nuclease-free purified water. 
4) Purification of PCR products. 
The desired PCR products were purified by 
loading onto a 4% Agarose E-gel, 20 μL per lane 
(3 lanes per sample). 5 μL of TrackIT 50bp 
Ladder was loaded into a single lane and used as 
a DNA size marker. The gel was electrophoresed 
for approximately 30 minutes, until the desired 
bands (at approximately 100bp ± 10bp, see 
Supplementary Figure 1), were at the bottom of 
the gel. The gel was imaged using a Dark 
Reader® Transilluminator and the desired bands 
were excised using a clean razor blade. 
Approximately, 4 volumes of ADB buffer were 
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added to the gel pieces and the mixture was 
incubated for 5-10 minutes at 37 ºC while mixing 
several times during the period. PCR products 
were isolated from the mixture using a Zymo-25 
DNA column clean up protocol. The desired PCR 
products were eluted from the column with 32 μL 
nuclease-free, purified water. 1 µL of the eluted 
DNA products was used for quantification with a 
Qubit Fluorometer and the dsDNA High 
Sensitivity assay. 
5) Illumina flow cell loading. 
The concentration of the desired products was 
determined from the Qubit Fluorometer and used 
to prepare an equimolar pool of 7 pM solution for 
cluster generation on an Illumina flow cell. 
5.3.3 PALM Barcoding for DNA 
Materials: All oligonucleotides were ordered HPLC 
purified from Integrated DNA Technologies Inc. (IDT). 
Enzymes were obtained from Invitrogen, Life 
Technologies, Inc., New England Biolabs, and 
Enzymatics Inc.  
 PALM Adapters (50 µM mixture after 
annealing) 
Adapter 1   
5' P-GATCGGAAGAGCACACGTCT 
Adapter 2   
5' ACACTCTTTCCCTACACGACGCTCTTCCGATC*T 
 PALM PCR primers 
PALM PCR primer 1 (25 µM) 
5′AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGA
CGCTCTTCCGATC*T 
PALM PCR primer 2 (25 µM)  
5′P-GTGACTGGAGTTCAGACGTGTGCTCTTCCGATC*T 
 PALM Barcodes (50 µM final 
concentration in annealed solution 
50mM NaCl/10mM Tris pH 7.5) 
barcode 1-P  5′P-G-ATCACG-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 1-T  5′ CAAGCAGAAGACGGCATACGAGATCGTGATC*T 
barcode 2-P  5′ P-G-CGATGT-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 2-T  5′ CAAGCAGAAGACGGCATACGAGATACATCGC*T 
barcode 3-P  5′ P-G-TTAGGC-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 3-T  5′ CAAGCAGAAGACGGCATACGAGATGCCTAAC*T 
barcode 4-P  5′ P-G-TGACCA-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 4-T  5′ CAAGCAGAAGACGGCATACGAGATTGGTCAC*T 
barcode 5-P  5′ P-G-ACAGTG-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 5-T  5′ CAAGCAGAAGACGGCATACGAGATCACTGTC*T 
barcode 6-P  5′ P-G-GCCAAT-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 6-T  5′ CAAGCAGAAGACGGCATACGAGATATTGGCC*T 
barcode 7-P  5′ P-G-CAGATC-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 7-T  5′ CAAGCAGAAGACGGCATACGAGATGATCTGC*T 
barcode 8-P  5′ P-G-ACTTGA-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 8-T  5′ CAAGCAGAAGACGGCATACGAGATTCAAGTC*T 
barcode 9-P  5′ P-G-GATCAG-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 9-T  5′ CAAGCAGAAGACGGCATACGAGATCTGATCC*T 
barcode 10-P 5′P-G-TAGCTT-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 10-T 5′ CAAGCAGAAGACGGCATACGAGATAAGCTAC*T 
barcode 11-P 5′ P-G-GGCTAC-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 11-T 5′ CAAGCAGAAGACGGCATACGAGATGTAGCCC*T 
barcode 12-P 5′ P-G-CTTGTA-ATCTCGTATGCCGTCTTCTGCTTG/3AmMO/ 
barcode 12-T 5′ CAAGCAGAAGACGGCATACGAGATTACAAGC*T 
(P = 5′phosphate, 3AmMO = 3′amine, and * = phosphorothioate 
linkage) 
 10X Phosphorylation buffer, dNTP mix, T4 DNA 
polymerase, E. coli DNA Polymerase I Large 
(Klenow) Fragment, T4 Polynucleotide Kinase, 
10X NEBuffer2, 10 μL 1 mM dATP, Klenow 
Fragment (3′→5′ exo-), 5X Phusion HF buffer, 
Phusion DNA Polymerase and Taq DNA 
polymerase, T4 DNA ligase, Quick Ligation 
Reaction buffer (New England Biolabs).   
 Qubit Fluorometer, and dsDNA High Sensitivity 
assay, Magnetic Particle Concentrator, E-Gel EX 
4% Agarose Gel, TrackIt 50 bp ladder, and 10 mM 
dATP, 0.5M EDTA pH8 (Invitrogen, Life 
Technologies, Inc.) 
 Agarose Dissolving Buffer (ADB) and DNA Clean 
and concentrator -5 and -25 kits (Zymo Research 
Co.) 
 T4 DNA Ligase (Rapid), using 2X Rapid Ligation 
Buffer (Enzymatics, Inc.)  
 TE buffer pH8 (Sigma-Aldrich, Co.) 
 2100 Bioanalyzer and High Sensitivity DNA kit 
(Agilent Technologies)  
 Agencourt AMPure XP magnetic beads (Beckman 
Coulter, Inc.) 
 Dark Reader® transilluminator (Clare Chemical 
Research, Inc.) 
 
Methods: 
1) End repair 
5 ng of dsDNA was mixed with 10 µl of 10X 
Phosphorylation buffer, 4 µl of 10 mM dNTP 
mix, 5 µl of T4 DNA polymerase, 1 µl of E. coli 
DNA Polymerase I, Large (Klenow) Fragment 
and 5µl T4 Polynucleotide Kinase in a total 
reaction volume of 100µl and incubated at 20°C 
for 30 min. The end repaired products were then 
isolated from the reaction using a Zymo-5 DNA 
column clean up protocol and eluted from the 
column in 32 µL nuclease-free purified water. 
2) 3′ A-tailing of PCR products. 
The eluted, end repaired DNA was mixed with 5 
µl 10X NEBuffer2, 10 μL 1 mM dATP and 3 µL 
Klenow Fragment (3′→5′ exo-). The reaction was 
then incubated at 37°C for 30 minutes. The A-
tailed DNA was then isolated from the reaction 
using a Zymo-5 DNA column clean up protocol 
and eluted from the column in 23 µL nuclease-
free purified water. 
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3) Ligation of 3′- and 5′- adapters 
23 µl of eluted, A-tailed DNA was mixed with 25 
µl 2X Quick Ligation Reaction Buffer, 1 µl 
PALM adaptors mix (15 µM each) and 1 µl 
Quick T4 DNA Ligase. The mixture was 
incubated at room temperature for 15 minutes. 
The DNA was then isolated from the reaction 
using a Zymo-5 DNA column clean up protocol 
and eluted from the column in 20 µL nuclease-
free purified water. 
4) Gel purification 
The desired PCR products were purified by 
loading onto 4% Agarose EX-gel, 20 μL per lane. 
2 μL of TrackIT 50bp Ladder (+ 18 µl of H2O) 
was loaded into a single lane and used as a DNA 
size marker. The gel was electrophoresed for 
approximately 20 minutes. The gel was imaged 
using a Dark Reader® Transilluminator and the 
desired product (200-250 bp) was excised using a 
clean razor blade. Approximately 4 volumes of 
Zymo ADB buffer were added to the gel pieces 
and the mixture was incubated for 10 minutes at 
37 ºC while mixing several times during the 
period. PCR products were isolated from the 
mixture using a Zymo-5 DNA column clean up 
protocol. The desired PCR products were eluted 
from the column in 29 μL nuclease-free, purified 
water. 
5) PCR Amplification. 
The following reagents were combined in a PCR 
tube: 29 µl of size selected DNA, 10 μL 5X 
Phusion HF buffer, 1 uL PALM DNA PCR 
primer 1, 1 uL PALM DNA PCR primer 2, 1.5 µl 
dNTP mix, 7 μL nuclease-free purified water and 
0.5 µl Phusion DNA Polymerase. The mixture 
was then placed in a thermocycler using the 
following program: 1 initial hold, 98ºC, 30 
seconds; cycled 15 times, 98ºC, 10 seconds; 
60ºC, 30 seconds; and 72ºC, 30 seconds; 1 final 
hold, 72ºC, 5 minutes. After the PCR reaction 
was complete, the PCR products were purified 
using a Zymo-25 DNA column clean up protocol 
and eluted from the column in 38.5 µL nuclease-
free purified water. 
6) 3′ A-tailing of PCR products. 
The eluted PCR products were mixed with 5 µl 
10X Taq buffer, 5 μL 10 mM dATP and 1.5 µL 
Taq polymerase. The reaction was then incubated 
at 72°C for 30 minutes. The A-tailed PCR 
products were then isolated from the reaction 
using a Zymo-5 DNA column clean up protocol 
and eluted from the column in 21 µL nuclease-
free purified water. 
7) Ligation of PALM barcodes to PCR products. 
100 ng of the eluted PCR products were mixed 
with 2 µL of annealed PALM barcode (50 µM) in 
a final volume of 23 μL and added to 25 μL of 2X 
Rapid Ligation buffer with 2 μL T4 DNA Ligase 
(Rapid) and incubated at 20°C for 30 minutes. 1 
µl of 0.5 M EDTA was added to stop the ligation 
reaction. 
8) AMPure XP magnetic bead isolation of DNA 
products.  
After the ligation reaction, 90 μl of AMPure XP 
beads was added, mixed, and allowed to incubate at 
room temperature for 5 minutes. Using a Magnetic 
Particle Concentrator (MPC), the beads were 
pelleted against the wall of the tube. The tube will 
remained in the MCP during all subsequent wash 
steps. The supernatant was removed, and the beads 
were washed twice with 500 μL of 70% ethanol 
(allowed to sit for 1 minute each time during wash). 
The AMPure XP beads were allowed to air dry for 
approximately 5 minutes. Then the tube was 
removed from the MPC and 20 μL of TE was added 
and vortexed to re-suspend the beads. After a 2 
minute wait step, the tube was placed back in the 
MPC to pellet the beads against the wall of the tube 
and the eluate was removed and transferred to a 
fresh microfuge tube. 
 
9) Agilent High Sensitivity DNA chip analysis 
and Illumina flow cell loading. 
1 µl of the eluted DNA library was run on an 
Agilent High Sensitivity DNA chip to determine 
size and concentration of the desired barcoded 
products. The concentration of the desired products 
was determined from the Agilent 2100 Bioanalyzer 
electropherogram and used to prepare an equimolar 
pool of 9 pM solution for cluster generation on an 
Illumina flow cell. 
10) Final (optional) gel purification 
The equimolar pool was purified by loading onto 
4% Agarose EX-gel, 20 μL per lane. 5 μL of 
TrackIT 50bp Ladder was loaded into a single lane 
and used as a DNA size marker. The gel was 
electrophoresed for approximately 20 minutes. The 
gel was imaged using a Dark Reader® 
Transilluminator and the desired product (300-350 
bp) were excised using a clean razor blade. 
Approximately, 4 volumes of Zymo ADB buffer 
were added to the gel pieces and the mixture was 
incubated for 5-10 minutes at 37 ºC while mixing 
several times during the period. PCR products were 
isolated from the mixture using a Zymo-5 DNA 
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column clean up protocol. The desired PCR 
products were eluted from the column in 30 μL 
nuclease-free, purified water. This eluate was used 
to prepare an equimolar pool of 9 pM solution for 
cluster generation on an Illumina flow cell. 
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In Part II Chapter II and III, technical optimizations were made to discover the best 
experimental setup to collect and prepare transcriptome material for 2
nd
 generation 
sequencing. In this Chapter, these optimizations were used to perform a transcriptome 
analysis of glandular and filamentous trichomes. The experiment had two goals. The principal 
aim was to discover candidate genes that might be involved in artemisinin biosynthesis. These 
candidates show a decreased expression in filamentous trichomes and an enhanced expression 
in glandular trichomes and belong to the groups of cytochrome P450, peroxidases or 
dioxygenases that might be involved in the formation of the endoperoxide bridge in 
artemisinin. Little is known about the production of secondary metabolites in filamentous 
trichomes. They are assumed to form just a physical barrier by steric hindrance of herbivores. 
Therefore, tracking genes with an enhanced expression in filamentous trichomes was the 
second goal. 
Since Maes et al. [1] showed the upregulation of artemisinin biosynthesis genes after 
treatment with jasmonic-acid, some plants were treated with this jasmonic-acid in our 
experiment to make transcriptome differences for artemisinin candidate genes more 
pronounced between glandular and filamentous trichomes. 
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1 Introduction 
Artemisia annua L. (Sweet Wormwood) is a medicinal plant that produces artemisinin which 
is a sesquiterpene with anti-malarial properties. Since every year around 216 million people 
are infected with malaria [2], a high supply of artemisinin is needed at a reduced cost. 
Artemisinin production is being enhanced in A. annua by crossing high-producing plants [3]. 
Another strategy to increase production of artemisinin is synthesis of artemisinic-acid in 
engineered yeast and subsequent (photo)chemical conversion to artemisinin [4, 5]. A better 
insight in artemisinin biosynthesis could lead to a cheaper production method.  
An important breakthrough unravelling artemisinin biosynthesis, was the localization of 
artemisinin production in the glandular trichomes [6]. Trichomes, named after the Greek word 
for hair are epidermal outgrowths covering plant organs. In A. annua, two types of trichomes 
are present: biseriate peltate glandular trichomes (Figure 1 A) and filamentous trichomes 
composed of stalk cells and an elongated cell in a T-shape (Figure 1 B) [7]. Duke et al. 
compared a normal biotype of A. annua with both filamentous and glandular trichomes to a 
biotype with only filamentous trichomes. Only in the presence of glandular trichomes, 
artemisinin was detected [6].  
This information was used to discover candidate genes for artemisinin biosynthesis with an 
expressed sequence tag (EST) approach [8]. Three EST libraries were constructed: glandular 
trichome, flower bud and glandular trichome-minus-flower-bud subtracted library. Several 
genes that were preferentially expressed in glandular trichomes are involved in artemisinin 
biosynthesis such as CYP71AV1, ALDH1, DBR2 and ADH1 [8-11]. 
Enzymes involved in artemisinin biosynthesis are known up to the formation of 
dihydroartemisinic acid. It is not yet clear whether the last step(s) from dihydroartemisinic 
acid to artemisinin involves a spontaneous auto-oxidation or is catalyzed by enzymes. Brown 
and Sy favour the theory of spontaneous chemistry because they see parallels between in vitro 
auto-oxidation and intermediates present in vivo [12]. Additionally, plants fed with labelled 
dihydroartemisinic acid and dried, contained the same proportion of labelled artemisinin as 
plants that were kept alive [12]. These are the main arguments for chemical conversion. On 
the other hand, while 70% of label incorporation was detected in the metabolites derived from 
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dihydroartemisinic acid; artemisinin and arteannuin H had only 5-15% label incorporation 
[12]. Therefore, it cannot be excluded that there is another more important pathway leading to 
artemisinin which was not accessible by the labelled precursor and that enzymes might be 
involved to catalyze this process in A. annua.  
 
Figure 1: Glandular and filamentous trichomes of A. annua.  
A: Glandular trichome with on top a pair of white apical cells and two pairs of green sub-
apical cells surrounded by a sub-cuticular cavity (cells at the basis of the trichome are 
partially removed); B: Filamentous trichomes (T-shape) with stalk cells and elongated cell; C: 
Glandular trichomes captured by laser pressure catapulting in the cap of a tube; D: 
Filamentous trichomes captured by laser pressure catapulting in the cap of a tube. 
To find candidate genes that catalyze the last step(s) to artemisinin, a more detailed analysis 
was needed of the transcriptome of glandular trichomes. Sequencing of the transcriptome 
from enriched glandular trichome preparations from A. annua was performed by Graham et 
al. on the Roche 454 platform to identify genes and markers for fast-track breeding [3]. In 
another study, Wang et al. performed a global transcriptome characterization of glandular 
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trichomes. To confirm the expression of some genes in glandular trichomes a semi-
quantitative RT-PCR analysis was performed on filamentous and glandular trichomes. Three 
genes involved in terpene biosynthesis were tested: amorpha-4,11-diene synthase, a 
sesquiterpene cyclase and (3R)-linalool synthase. They found that these genes were expressed 
in glandular trichomes as well as in filamentous trichomes [13] and this raised the question 
whether filamentous trichomes are involved in the production of secondary metabolites.  
Trichomes are in general classified as non-glandular (e.g. filamentous trichomes in A. annua) 
or glandular, based on their secretory capacity. In plants, glandular trichomes are most often 
production sites for multiple secondary metabolites which form a first-line defence at the 
surface of the plant through their capacity to entrap, deter or poison pathogens and herbivores 
[14]. Because of their interesting metabolite content as illustrated with artemisinin, a large 
number of studies have been devoted to glandular trichomes. 
In contrast to the extensive literature describing glandular trichomes, less attention has been 
paid to non-glandular trichomes. Non-glandular trichomes are assumed to form a physical 
barrier by steric hindrance of herbivores [15, 16]. Non-glandular trichomes are mainly 
described for taxonomic and phylogenetic purposes [17-21] but little is known about their 
production of secondary metabolites [22].  
To detect potential candidate genes for artemisinin biosynthesis and to investigate if 
filamentous trichomes produce important secondary metabolites, it is interesting to compare 
filamentous and glandular trichomes. Therefore, we performed a comparative transcriptome 
analysis of filamentous and glandular trichomes on the Illumina HiSeq platform. Several 
cytochromes, peroxidases and dioxygenases that are potentially involved in the biosynthesis 
of artemisinin and/or other terpenes were upregulated in glandular trichomes. Our 
transcriptome analysis confirms the established metabolic capacities of A. annua glandular 
trichomes but also points to specific metabolic activities in A. annua filamentous trichomes.  
Additionally, two other transcriptome experiments were set up to discover potential candidate 
genes. First, the effect of jasmonic acid (JA) elicitation on glandular and filamentous 
trichomes was investigated as e.g. Maes et al. showed that artemisinin production can be 
stimulated by JA [1]. However, in our experimental setup, no influence of JA treatment was 
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detected. A possible explanation is that this is due to the use of plants in different 
developmental stages.  
2 Methods 
2.1 Overview of collected samples 
In total 6 sample-types have been collected from capitula (flower heads) of A. annua (Table 
1). Three independent repeats of glandular (Figure 1 C) and filamentous (Figure 1 D) 
trichomes were collected from the same mock- and JA-treated plants. In addition to this, two 
repeats of separated apical and sub-apical cells of glandular trichomes were collected from 
mock-treated plants. The RNA from one of the 2 repeats for each cell type was split in two 
and separately amplified, creating 3 repeats for sequencing. For the apical and sub-apical 
experiment, see Part III, Chapter II. 
Sample-type Apical cells 
Sub-apical 
cells Glandular trichomes 
Filamentous 
trichomes 
Treatment mock mock mock JA mock JA 
RNA extract 
1 
Unfixated Unfixated 
Unfixated 
Rep1 
Unfixated 
Rep1 
Unfixated 
Rep1 
Unfixated 
Rep1 
Amplification 
ampl 
1 
ampl 
2 
ampl 
1 
ampl 
2 
ampl ampl ampl ampl 
RNA extract 
2 
Fixated Fixated 
Unfixated 
Rep2 
Unfixated 
Rep2 
Unfixated 
Rep2 
Unfixated 
Rep2 
Amplification ampl ampl ampl ampl ampl ampl 
RNA extract 
3         
Unfixated 
Rep3 
Unfixated 
Rep3 
Unfixated 
Rep3 
Unfixated 
Rep3 
Amplification 
    
ampl ampl ampl ampl 
Table 1: Overview of collected samples. 
Table with an overview of collected samples from A. annua. Unfixated glandular and 
filamentous trichomes are collected from mock- and JA-treated samples in 3 repeats (Rep). 
For apical and sub-apical cells, one sample of unfixated and one sample of fixated cells are 
collected. The unfixated sample was amplified in 2 separate amplifications (ampl). 
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2.2 Plant preparation 
Experiments were executed on Artemisia annua L. Anamed A3 cultivar 
(http://www.anamed.net). This cultivar contains up to 1,4% artemisinin (dry weight leaves) and 
is the result of cross breeding high-artemisinin producing plants by Mediplant Inc. (Conthey, 
Switzerland) [23]. Anamed A3 can grow well in tropical regions and is not as photosensitive as 
other breeds [24]. Under 8 hours day and 16 hours night, Anamed A3 starts flowering at the 
earliest after 6 months [see Additional File 1]. The length of this pre-flowering period is in line 
with observations under field conditions [25]. 
Seeds from A. annua Anamed were sterilized for 2 min in 70% EtOH (Merck, Darmstadt, 
Germany) and 10 min in a solution with 3.84 ml NaOCl (10-13% chlorine from Sigma-Aldrich, 
Steinheim, Germany), 5 µl Tween 20 (MP Biomedicals, Illkirch, France) and 6.16 ml sterile 
water. Subsequently, seeds were rinsed with sterile water and germinated on moist paper. After 1 
or 2 weeks, shoots were transferred to soil and grown under a regime with 8 hours day, 16 hours 
night and a temperature of 20°C. After 6 months, flowers were appearing. For JA elicitation, 
plants were treated for 8 days before the start of the sampling procedure by spraying every 2 
days with a solution of 100 µM JA (Duchefa, Haarlem, The Netherlands) containing 1.5 mM 
Tween20 (MP Biomedicals) and adding every 2 days 5 ml of 100 µM JA to the soil. During the 
sampling procedure, treatment was continued every 2 days. Control groups were treated with a 
mock (water) solution in a separate room.  
2.3 Glandular and filamentous sample preparation 
On the basal bracts and pedicel of the capitulum, filamentous trichomes are abundantly present 
[7]. Glandular trichomes are protruding on the corolla of the floret buds from the capitulum but 
are sunken in the capitulum bracts and in leaves [7]. An image of a flower head from A. annua 
Anamed was taken with Tabletop SEM (TM-1000, Hitachi, Tokyo, Japan) [see Additional File 
2]. Sunken trichomes are difficult to collect with laser capture microdissection and therefore, 
capitula were used to collect glandular and filamentous trichomes. Trichomes were collected 
from mock and JA-treated plants in 3 independent biological repeats. For each repeat, trichomes 
were collected from a pool of 3 plants. The same plants were used for capturing 190 glandular 
and 670 filamentous trichomes.  
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On a RNA free microscope slide, a capitulum was cut in a drop of cold buffer with 25 mM 
MOPSO (pH6.3) (Sigma-Aldrich), 200 mM sorbitol (Alfa Aesar, Karlsruhe, Germany), 10 mM 
sucrose (Acros, Geel, Belgium), 5 mM thiourea (Sigma-Aldrich), 2 mM DTT (Sigma-Aldrich), 5 
mM MgCl2 (Sigma-Aldrich) and 0.5 mM sodium-phosphate (Acros) [26]. Trichomes were 
captured, using the Palm MicroBeam system (P.A.L.M Microlaser Technologies, München, 
Germany) with a nitrogen UV-A laser (wavelength 337 nm). The laser-beam was focussed on 
the tissue for laser microdissection, to separate trichomes or cells from the surrounding tissue. 
Free trichomes were thereafter captured with laser pressure catapulting by focussing the laser 
beam just below the tissue. Samples were collected in 30 µl lysis buffer with ß-mercaptoethanol 
(Absolutely RNA Nanoprep Kit Stratagene, La Jolla, CA). An image of collected glandular and 
filamentous trichomes is shown in Figure 1 C and D. RNA was extracted with the Absolutely 
RNA Nanoprep protocol with DNase treatment. Samples were eluted in 10µl and half was used 
as starting material for RNA amplification. 
2.4 RNA amplification and sequencing 
Samples were amplified with a linear amplification system: the Ovation RNA-Seq System 
with 1 h 30 min Spia-amplification (NuGen, AC Bemmel, The Netherlands). In this 
amplification procedure, random primers and oligo dT primers are used during RNA 
amplification and consequently the 5’ end of the mRNA is better amplified compared to when 
only oligo dT primers are used. The cDNA priming reaction used in the NuGEN amplification 
kits are designed to avoid amplification of rRNA sequences. After RNA amplification, 
barcoded Illumina sequencing libraries were made using a post amplification ligation-
mediated strategy [27]. The 18 samples were sequenced with a read-length of 100 bp in 3 
lanes of an Illumina HiSeq 2000 flowcell. 
2.5 Quantitative real time (qRT)-PCR 
Nugen amplified DNA from 3 independent mock-treated glandular and filamentous trichome 
samples was analyzed with qRT-PCR. As template, 2 ng DNA was used in 10 µl reactions 
containing 5µl iTaq SYBR Green Supermix with ROX (Bio-Rad, Watford, UK) and 400 nM 
primers. The qRT-PCR experiment was performed on a Light Cycler 480 (Roche) with 
hotstart at 95 °C for 2 min. and 42 cycles 95 °C (15 sec.), 52 °C (1 min.), including melting 
curve analysis. Each qRT-PCR reaction was executed in duplo and these technical repeats 
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were averaged prior to qbasePLUS (version 2.3) analysis with normalization to input DNA 
concentration [28]. To validate this normalization strategy, 3 genes were included that are 
expected to be similarly expressed in both trichome types: Actin 2 (homologue AT3G18780), 
protein phosphatase 2A subunit A3 (PP2AA3; homologue AT1G13320) and a 
pentatricopeptide repeat (PPR) superfamily protein (homologue AT5G55840). These genes 
were selected based on Arabidopsis data from Czechowski et al. [29] and expression of 
homologous transcripts in our RNASeq experiment. Other transcripts analyzed were 
artemisinin-synthesis and triterpene-synthesis related. Primers [see Additional File 3] were 
adopted from other manuscripts [1, 30] or designed with Primer-BLAST from NCBI [31].  
2.6 Trinity and Blast2GO 
A de novo transcriptome was assembled from all 18 samples. Trinity Release-2011-07-13 was 
used to perform an ALLPATHS error correction [32] on the reads prior to the de novo 
assembly which was made with Trinity Release-2011-08-20 [33]. The 150,288 Trinity contigs 
were annotated using BLAST and the NCBI non-redundant protein database. The best 5 
BLAST hits were used to indicate a putative function. The Blast2GO suite [34] was used to 
generate gene ontology terms based on the BLAST output. Two sets of settings were 
sequentially used: strict and more permissive. In the more strict settings, a BLAST high-
scoring segment pairs (hsp) length of 33 and a minimum hsp coverage of the query of 33 was 
required. The more permissive setting allowed for a shorter BLAST hsp length of 20 with no 
minimum hsp coverage of the query. 
2.7 Bowtie and RSEM 
Bowtie [35] and RSEM (RNASeq by Expectation Maximization) [36] were used for mapping 
the 289 million reads to the Trinity de novo assembly and counting the number of reads that 
matched to each contig. Standard options were used, but RSEM’s polyA tail option was 
disabled. 
2.8 edgeR 
To perform the differential expression analysis, an R script was developed that makes use of 
the Bioconductor edgeR package [37]. All glandular and filamentous samples were 
normalized together. Normalization was performed by trimmed mean of M values (TMM). 
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TMM equates the overall expression levels of genes between samples under the assumption 
that the majority of them are not differentially expressed [38]. A p-value < 0.05, adjusted for 
multiple testing, was used to determine which contigs could be differentially expressed. The 
edgeR parameter prior.n was set to 1. 
2.9 MapMan 
MapMan is a program to visualize various pathways and to indicate genes or contigs that are 
up or down-regulated [39]. Prior to MapMan, functional bins need to be assigned to contigs of 
the de novo assembly. To assign the bins, Mercator was used (default options, Blast_cutoff: 
50 and IS_DNA). Not all artemisinin biosynthesis genes were automatically assigned to a bin. 
For those genes, additional bins were added based on the definitions of the best 5 blast hits. 
The output of edgeR was visualized with MapMan to show which metabolic pathways are 
significantly differentially expressed.  
3 Results and discussion 
3.1 De novo assembly of the transcriptome 
All 18 samples were sequenced in 3 lanes of an Illumina HiSeq 2000 flowcell. For each 
sample, on average 16 million single-end reads of 100 bp were generated. Around 60% of the 
reads had hits with a combined LSU and SSU rRNA reference database [40] and tRNA 
database with all known tRNAs [41]. The total of 289 million reads generated were processed 
using Trinity [33] to assemble a de novo transcriptome [see Additional File 4] containing 
150,288 contigs in 108,400 homologous groups with an average contig-length of 412 bp and a 
minimum and maximum length of 201 and 7775 bp, respectively (Table 2).  
To have a better estimate of the quality of the Trinity contigs, all 88 full-length A. annua 
mRNA sequences available in the NCBI non-redundant protein database were compared with 
the Trinity contigs. Of those, only 2 had no BLAST hits to the Trinity contigs. Each Trinity 
contig that showed a hit with one of the NCBI sequences, covered on average 58% of the 
length of the NCBI sequence. A combination of contigs with the same BLAST-hit could 
together cover on average 84% of the NCBI sequence. If the set of NCBI sequences is 
assumed to be representational of the real transcripts, one can expect that more than 80% of 
the length of a random transcript is present in our assembly. 
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Contig length (bp) Number of contigs 
< 500 118556 
500-1000 24993 
1000-1500 4658 
1500-2000 1299 
2000-3000 643 
> 3000 133 
Table 2: Length distribution of Trinity contigs. 
3.2 Annotation and characterization of de novo transcripts 
Eighty-four% of the 150,288 contigs showed at least one BLAST hit with the NCBI non-
redundant protein database. The first five BLAST hits served as an indication for the putative 
function of a contig. The contigs were also annotated with the Blast2GO suite [34], which 
links BLAST hits to gene ontology (GO) terms: 46,711 contigs had a good connection to GO 
terms, using strict settings for Blast2GO; 5,596 contigs still had a connection to GO terms 
with more permissive settings of Blast2GO; the remaining 73,389 contigs with BLAST hits 
did not point to any GO terms. As A. annua is not a model organism and does not belong to a 
family of a model organism it is logical that a lot of contigs with BLAST hits were not 
annotated with GO terms. It is mostly for genes that show strong homologies with genes of 
model organism that one can expect a successful annotation using this strategy. Moreover, a 
gene that performs a different function but has a homology with a gene of a model organism, 
can be annotated wrongly.  
To further characterize our de novo Illumina transcripts, they were also compared to the 454 
glandular trichome A. annua contigs of Wang et al. [13]. Of their 42,678 contigs, 79% had a 
BLAST hit within our Trinity contigs. Vice versa, only 20% of our contigs had a BLAST hit 
within their contig set. This was not due to contamination of rRNA and tRNA reads that could 
have resulted from our method of mRNA amplification since only 0.6% of all our contigs 
showed a hit with rRNA or tRNA. Therefore the fact that the majority of our contigs are 
differential from those of Wang et al. is most likely the result from a greater coverage. 
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3.3 Influence of JA treatment 
The transcriptome of mock and JA-treated trichome samples was compared and no significant 
differences (adjusted p-value < 0.05) were detected. Accordingly, at the metabolite level, 
equal amounts of artemisinin, arteannuin B, dihydroartemisinic acid and artemisinic acid were 
measured with HPLC-MS/MS as shown in additional data [see Additional File 5 and 
Additional File 6]. This indicates that the JA-treatment did not have a major influence in our 
experimental set-up. This was not expected since Maes et al. measured higher artemisinin 
levels after JA treatment [1]. A possible explanation is the use of plants in different 
developmental stages: Maes et al. used young seedlings while in our RNASeq experiment 6-
months old plants with closed capitula were used. It has been shown that in flowers of 
Arabidopsis thaliana, JA levels increase 6.7-fold just before flower bud opening [42, 43]. 
Therefore it is plausible that endogenous JA-signalling already reached a maximum effect in 
our samples and that exogenous JA treatment did not trigger an additional response. 
3.4 Glandular versus filamentous trichomes 
Transcript levels from glandular trichomes and filamentous trichomes were compared to 
obtain a list of significantly differentially expressed contigs (adjusted p-value < 0.05). To 
make a robust statistical comparison, 3 samples of glandular trichomes with JA and 3 samples 
with mock-treatment were compared to the 6 samples (mock and JA) of filamentous 
trichomes. Of 150,288 contigs; 631 were significantly differentially expressed and all these 
contigs are listed in additional data [see Additional File 7]. From these, 204 contigs were 
more expressed in filamentous trichomes whereas, 427 contigs were more expressed in 
glandular trichomes. An overview with contigs discussed in this article and their normalized 
counts for each sample, log2-fold changes and adjusted p-values are shown in additional data 
[see Additional File 8]. 
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Figure 2: Differentially expressed MVA and MEP-pathway genes in glandular and 
filamentous trichomes.  
MapMan figure (adapted from [44]) with comparison of MVA and MEP pathways in 
glandular and filamentous trichomes. Significantly more expressed contigs in glandular 
trichomes are shown in red with colour scale to indicate the log2-fold changes. No contigs 
were significantly more expressed in filamentous trichomes. Grey represents contigs that were 
not significantly differentially expressed. MVA pathway: acetyl-CoA C-acetyltransferase 
(AACT), 3-hydroxy-3-methyl-glutaryl coenzyme A synthase (HMGS), 3-hydroxy-3-methyl-
glutaryl coenzyme A reductase (HMGR), mevalonate kinase (MVK), phosphomevalonate 
kinase (PMK), diphosphomevalonate decarboxylase (PMD), isopentenyl diphosphate 
isomerase (IDI). MEP pathway: 1-deoxy-D-xylulose-5-phosphate synthase (DXS), 1-deoxy-
D-xylulose-5-phosphate reductoisomerase (DXR), 2-C-methyl-D-erythritol-4-phosphate 
cytidylyltransferase (MCT), 4-cytidine 5’-diphospho-2-C-methyl-D-erythritol kinase (CMK), 
2-C-methyl-D-erythritol-2,4-cyclodiphosphate synthase (MCS), hydroxy-2-methyl-2-(E)-
butenyl 4-diphosphate synthase (HDS) and hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate 
reductase (HDR). 
3.5 MVA and MEP pathway in glandular and filamentous trichomes 
From the upregulated contigs, 5% in glandular and 0% in filamentous trichomes were 
involved in the mevalonate (MVA) or 2-C-methyl-D-erythritol 4-phosphate (MEP) pathways. 
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The MEP and MVA pathways produce isopentenyl diphosphate and its isomer dimethylallyl 
diphosphate, which are precursors for the production of terpenes.  
MEP and MVA pathways were detected in glandular and filamentous trichomes. All 
transcripts coding for enzymes of the MEP pathway were significantly upregulated in 
glandular trichomes (Figure 2). From the MVA pathway, only acetyl-CoA C-acetyltransferase 
(AACT) and 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) were significantly 
upregulated in glandular trichomes (Figure 2). Up-regulation of HMGR in glandular 
trichomes is important since it is shown that HMGR activity limits artemisinin biosynthesis 
[45, 46].  
3.6 Artemisinin biosynthesis in glandular and filamentous trichomes 
Terpene synthesis genes were accounting for 6% of the upregulated contigs in glandular 
trichomes and only 1% in filamentous trichomes. Starting from the MVA and MEP pathway, 
farnesyl diphosphate is synthesised by farnesyl diphosphate synthase (FDS) whose transcripts 
were not significantly upregulated in glandular trichomes (Figure 3 and Additional File 8). 
Subsequently, farnesyl diphosphate is converted to amorpha-4,11-diene which is the starting 
product for artemisinin biosynthesis. This reaction is catalyzed by amorpha-4,11-diene 
synthase (ADS) [47] and transcripts coding for this enzyme were detected more in glandular 
trichomes . By CYP71AV1, amorpha-4,11-diene is converted to artemisinic alcohol [4, 8]. 
Thereafter, artemisinic alcohol is oxidized by CYP71AV1 [4, 8] and alcohol dehydrogenase 1 
(ADH1) [11] to artemisinic aldehyde. Artemisinic aldehyde is further oxidized by aldehyde 
dehydrogenase 1 (ALDH1) [9] and CYP71AV1 [4, 8] to artemisinic acid or reduced by 
artemisinic aldehyde Δ11(13) double bond reductase (DBR2) [10] to form dihydroartemisinic 
aldehyde. A broad substrate oxidoreductase (RED1) can convert dihydroartemisinic aldehyde 
to dihydroartemisinic alcohol [48]. This reaction competes with ALDH1 using 
dihydroartemisinic aldehyde to form dihydroartemisinic acid [9]. Dihydroartemisinic acid is 
considered to be the precursor leading to artemisinin [10, 49, 50]. Transcripts corresponding 
to all these enzymes involved in the conversion of amorpha-4,11-diene to dihydroartemisinic 
acid were significantly upregulated in glandular trichomes, except for RED1 (Figure 3).  
These results confirm previous data pointing to glandular trichomes as the major artemisinin 
production site. A short dip in chloroform causes the collapse of the sub-cuticular space of 
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glandular trichomes and extracts almost all artemisinin [6, 51]. In addition to this, no 
artemisinin has been detected in a biotype of A. annua with only filamentous trichomes [6]. 
Nevertheless, in all samples of filamentous trichomes, transcripts corresponding to known 
artemisinin biosynthesis genes were detected, albeit at very low levels [see Additional File 8]. 
This is in agreement with previous reports, in which expression of ADS was also detected by 
RT-PCR in filamentous trichomes [13]. It should be noted though that in contrast, no staining 
of filamentous trichomes was observed in a promoter-GUS fusion study with the ADS 
promoter [52].  
 
Figure 3: Differentially expressed artemisinin biosynthesis genes in glandular and 
filamentous trichomes. MapMan file with comparison of artemisinin biosynthesis pathways 
in glandular and filamentous trichomes. Significantly more expressed contigs in glandular 
trichomes are shown in red with colour scale to indicate the log2-fold change. There were no 
contigs with higher expression in filamentous trichomes. Grey represents contigs that were 
not significantly differentially expressed. 
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3.7 Candidate genes for artemisinin biosynthesis 
Contigs that are upregulated in glandular trichomes are possibly linked to artemisinin 
biosynthesis genes. The subset of these contigs which were annotated as cytochromes, 
peroxidases and dioxygenases might be possible candidates for the endoperoxide ring 
formation in artemisinin. An overview of these contigs is given in Table 3, more results per 
repeat are given in additional data [see Additional File 8] 
Comp69 was detected 6 log2-fold more in glandular compared to filamentous trichomes. The 
best BLAST-hit was with CYP81B1 [GenBank: CAA04117] from Helianthus tuberosus. This 
enzyme is functionally characterized to hydroxylate medium-chain saturated fatty acids [53]. 
In addition to this, CYP81B1 can be assumed to epoxidize these fatty acids [53, 54]. In 
glandular trichomes, comp548_c0_seq1 and comp548_c0_seq2 were detected 5 log2-fold 
more than in filamentous trichomes, these contigs were annotated as P450 mono-oxygenase 
and showed homology with predicted sequences from the CYP82 family and CYP82C9v3 
[GenBank: XP_002327091] from Populus trichocarpa. This CYP82 family is relatively 
uncharacterized [55]. A characterized enzyme from this family is CYP82G1 [GenBank: 
Q9LSF8] from Arabidopsis thaliana which is involved in homoterpene biosynthesis in which 
epoxidation might occur [56, 57]. But this characterized protein was not present in the list of 
best-BLAST hits with comp548. Another cytochrome P450 significantly more expressed in 
glandular trichomes was comp2774. The full length of this transcript was determined by 
Misra et al. and called CIM_CYP03 (CYP72A) [GenBank: GU318227] [58]. The activity of 
this enzyme was tested in vitro with artemisinic acid, dihydroartemisinic acid, arteannuin B 
and artemisinin as substrates but no activity was detected [58]. Other contigs significantly 
more expressed in glandular trichomes were comp15043_c0_seq2 annotated as CYP76B1 and 
comp3673 as cytochrome P450. Comp586_c0_seq3 and comp586_c0_seq4 were annotated as 
a cytochrome c-type. Some other cytochromes were significantly more expressed in 
filamentous trichomes as shown in additional data [see Additional File 8]. 
Comp252 (seq1, seq3, seq4 and seq5), 2084 and 6217_c0_seq4_1 are peroxidases detected 
respectively 6 log2-fold, 4 log2-fold and 30 log2-fold more in glandular trichomes. Comp2084 
was more specifically annotated as peroxidase 49 precursor and comp6217 was annotated as 
gluthatione peroxidase. In filamentous trichomes, two contigs annotated as peroxidases were 
significantly more expressed than in glandular trichomes. These contigs are comp3274 
Chapter I: Transcriptome analysis of glandular and filamentous 
trichomes 
Part III 
 
123 
 
annotated as peroxidase 1 from A. annua and comp16324 as alkaline leaf peroxidase from 
Cyanara cardunculus. 
Annotation Contig 
Sum 
normalized 
counts of 
filamentous 
trichomes 
Sum 
normalized 
counts of 
glandular 
trichomes 
log2 Fold 
change 
Adjusted 
p-value 
Cytochromes           
CYP81 comp69_c0_seq1_1 1145 93262 5.9E+00 8.2E-05 
            
CYP82 comp548_c0_seq1_1 91 5887 5.2E+00 3.5E-03 
  comp548_c0_seq2_1 116 5247 4.8E+00 5.0E-02 
  sum 207 11134     
            
CYP76B1 comp15043_c0_seq2_
1 
0 269 3.2E+01 4.6E-02 
            
CYP72A comp2774_c0_seq1_1 14 1797 6.2E+00 9.1E-03 
            
CYP450 comp3673_c0_seq1_1 11 1656 6.4E+00 2.4E-02 
            
cytochrome c-type comp586_c0_seq1_1 27 3615 6.4E+00 1.3E-03 
  comp586_c0_seq3_1 21 4979 7.4E+00 3.5E-05 
  comp586_c0_seq4_1 0 157 3.1E+01 2.5E-02 
  sum 48 8752     
Peroxidases           
Peroxidase comp252_c0_seq1_1 79 6386 5.5E+00 9.1E-03 
  comp252_c0_seq3_1 20 1411 5.5E+00 1.3E-02 
  comp252_c0_seq4_1 73 6806 6.3E+00 4.5E-03 
  comp252_c0_seq5_1 8 922 6.8E+00 1.4E-02 
  sum 180 15525     
            
Peroxidase 49  comp2084_c0_seq1_1 134 3368 4.3E+00 3.0E-02 
            
Gluthatione peroxidase comp6217_c0_seq4_1 0 99 3.0E+01 4.5E-02 
            
Dioxygenases           
Flavanone  
3-hydroxylase 
comp225_c0_seq1_1 1352 26668 3.8E+00 1.0E-02 
Flavan ne  
3-hydroxylase 
comp453_c0_seq1_1 657 20961 4.5E+00 1.3E-02 
Table 3: Potential candidate genes for artemisinin biosynthesis. 
Potential candidate cytochromes, peroxidases and dioxygenases with a significantly higher 
expression level in glandular trichomes. The normalized counts of 6 samples with filamentous 
trichomes are summed and compared with 6 glandular trichome samples. Log2-fold changes 
are given as well as adjusted p-values. 
Two dioxygenases were significantly more expressed in glandular trichomes: 
comp225_c0_seq1 and comp453 were both annotated as naringenin 2-oxoglutarate 3-
dioxygenase (flavanone 3-hydroxylase). 
Part III Chapter I: Transcriptome analysis of glandular and filamentous 
trichomes 
 
124 
 
3.8 Other terpene synthases in glandular and filamentous trichomes 
Several contigs corresponding to enzymes involved in the biosynthesis of other 
sesquiterpenoids were significantly upregulated in glandular trichomes as well. These contigs 
are listed in the supplementary data [see Additional File 8]. Despite a higher germacrene-A 
synthase expression in glandular trichomes, germacrene-A was only detected in biotypes 
without glandular trichomes [59]. This can be the effect of up-regulation of germacrene-A 
oxidase which further oxidizes germacrene-A [60].  
In filamentous trichomes, contig comp2645 corresponding to 8-epi-cedrol synthase, was 
significantly upregulated [see Additional File 8]. Low expression of 8-epi-cedrol synthase in 
glandular trichomes has been observed by qRT-PCR [26]. In vitro, recombinant 8-epi-cedrol 
synthase converts farnesyl diphosphate to 8-epicedrol, cedrol and minor amounts of α- cedrene 
and (E)-β-farnesene [61, 62]. Since a higher amount of 8-epi-cedrol synthase was detected in 
filamentous trichomes, these trichomes might synthesize the majority of these metabolites. 
Differences in (E)-β-farnesene concentration in glanded and glandless biotypes were estimated 
from Tellez et al. by correlating relative peak area to the oil content in fresh plant material [59]. 
Based on these estimates, the level of (E)-β-farnesene is approximately 1.8 times higher in 
glandless biotypes. This might correlate with the upregulated expression of 8-epi-cedrol synthase 
in filamentous trichomes. From α-cedrene, only trace amounts were measured in glanded and 
glandless biotypes [59] and the major product cedrol epimers were even not detected in extracts 
of A. annua [61, 62].  
Regarding diterpenoid biosynthesis, only contigs annotated as momilactone A synthase were 
significantly more expressed in glandular trichomes [see Additional File 8]. Concerning 
monoterpenoid biosynthesis, many monoterpenoid synthases were significantly upregulated in 
glandular trichomes [see Additional File 8]. This is corroborated when comparing isoprenoid 
contents in glanded and glandless A. annua [59]. In oil from glanded biotypes, monoterpenes 
were predominant whereas in oil from glandless biotypes monoterpenes were almost absent.  
β-amyrin synthase, an enzyme that converts 2,3-oxidosqualene to the triterpene saponin β-
amyrin, has been characterized in A. annua [63]. This enzyme was represented in the de novo 
assembly by comp33386, comp59983, comp96251 and comp23239 and these contigs were not 
significantly differentially expressed. Contig comp7642_c0_seq2_1 shows homology with both 
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dammarenediol synthase and (β-)amyrin synthase and is a yet uncharacterized oxidosqualene 
cyclase (U_OSC). This contig was detected significantly more in filamentous trichomes [see 
Additional File 8]. 
3.9 Lipid biosynthesis in glandular and filamentous trichomes 
In glandular trichomes, 15% of the significantly upregulated contigs were annotated to lipid 
biosynthesis. Transcripts and their corresponding significantly differentially expressed contigs 
are listed in supplementary data [see Additional File 8]. Acetyl-CoA carboxylase converts 
acetyl-CoA to malonyl-CoA and was significantly upregulated in glandular trichomes as 
shown in Figure 4. Subsequently, malonyl CoA-acyl carrier protein transacylase converts 
malonyl-CoA to malonyl-ACP [64]. This transcript was not significantly upregulated. Fatty 
acid biosynthesis is initiated by the condensation of malonyl-ACP with acetyl-CoA by β-
ketoacyl-ACP synthase III (KAS). β-ketoacyl-ACP is reduced by β-ketoacyl-ACP reductase, 
dehydrated by β-hydroxyacyl-ACP dehydratase and reduced by enoyl-ACP reductase to yield 
butyryl-ACP. The latter transcripts except enoyl-ACP reductase were significantly more 
expressed in glandular trichomes as shown in Figure 4. The acyl-ACP end product has two 
carbons more than the original acetyl molecule [64]. Similar elongation cycles are continued 
with condensation of malonyl-ACP and acyl-ACP and the removal of the β-ketogroup. Three 
types of KAS were present with different acyl chain length specificities: KASIII (C2 to C4), 
KASI (C4 to C16) and KASII (C16 to C18) [64]. All 3 types of KAS were upregulated in 
glandular trichomes. 
Further extension of C16 and C18 to longer fatty acids requires their liberation from ACP by 
acyl-ACP thioesterase. Subsequently, fatty acids are exported out of the plastid to the 
endoplasmic reticulum [64]. The extension of fatty acids from long (C16,C18) to very long 
chains is catalyzed by β-ketoacyl-CoA synthase, β-ketoacyl-CoA reductase, β-hydroxyacyl-
CoA dehydratase and enoyl-CoA reductase [65]. The rate-limiting step and specificity is 
determined by the β-ketoacyl-CoA synthase which was significantly more expressed in 
glandular trichomes [see Additional File 8]. 
Fatty acyl-CoA reductase 1 (TFAR1) [1] was significantly more expressed in glandular 
trichomes. The encoded enzyme catalyzes the formation from acyl-CoA to fatty alcohols and 
is potentially involved in wax formation [1]. For the formation of unsaturated fatty acids, 
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omega-3 fatty acid desaturase is significantly upregulated in glandular trichomes. Contigs 
annotated as cyclopropane-fatty-acyl phospholipid synthase were highly expressed in 
glandular trichomes. This enzyme is forming a cyclopropane ring in unsaturated fatty acyl 
chains [66, 67]. Some contigs coding for lipid transfer proteins were significantly upregulated 
in glandular trichomes whereas other contigs coding for lipid transfer proteins were 
upregulated in filamentous trichomes [see Additional File 8]. 
The observed upregulation of lipid biosynthesis in glandular trichomes is in agreement with 
the results obtained by Tellez et al. [59], who measured that in glanded leaves 0.24% of fresh 
weight is oil and in glandless leaves only 0.06%.  
 
Figure 4: Differentially expressed lipid biosynthesis genes in glandular and filamentous 
trichomes.  
MapMan file with comparison of lipid biosynthesis pathways in glandular and filamentous 
trichomes. Significantly more expressed contigs in glandular trichomes are shown in red with 
colour scale to indicate the log2-fold change. There were no contigs with higher expression in 
filamentous trichomes. Grey represents contigs that were not significantly differentially 
expressed. 
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3.10 qRT-PCR 
Enrichment for artemisinin-synthesis and triterpene-synthesis related transcripts in glandular and 
filamentous trichomes, respectively, was verified by qRT-PCR [see Additional File 9]. In mock-
treated filamentous and glandular trichomes, similar expression levels were detected for Actin2, 
PP2AA3 and PPR protein in both RNASeq and qRT-PCR. Similarly, with both techniques, no 
clear difference in FDS was observed between both trichome types. With qRT-PCR, the mean 
expression levels of CYP71AV1, DBR2, Aldh1, Fatty acyl-CoA reductase 1 (TFAR1) and 10 
candidate genes for artemisinin biosynthesis were higher in glandular trichomes whereas the 
transcripts corresponding to uncharacterized oxidosqualene cyclase (U_OSC) and 8-epi-cedrol 
synthase were more abundant in filamentous trichomes. Hence, this qRT-PCR experiment 
confirmed the RNASeq data. 
4 Conclusions 
On the transcript level, MEP and MVA pathways were significantly upregulated in glandular 
trichomes in comparison with filamentous trichomes. In addition to this, transcripts coding for 
the artemisinin biosynthesis pathway, other sesquiterpene biosynthesis and monoterpene 
pathways were predominantly expressed in glandular trichomes. Novel cytochrome-, 
peroxidase- and dioxygenases-encoding genes highly expressed in glandular trichomes were 
detected and these might be potential candidate genes for the formation of the endoperoxide 
bridge in artemisinin. Lipid biosynthesis pathways were highly expressed in glandular 
trichomes and less in filamentous trichomes. In filamentous trichomes, some specific genes 
from sesquiterpenoid and triterpenoid pathways such as 8-epi-cedrol synthase and 
oxidosqualene cyclase were detected significantly more than in glandular trichomes. Between 
the transcriptome of apical and sub-apical cells from glandular trichomes, no differences 
could be observed in the expression of artemisinin biosynthetic enzymes.  
This transcriptome analysis underscores the vast metabolic capacities of A. annua glandular 
trichomes and simultaneously points to the existence of specific terpene metabolic pathways 
in the filamentous trichomes. Therefore, it would be interesting to examine metabolic 
activities in filamentous trichomes of other plant species. Besides this, it would also be 
interesting to characterize the potential candidate genes for artemisinin biosynthesis. If they 
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are involved in the production of artemisinin, they can be used to produce artemisinin in yeast 
cells. 
5 Supporting information  
Additional File 1 
 
Artemisia annua Anamed grown in 8h light, 16h night. 
Pictures of 7 months old Artemisia annua Anamed plants (A, B) grown in a growth room 
under 8h light, 16h night photoperiod. C: detail of the flower bud stage used to collect 
trichomes. 
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Additional File 2 
 
Trichomes on a flower head of A. annua. 
SEM picture of a flower head (capitulum) from A. annua Anamed with some bracts opened to 
show floret buds. On the floret buds, glandular trichomes are protruding whereas they are 
sunken in the capitulum bracts. Filamentous trichomes are abundantly present on the basal 
bracts. 
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Additional File 3 
Transcripts Primer sequences 
Actin 2 TCAGGCCGTGCTTTCTCTTT AGATGGGCACTGTATGGGAC 
PP2AA3 TACCATATACCGCACACGCC GGGAAGTTGTTACAGCCCCA 
PPR GGGAAACTTAAGGTTGCGGT ACCATCCCGAGAGTACCCAT 
FDS CCCGAGGTGATTGGAAAGATTG
[1]
 CGAATACAGCCTGAAGATTGAGAG
[1]
 
CYP71AV1 CGAGACTTTAACTGGTGAGATTGT
[26]
 CGAAGCGACTGAAATGACTTTACT
[26]
 
DBR2 ATGGAAGTGAGGAGGAAG
[1]
 AAACAAGGTCAGGATTCG
[1]
 
Aldh1 TCGGAGTAGTTGGTCACATC
[1]
 TCACGCCATCAGGAACAC
[1]
 
P450 comp69 CTATTGCGCTTTGGGTCACG GTAATCGAGGGCGGTTAGCA 
P450 comp2774 TTTGATTGGGGGTTGCCAGA CATGGTTAACCCCGGCAAAA 
P450 comp 15043 TTGTGGACTTGTTTGTGGCG GTGTGCGGGTTGCGTAGAA 
P450 comp 3673 AGCGAGGATCACGTTGCATT GCGGTCACCACATGAGGATT 
P450 comp 548 GCACTCCAAGAGTTGCGGAT AGTAATTCCCGCGCTTTCAG 
Per comp2084 TTCGTACAGGGCTGTGATGG TGGGTGCGTTCTTTTCTCCT 
Per comp252 CAGGTCAGACCAGCAGTTGT CCGCGAAATCCTCATGGAAAC 
Per comp6217 TTCTAGTCGACCGTGAGGGA TTCTCGATGCTGAGTGGACTG 
Diox comp225 AGGAGAAGCGGTGCAAGATT AACTGCCCTCCACTCTTTGG 
Diox comp453 GGTGGCGAAGACTTGGTCTA CATGTCGGTATGTGGGGCTA 
TFAR1 CAAACCCTTTTCAGTTCACCA
[1]
 ATGACAGCCTTTCCATCCTTT
[1]
 
U_OSC CGGTCGAGCGTCAAGAAGTA CGCATAAGCAAATCACCGCA 
epi-cedrol synthase TTGGTTCCCATAAGGGCGAG CGTAGGCTTGTTGCTCGCTA 
Primers for qRT-PCR. 
Overview of primer sequences used for qRT-PCR. 
Additional File 4: Transcriptome assembly of trichomes from Artemisia annua. 
All 150,288 de novo assembled sequences and their contig-numbers generated with Trinity. 
This list is provided in the supplementary CD. 
Additional File 5: Metabolite concentrations in flower heads of mock- and JA-treated 
plants. 
After sampling for RNA extraction, metabolites from remaining flower heads were separately 
extracted by a 1 min chloroform-dip [51]. Artemisinin, arteannuin B, dihydroartemisinic acid 
and artemisinic acid were quantified by means of a HPLC-MS/MS method, developed by Van 
Nieuwerburgh et al., with following modifications [51]. The mobile phase of pump A 
consisted of ULC-MS pure water (Biosolve, Valkenswaard, the Netherlands) with 0.1% 
formic acid (Biosolve) and the mobile phase of pump B was 90% ULC-MS pure acetonitrile 
(Biosolve) and 10% water with 0.1% formic acid. Metabolites were separated in a run of 34 
minutes (40% A and 60% B for 8 minutes, linear gradient of 9 minutes to 15% A and 85% B, 
100% B for 5 minutes, 40% A and 60% B for 12 minutes). The capillary voltage of the ESI-
source was 2.4 kV and the flow rate of nitrogen as desolvation gas was 400 l/h. Argon was 
used as a collision gas at 0.9 bar. The collision energy for dihydroartemisinic acid was set at 
12 eV (m/z 237→163 + 191 + 201 + 219) and for arteannuin B the collision energy was 10 
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eV (m/z 249→185 + 189 + 231). The internal standard used was santonin with the collision 
energy set at 9 eV (m/z 247→173.2 + 201.2). For the other compounds, the same settings 
were used as in Van Nieuwerburgh et al. [51]. Standards santonin (I.S.) and artemisinin were 
supplied by Sigma-Aldrich, arteannuin B and artemisinic acid by the Walter Reed Army 
Institute of Research (Washington, U.S.A.) and dihydroartemisinic acid was donated by 
Patrick Covello (National Research Council Canada). 
 
Metabolite concentrations in flower heads of mock- and JA-treated plants.  
Metabolite concentrations are shown in µg per g fresh flower head material of mock-treated and JA-treated plants. The results of all 3 repeats 
are shown separately. The concentration shown for each repeat is the average concentration of metabolites from 3 plants. The material for 
HPLC-MS/MS was derived from the same plants used for RNASeq. A: artemisinin, B: arteannuin B, C: dihydroartemisinic acid and D: 
artemisinic acid concentrations were measured. Equal quantities of artemisinin, arteannuin B, dihydroartemisinic acid and artemisinic acid 
were detected in mock- and JA-treated flower buds. Error bars represent standard deviations. 
Additional File 6: Metabolite concentrations in entire plant material of mock- and JA-
treated plants. 
After sampling for RNA extraction, metabolites from remaining plant material were 
separately extracted by a 1 min chloroform-dip [51]. Artemisinin, arteannuin B, 
dihydroartemisinic acid and artemisinic acid were quantified by means of a HPLC-MS/MS 
method, developed by Van Nieuwerburgh et al., with following modifications [51]. The 
mobile phase of pump A consisted of ULC-MS pure water (Biosolve, Valkenswaard, the 
Netherlands) with 0.1% formic acid (Biosolve) and the mobile phase of pump B was 90% 
ULC-MS pure acetonitrile (Biosolve) and 10% water with 0.1% formic acid. Metabolites 
were separated in a run of 34 minutes (40% A and 60% B for 8 minutes, linear gradient of 9 
minutes to 15% A and 85% B, 100% B for 5 minutes, 40% A and 60% B for 12 minutes). The 
capillary voltage of the ESI-source was 2.4 kV and the flow rate of nitrogen as desolvation 
gas was 400 l/h. Argon was used as a collision gas at 0.9 bar. The collision energy for 
dihydroartemisinic acid was set at 12 eV (m/z 237→163 + 191 + 201 + 219) and for 
arteannuin B the collision energy was 10 eV (m/z 249→185 + 189 + 231). The internal 
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standard used was santonin with the collision energy set at 9 eV (m/z 247→173.2 + 201.2). 
For the other compounds, the same settings were used as in Van Nieuwerburgh et al. [51]. 
Standards santonin (I.S.) and artemisinin were supplied by Sigma-Aldrich, arteannuin B and 
artemisinic acid by the Walter Reed Army Institute of Research (Washington, U.S.A.) and 
dihydroartemisinic acid was donated by Patrick Covello (National Research Council Canada). 
 
Metabolite concentrations in entire plant material of mock- and JA-treated plants.  
Metabolite concentrations are shown in µg per g fresh plant material of mock-treated and JA-treated plants. The results of all 3 repeats are 
shown separately. The concentration shown for each repeat is the average concentration of metabolites from 3 plants. The material for 
HPLC-MS/MS was derived from the same plants used for RNASeq. A: artemisinin, B: arteannuin B, C: dihydroartemisinic acid and D: 
artemisinic acid concentrations were measured. Equal quantities of artemisinin, arteannuin B, dihydroartemisinic acid and artemisinic acid 
were detected in mock- and JA-treated flower buds. Error bars represent standard deviations. 
Additional File 7: Significant differences in transcriptome expression in glandular and 
filamentous trichomes. 
List with all contigs that are significantly differentially expressed in glandular and 
filamentous trichomes. This list is provided in the supplementary CD. 
Additional File 8: Overview from the commented differences between glandular and 
filamentous trichomes. 
Overview of all contigs discussed in this article including calculation of log2-fold changes and 
adjusted p-values. This list is provided in the supplementary CD. 
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Additional File 9: qRT-PCR Results. 
 
qRT-PCR analysis on filamentous and glandular trichomes. 
Bar chart showing qRT-PCR results on Nugen amplified material and on top the abundance of 
the corresponding transcripts in the RNASeq data (similar, decreased or enhanced abundance 
in filamentous and glandular trichomes). Of 3 biologic repeats, geometric averages from 
relative quantities were calculated with qbasePLUS and shown against a linear scale with as 
error bars the standard errors of the geometric mean. CF and CG represent mock-treated 
filamentous and glandular trichomes, respectively. 
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The discovery of new candidate genes more expressed in glandular trichomes and potentially 
involved in the production of artemisinin, was reported in Chapter I. In the current Chapter, 
HPLC-MS/MS experiments were performed to find the exact location of artemisinin and its 
bio-precursors inside the glandular trichomes. In literature, there were indications that the 
artemisinin precursors were synthesized on top of the glandular trichomes, in the apical cells. 
Therefore, apical and sub-apical cells were collected to determine the metabolite levels. 
Besides the metabolite experiments, transcriptome experiments were executed on these cell 
types to investigate if all known artemisinin biosynthesis genes are expressed in apical and 
not in sub-apical cells and to see in which cell type the new candidate genes were expressed. 
The technical optimizations from Part II were used during the transcriptome analysis: RNA 
was collected as optimized in Part II Chapter II, amplified and the library was prepared 
according to the post amplification ligation-mediated strategy barcoding protocol from Part II 
Chapter III and sequenced on the Illumina HiSeq platform. 
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1 Introduction  
Secretory cells from glandular trichomes are distinguishable in a pair of apical cells on top of 
the trichome and two pairs of sub-apical cells below. These cells are morphologically 
different: apical cells contain proplastids or leucoplasts instead of normal chloroplasts in sub-
apical cells [68]. This raised the question whether these morphological differences imply a 
division of biosynthetic function [68]. For example, is artemisinin produced in only one cell 
type or in all secretory cells? To address this question, Olsson et al. collected apical and sub-
apical cells with laser capture microdissection to determine which genes were expressed in 
both cell types [69]. In both cells, transcript expression of farnesyl diphosphate synthase was 
detected. This enzyme catalyzes the formation of farnesyl diphosphate which is a general 
precursor for sesquiterpenes and triterpenes. Transcriptional expression of ADS, CYP71AV1 
and DBR2, three enzymes involved in artemisinin biosynthesis, was detected only in apical 
cells and not in sub-apical cells [69]. This indicated that artemisinic acid and 
dihydroartemisinic aldehyde are produced in the apical cells of the glandular trichomes. As 
the last steps of the artemisinin biosynthesis pathway are unknown, this conclusion cannot be 
drawn for artemisinin itself.  
Therefore, in this PhD project, efforts were made to localize artemisinin itself by performing 
metabolite analysis on apical, sub-apical cells and the content of the sub-cuticula space from 
A. annua glandular trichomes. Laser capture microdissection was used to collect the cells and 
the sub-cuticular space was sampled with micropipetting. Artemisinin and its precursors were 
measured with a previously in-house developed HPLC-ESI-Q-TOF tandem mass 
spectrometry method [51]. 
Since Olsson et al. [69] detected transcript expression of artemisinin biosynthesis genes only 
in apical cells, a comparison of apical and sub-apical cells with RNASeq might lead to the 
discovery of other genes involved in artemisinin biosynthesis. Therefore, the transcriptome of 
apical and sub-apical cells was analysed with 2
nd
 generation sequencing. For this, the 
experimental procedure used was similar to the RNASeq on glandular and filamentous 
trichomes in Part III Chapter I. 
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2 Materials and methods 
2.1 Plant material 
Seeds were sterilized as explained in Part III Chapter I Paragraph 2.2. For metabolite and 
transcriptome analysis, two different cultivars were used.  
For metabolite analysis, seeds from A. annua cultivar Brazil (line 2/39) were provided by Patrick 
Covello (National Research Council Canada). These plants were grown in a growth room with a 
12h day/12h night regime for a few months and then transferred to a greenhouse (16h day/8h 
night) for length growth. After a few months, the plants were transferred back to the growth 
room to initiate flowering. 
For transcriptome analysis, A. annua cultivar Anamed (http://www.anamed.net) was used. These 
plants were grown under a regime with 8 hours day and 16 hours night. After 6 months, flower 
heads appeared. 
2.2 Collection techniques 
2.2.1 Laser capture microdissection for metabolite analysis 
To measure the presence of artemisinin and its (proven and hypothetical) bio-precursors: 200 
apical and 200 sub-apical cells were isolated by laser capture microdissection from fixated 
flower head buds. Fixation was carried out by subjecting the samples to a 4% formaldehyde 
(Merck, Hohenbruhn, Germany) in phosphate buffered saline (Gibco, Paisly, UK) solution for 
3 to 4 hours in vacuum [69]. Glandular and filamentous trichomes were collected as well but 
for this, plant material was not fixated. Closed flower heads were cut finely in ULC-MS pure 
water (Biosolve, Valkenswaard, the Netherlands) or fixative and samples were microdissected 
and catapulted with a laser microscope in ULC-MS pure water. 
2.2.2 Laser capture microdissection for transcriptome analysis 
For the transcriptome experiment, 300 unfixated apical and sub-apical cells were collected. 
Flower head buds were cut into pieces in a cold buffer with 25 mM MOPSO (pH6.3) (Sigma-
Aldrich), 200 mM sorbitol (Alfa Aesar, Karlsruhe, Germany), 10 mM sucrose (Acros, Geel, 
Belgium), 5 mM thiourea (Sigma-Aldrich), 2 mM DTT (Fluka, Sigma-Aldrich), 5 mM 
MgCl2 (Sigma-Aldrich) and 0.5 mM sodium-phosphate (Acros) [26]. Cells were separated 
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with laser microdissection and captured with laser pressure catapulting (Figure 5). As 
explained in Part II Chapter II, formaldehyde deteriorates the yield and quality of extracted 
RNA but laser microdissection of unfixated apical and sub-apical cells was very difficult. 
Therefore, in another set of samples, 500 fixated cells of each cell-type were collected for 
transcriptome analysis. All cells for transcriptome analysis were collected in 30 µl of lysis 
buffer with β–mercaptoethanol from the Absolutely Nanoprep kit (Stratagene, La Jolla, CA, 
USA).  
 
Figure 5: Laser capture microdissection of apical and sub-apical cells. 
Laser capture microdissection with P.A.L.M of fixated apical and sub-apical cells from 
glandular trichomes of A. annua (scale bar is 25 µm). 
2.2.3 Micro-manipulation for metabolite analysis 
To determine which metabolites are stored in the sub-cuticular cavity, it is impossible to use 
laser microdissection since the sub-cuticular cavity is not enclosed by one continuous 
membrane. Therefore, it was attempted to collect the fluid from the sub-cuticular cavity with 
a micro-pipette. This technique is called micro-manipulation (see Figure 6) and was executed 
with an Olympus IX70 microscope. 
Closed flower heads were chopped up with a scalpel on a glass plate and then transferred to a 
petri dish. Ultra pure water was poured with care in the petri dish so the fragments remained 
on the bottom. To avoid cell debris which can obstruct the pipette, fragments with a lot of 
trichomes were selected and transferred to another petri dish and again ULC-MS pure water 
was gently poured over it. Pipettes made of micro capillaries (Drummond Scientific Co.) with 
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an average diameter of 200 µm (holding pipette) and 1µm (sample collecting pipette) were 
filled with mineral oil (Western Family). The sample collecting pipette was filled at the top 
with dimethylpolysiloxane (viscosity 12,500 cSt 25°C supplied by Sigma-Aldrich). To enable 
visual control of the fluid in the collecting pipette, ultra pure water was aspirated first which 
visualized the boundary between dimethylpolysiloxane and the oily fluid aspirated from the 
sub-cuticular cavity. 
 
Figure 6: Micro-manipulation system. 
The micro-manipulation system with a holding pipette and a collecting pipette, A: picture of 
an Olympus IX70 microscope for micro-manipulation, B: schematic overview of important 
components in a micro-manipulation device with an example of intra cytoplasmic sperm 
injection. 
(A: http://www.sycos.co.kr/product/index.php?act=eppen&cate=inject_NK2, B: [70]) 
With a holding pipette, the plant material was fixed while the sample collecting pipette was 
inserted in the sub-cuticular cavity. To confirm the presence of the micropipette in the sub-
cuticular cavity, the fluid was aspirated, respirated and again aspirated for collection. This 
was microscopically observed as respectively shrinking, expansion and shrinking of the sub-
cuticular cavity. The sample fluid was collected in a drop of ULC-MS pure water in another 
petri dish and transferred to a tube. The place where the drop of water was located in the petri 
dish was rinsed with another drop of water and also transferred to the tube. During fixation, 
crystals were formed in the sub-cuticular cavity as shown in Figure 7 and these crystals were 
not collected with micro-manipulation. Therefore, the experimental setup was changed to 
unfixated plant material to collect the content of the sub-cuticular cavities from 50 trichomes. 
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Figure 7: Micro-manipulation on fixated glandular trichomes. 
The content of the sub-cuticular cavity of glandular trichomes from A. annua collected with 
micro-manipulation (scale bar not available but glandular trichomes are approximately 37µm 
in size). 
2.3 Analysis methods 
2.3.1 Metabolite analysis with HPLC-MS/MS 
Artemisinin, arteannuin B, dihydroartemisinic alcohol, artemisinic alcohol, 
dihydroartemisinic acid, artemisinic acid, dihydroartemisinic aldehyde and artemisinic 
aldehyde were quantified by means of a HPLC-MS/MS method, adapted from Van 
Nieuwerburgh et al. [51]. The samples were pooled, sonicated (40 kHz) in an ultrasonic bath 
for 5 min, diluted to 50/50 H20/ACN with 0.1% formic acid and 0.1 ng/µl santonin as internal 
standard (I.S.) and 100 µl was injected for analysis. 
Chromatographic separations were performed on an Alltech Ultrasphere C18 IP 5µm column 
(150 x 2.1 mm). To protect the column, a Walters Xterra MS C18 5 µm guard column (2.1 x 
10 mm) was used. A Waters Alliance 2695 HPLC system was used to deliver the mobile 
phase at a flow rate of 0.2 ml/min. Pump A contained ULC-MS pure water (Biosolve, 
Valkenswaard, the Netherlands) with 0.1% formic acid (Biosolve), pump B 90% ULC-MS 
pure acetonitrile (Biosolve) and 10% water with 0.1% formic acid. Metabolites were 
separated in a run of 34 minutes: 40% A and 60% B for 8 minutes, linear gradient of 9 
minutes to 15% A and 85% B, 100% B for 5 minutes and finally 40% A and 60% B for 12 
minutes. Retention times were 4.21 minutes for santonin, 6.68 for arteannuin B, 8.78 for 
artemisinin, 15.55 for dihydroartemisinic acid, 16.36 for artemisinic acid, 16.99 for 
artemisinic alcohol, 17.94 minutes for dihydroartemisinic alcohol and 23.10 for artemisinic 
aldehyde. To divert ¼ to the LC/MS interface, a LC Packings ACUrateICP-04-20post-column 
splitter was used.  
A Q-TOF Ultima mass spectrometer (Micromass, Manchester, UK) with an electrospray 
source in positive mode was used for the detection. The capillary voltage was optimized at 2.4 
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kV. Source and desolvation temperature were respectively 130 and 300 °C. As desolvation 
gas, N was used with a flow rate of 400 l/h. Argon was used as collision gas at 0.9 bar. The 
collision energy for artemisinin was set at 7 eV (m/z 283.2→219.2 + 229.2 + 247.2 + 265.2), 
for arteannuin B 10 eV (m/z 249.2→185.2 + 189.2 + 231), dihydroartemisinic alcohol 9 eV 
(m/z 223.2→149.2 + 165.2+ 205.2), artemisinic alcohol 8 eV (m/z 221.2→203.2), 
dihydroartemisinic acid 12 eV (m/z 237.2→163.2 + 191.2  + 201.2 + 219.2), artemisinic acid 
11 eV (m/z 235.2→189.2 + 199.2 + 217.2) and artemisinic aldehyde 11 eV (m/z 
219.2→145.2 + 159.2 + 201.2). The internal standard used was santonin with the collision 
energy set at 9 eV (m/z 247→173.2 + 201.2). Standards santonin (I.S.) and artemisinin were 
supplied by Sigma-Aldrich, dihydroartemisinic acid, artemisininic alcohol, artemisininic 
aldehyde and dihydroartemisinic alcohol were donated by Patrick Covello (National Research 
Council Canada) and arteannuin B as well as artemisinic acid by the Walter Reed Army 
Institute of Research (Washington, U.S.A.). To ensure the specificity, only the sum of the 
fragments in MS/MS was used for quantification of the compounds. 
2.3.2 Transcriptome analysis with Illumina RNASeq 
RNA was extracted with the Absolutely RNA Nanoprep kit including a DNase treatment and 
the purified RNA was eluted in 10 µl. Of the RNA from the fixated samples, 5 µl was used as 
input for amplification. The 10 µl RNA from the unfixated samples was split in two and each 
subsample was separately amplified to create a third sample set for sequencing. 
Samples were amplified with a linear amplification system: Ovation RNA-Seq with 1 h 30 
min Spia-amplification (NuGen, AC Bemmel, The Netherlands). Illumina sequencing 
libraries were made by using a post amplification ligation-mediated strategy as explained in 
Part II Chapter III [27]. These samples were sequenced together with the glandular and 
filamentous trichomes with a read-length of 100 bp in 3 lanes of an Illumina HiSeq 2000 
flowcell. Bioinformatics analysis was performed as described for glandular and filamentous 
trichomes in Chapter I. 
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3 Results and discussion 
3.1 Metabolite analysis 
The content of 50 unfixated sub-cuticular cavities was sampled with micro-manipulation and 
after HPLC-MS/MS, metabolite concentrations were recalculated to amounts per glandular 
trichome as shown in Figure 8. This facilitates the comparison with several types of trichome 
samples such as apical, sup-apical and complete glandular trichomes. HPLC-MS/MS revealed 
high levels of dihydroartemisinic acid and artemisinic acid which were above the limit of 
quantification. The peak of artemisinin showed a peak-to-noise ratio of 2.5 and the other 
metabolites were not detected. 
 
Figure 8: HPLC-MS/MS analysis of the content from the sub-cuticular cavity of 
glandular trichomes. 
This graph represents the amounts of dihydroartemisinic acid (DHA-acid) and artemisinic 
acid (A-acid) detected in the sub-cuticular cavity of glandular trichomes with HPLC-MS/MS. 
The amount is adjusted to the amount per trichome. Since only one measurement was 
performed, standard deviations are not available. 
Another approach to find which metabolites are abundantly present in the sub-cuticular cavity 
was to collect unfixated glandular trichomes with intact sub-cuticular cavity and compare this 
to glandular trichomes from which the sub-cuticular cavity was removed. All trichomes were 
collected from one plant in three repeats. HPLC-MS/MS analysis of the same amount of 
trichome equivalents as in micro-manipulation, detected no artemisinin. As illustrated in 
Figure 9, dihydroartemisinic acid and artemisinic acid were detected in higher levels in 
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glandular trichomes with intact sub-cuticular cavities. This was consistent with the relatively 
high levels of dihydroartemisinic acid and artemisinic acid detected in fluid collected from 
these sub-cuticular cavities. The ratio of dihydroartemisinic acid to artemisinic acid was the 
same in fluid from sub-cuticular cavities, trichomes with and without sub-cuticular cavity.  
 
Figure 9: HPLS-MS/MS analysis of the glandular trichomes with sub-cuticular cavity 
and glandular trichomes with removed sub-cuticular cavity. 
This graph represents the amounts of dihydroartemisinic acid and artemisinic acid detected in 
glandular trichomes with and without sub-cuticular cavity. The sub-cuticular cavity was 
removed by LCM and metabolite amounts are adjusted to the amount per trichome. Error bars 
represent standard deviations from 3 repeats on one plant of A. annua. 
However, it should be noted that despite the same trends observed in both experiments, more 
dihydroartemisinic acid and artemisinic acid was detected in the sub-cuticular cavities alone 
than in the glandular trichome with intact sub-cuticular cavities (comparison of Figure 8 and 
Figure 9). Both tests were executed on another plant of the same cultivar and therefore, 
biological variation in artemisinin production might contribute to differences in metabolite 
levels. Another explanation might be that coeluting metabolites in the trichome cells caused 
ion suppression [71]. Sonication is well suited to extract metabolites from small samples [72] 
but it is possible that not all metabolites were extracted after 5 min. sonication of glandular 
trichomes in a sonication bath [73]. Another possible explanation for these discordant 
amounts of dihydroartemisinic acid and artemisinic acid detected after micro-manipulation 
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and laser capture microdissection might be the influence of the UV-A laser in the latter 
collection technique. 
 
Figure 10: Influence of UV-A radiation on metabolite levels. 
A standard of 0.8 ng/µl of each metabolite was irradiated for 1 hour with an UV-A laser and 
afterwards 8-fold diluted. Peak areas were compared to a standard of 0.1 ng/µl. Error bars 
represent standard deviation of 3 repeats. 
As explained in Part I Chapter II Paragraph 4.2, dihydroartemisinic acid can be foto-
chemically converted to artemisinin [5, 74] and therefore, the influence of UV-A light was 
investigated. A standard of 0.8 ng/µl of each standard metabolite (see page 143) in 50/50 
H20/ACN with 0.1% formic acid was irradiated on a glass slide for one hour by continuous 
laser pulses. To rinse the glass slide, the sample was diluted 8-fold to 0.1 ng/µl (with 
correction for evaporation) and compared to a standard of 0.1 ng/µl. In Figure 10, average 
peak areas were given for three technical repeats. The levels of artemisinin and arteannuin B 
were relatively constant with or without UV-A radiation but the levels of the other 
metabolites were clearly reduced with UV-A radiation. Precaution should be taken to 
extrapolate these results in H20/ACN medium with 0.1% formic acid to metabolites in a 
cellular environment. It is possible that UV-A radiation contributed (partially) to the 
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discordant metabolite concentrations measured in the micro-manipulated and laser capture 
microdissection samples.  
After analysing the content of the sub-cuticular cavity, experiments were focussed to cells of 
the glandular trichomes. Despite the possibly adverse effect of the UV-A laser, laser capture 
microdissection was the best suited method for separation and collection of specific trichome 
cells. Therefore, apical and sub-apical cells were collected and the equivalent of 90 cells in 
50/50 H20/ACN with 0.1% formic acid was injected for HPLC-MS/MS. As shown in Figure 
11, only the metabolites artemisinin, dihydroartemisinic acid and artemisinic acid were 
detected in apical cells in the first two experiments. In sub-apical cells, only 
dihydroartemisinic acid and artemisinic acid were detected but no artemisinin was observed. 
In a third test, artemisinin was not detected in apical and sub-apical cells (Figure 11). 
Additional experiments were performed but with inconsistent results. In some tests, 
artemisinin was not detected in apical cells and in another cultivar (Anamed), artemisinin was 
at the limit of detection in both apical and sub-apical cells.  
 
Figure 11: Metabolite analysis of apical and sub-apical cells. 
Only artemisinin, dihydroartemisinic acid and artemisinic acid were detected. Results are 
given from 3 independent experiments. The bar with an * was above the detection limit but 
below the quantification limit. Artemisinin was never detected in sub-apical cells. 
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Therefore, as negative control, filamentous trichomes were collected and the equivalent of 83 
trichomes was injected for HPLC-MS/MS. Artemisinin was detected with a peak-to-noise 
signal of 4 which was higher than the level detected in 90 apical cells of the same plant. This 
was not as expected since biotypes of A. annua with only filamentous trichomes lack 
artemisinin production [6]. Because of this, it was investigated if the detection of artemisinin 
in isolated filamentous trichomes might originate from contamination caused by the plant 
sample. 
For laser capture microdissection, closed flower heads were immersed in ULC-MS pure water 
(or fixative) and cut up into pieces. Metabolites can be present in the wax layer surrounding 
the plant tissues or can be released during cutting. To test the order of magnitude of this 
potential contamination, 15 intact flower head buds were incubated for 30 min. in 300 µl 
ULC-MS pure water, plant material sinked to the bottom and wash water was collected. After 
12 washing steps, flower head buds were cut finely and washed in 3 subsequent steps. No 
trichomes were present in the washing water. Water from washing step 1 and 12 of intact 
flower head buds was analyzed with HPLC-MS/MS and to investigate if subsequently cutting 
the flower head buds increased the metabolite release, the washing water after cutting flower 
head buds was also analyzed. For HPLC-MS/MS, 50 µl wash water was eluted to 200 µl 
50/50 H20/ACN with 0.1% formic acid. Three tests were performed on one plant. As 
illustrated on Figure 12, (undiluted) water from the first rinse of intact flower head buds 
contained between 0.75 and 1.2 ng/µl artemisinin. This level is relatively high (Figure 12) if 
compared to the amount measured in apical samples (Figure 11). Even in the 12
th
 washing 
step, artemisinin was still present. After cutting these flower heads, additional artemisinin was 
released in the washing water. Artemisinic alcohol, artemisinic aldehyde and 
dihydroartemisinic alcohol were below the limit of detection. 
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Figure 12: Metabolite analysis of wash water. 
HPLC-MS/MS analysis of metabolites released in water if flower head buds were incubated 
for 30 min in 3 experiments. Wash 1 and wash 12 were analyzed and after wash 12, flower 
head buds were cutted and washed again. The other metabolites were below the limit of 
detection. 
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Therefore, the conclusion was made that arteannuin B, artemisinin, dihydroartemisinic acid 
and artemisinic acid were present in relatively high levels in the water on the glass slide for 
laser capture microdissection. This raised the question whether this can cause contamination 
in the collection tube? To simulate this effect, flower head buds of A. annua were cut into 
pieces and for 30 min. incubated in water as shown in Figure 13. The volume of water added 
per flower head bud and incubation time was the same as for laser capture microdissection of 
glandular, filamentous trichomes, apical and sub-apical cells. This washing water (without 
plant tissues) was pipetted on a glass slide, leaf material from mint was added and mint 
glandular trichomes were collected from this liquid.  
Two tests were performed: one to enhance potential contamination: if the slide was drying, up 
to two times extra washing water was added to collect 55 mint trichomes and in another test to 
mimic the normal contamination level: if the slide was dried, a new slide was made to collect 
45 mint trichomes. In the test that mimicked the normal contamination level, artemisinin was 
detected with a peak-to-noise ratio of 4 and dihydroartemisinic acid was 0.038 ng per 
collected glandular mint trichome. With the addition of extra washing water upon 
evaporation, the amount of artemisinin, dihydroartemisinic acid and artemisinic acid 
measured per glandular mint trichome was respectively 0.011, 0.038 and 0.026 ng. The other 
metabolites were not detected. 
 
Figure 13: Test for contaminating metabolites during laser capture microdissection. 
Finely cut flower head buds of A. annua were incubated in water for 30 min. This water was 
collected and pipetted on a glass slide. A leaf of mint was finely cut and mint glandular 
trichomes were collected with laser capture microdissection. The red dots represent 
artemisinin-related metabolites dissolving in the incubation water. 
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As shown with mint trichomes, metabolites from the outer plant surface and from cutted cells 
of A. annua, dissolve in the aqueous preparate and cause contamination of the laser capture 
microdissection samples. Therefore, it is required to put all data from paragraph 3.1 into 
perspective with this contamination problem and this makes it extremely difficult to draw 
conclusions. We can conclude that it was not possible to locate artemisinin in one or another 
cell type of the glandular trichomes and it seems that there is a lot of arteannuin B, 
artemisinin, dihydroartemisinic acid and artemisinic acid present on the outer surface of the 
flower head buds. These results were probably not caused by incubation in hypotonic ULC-
MS pure water since similar results were obtained by incubation in phosphate buffered saline 
but it must be noted that the HPLC-MS/MS method was not validated for detecting natrium-
adducts. The possible presence of these metabolites on the outer plant surface was also in line 
with the fact that during a 5 sec. chloroform dip, 97% from all artemisinin was extracted from  
leaf tissue [6]. 
3.2 Transcriptome analysis 
For RNASeq of glandular and filamentous trichomes, more input material was available than for 
apical and sub-apical cells. The small number of micro-dissected apical and sub-apical cells 
yielded a suboptimal amount of input for the Ovation RNA-Seq amplification. Because of this, 
amplification was expected to be biased towards high abundant transcripts. Additionally, a high 
variation in the counts of low abundant transcripts was expected. Therefore less stringent settings 
were chosen (prior.n=estimated) by using a more tagwise dispersion. Out of 150,288 contigs, 
195 contigs were reported as significantly differentially expressed (adj. p-value < 0.05). From 
these differences, 66 contigs were more expressed in apical cells, and 129 more in sub-apical 
cells. If these differences were examined, no clear connection was observed with functional 
metabolic pathways. 
Normalized counts for artemisinin biosynthesis genes are shown in Figure 14 but none of the 
genes involved in artemisinin biosynthesis was significantly differentially expressed. This is 
contradictory to the results published in 2009 by Olsson et al. [69] who detected expression of 
artemisinin biosynthesis genes solely in apical cells. While our experiment was executed, the 
same research group presented in 2012 another manuscript in which they did more elaborate 
qRT-PCR tests [26]. Finally, they concluded that artemisinin biosynthesis genes are expressed in 
both apical and sub-apical cells and this is in agreement with our RNASeq data. 
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If the data set was analyzed with more strict settings as used for the analysis of glandular and 
filamentous trichomes: edgeR parameter prior.n set to 1, no significant differences were obtained 
with adjusted p-value < 0.05. 
 
Figure 14: Expression of artemisinin biosynthesis genes in apical and sub-apical cells 
from glandular trichomes. 
Normalized counts for artemisinin biosynthesis genes in apical (AP) and sub-apical (SA) 
cells. Error bars represent standard deviations. 
4 Conclusions 
Attempts to analyze metabolite levels of artemisinin and its bio-precursors in apical or sub-
apical cells and glandular or filamentous trichomes were not successful. The reason for this 
was that the surface of the plant is covered with a wax layer which contains a variety of 
secondary metabolites including artemisinin. Therefore it was impossible to distinguish 
whether metabolites were originating from the cell content or from the wax layer on the plant 
surface which contaminates the aqueous microscopy slide. 
The transcriptome comparison of apical and sub-apical cells revealed no significant 
differences in expression of artemisinin related genes. The 195 significantly differentially 
expressed genes were not clearly linked to functional pathways. 
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5 Supporting information  
Additional File 10: Significant differences of transcriptome expression in apical and sub-
apical cells. 
List with all contigs that are significantly differentially expressed in apical and sub-apical 
cells. This list is provided in the supplementary CD. 
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The first aim of this PhD project was to optimize a workflow to perform a whole 
transcriptome analysis of trichome-tissues with 2
nd
 generation sequencing. In the following 
paragraphs, an overview of these optimizations will be given and this will be linked to the 
experimental setup of the final RNASeq experiments with whole trichome samples and apical 
and sub-apical cells. Thereafter, the biological results of these experiments will be discussed. 
The first step in this whole optimization procedure was to collect trichome samples with laser 
capture microdissection. Laser microdissection was facilitated with formaldehyde fixation but 
this fixation clearly deteriorated the extracted RNA yield and quality. These results were in 
line with the observations of Olofsson et al. [1]. Therefore, if possible, formaldehyde fixation 
must be avoided. Filamentous and glandular trichomes were easily collected without fixation 
(Part III Chapter I) but this was not the case for apical and sub-apical cells. To collect the 
latter (Part III Chapter II), in the first experiment, the sample preparation protocol from 
Olofsson et al. [1] was used. In this protocol, formaldehyde fixation was omitted and 
microdissection of the plant material was performed in a buffer. Our practical experience was 
that in this way, laser microdissection to separate apical and sub-apical cells was difficult to 
perform and leakage occurred. Therefore, another experiment to collect apical and sub-apical 
cells for RNASeq was performed with fixation. 
With laser pressure catapulting, trichome samples were collected in lysis buffer with β–
mercaptoethanol. Switching collection tubes for each collected trichome was time consuming, 
therefore, RNA quality in lysis buffer with β–mercaptoethanol was monitored after 2 h. or 10 
min. of incubation at room temperature. After 2 h of incubation, RNA quality was not 
deteriorated. Other optimization tests indicated that the RNA Nanoprep kit was appropriate to 
extract RNA from A. annua but that RNA with a better quality was obtained if the extraction 
was performed on ice. After extraction, RNA was linearly amplified to provide enough 
starting material for 2
nd
 generation sequencing. In the linear amplification process with 
Ovation RNA-Seq system, oligo dT and random primers were used. An advantage was that 
with such a method, the coverage at the 5’ RNA end is better [2]. Therefore, it was decided to 
use this amplification kit. In the results of our RNASeq experiment, it was seen that 60 % of 
the reads obtained were rRNA. That was the drawback of using these random primers and 
therefore, in the future, it should not be recommend to use the Ovation RNA-Seq system for 
plant tissues. 
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The following step after RNA amplification was library preparation for 2
nd
 generation 
sequencing. Library preparation includes the introduction of a barcode if a group of samples 
e.g. glandular and filamentous trichomes is sequenced in one lane. After sequencing, the reads 
can be assigned to the appropriate sample by the barcodes. In the commercially available 
TruSeq DNA library preparation kit of Illumina, barcodes are ligated before PCR 
amplification. Introducing different barcodes prior to amplification might result in 
amplification bias [3-5] in which some products with one barcode might be more efficiently 
amplified than products with another barcode. To investigate if the multiplex barcodes from 
the TrueSeq cause amplification bias, a Post Amplification Ligation-Mediated (PALM) 
protocol was developed which adds the barcodes after the PCR amplification step from the 
library preparation [6]. From these experiments, the conclusion was drawn that virtually no 
bias was observed between the different barcodes in both the PALM and TruSeq protocol. 
Therefore, both protocols were appropriate for analyzing the multiplexed trichome samples 
and the decision was made to use the PALM protocol.  
With the PALM protocol, a library was made of the trichome samples, clusters were 
generated and trichome samples were single-end 100 bp sequenced on the IlluminaHiSeq 
platform. A transcriptome assembly was made de novo which contained 150,288 contigs and 
from these contigs, 631 were significantly differentially expressed if glandular and 
filamentous trichomes were compared (Part III Chapter I). In filamentous trichomes, 204 
contigs were significantly more expressed whereas 427 contigs were upregulated in glandular 
trichomes.  
MEP and MVA pathways which produce precursors for the artemisinin biosynthesis were 
significantly more expressed in glandular trichomes if the comparison was made to 
filamentous trichomes. All genes were significantly upregulated in the MEP pathway whereas 
in the MVA pathway, only acetyl-CoA C-acetyltransferase (AACT) was upregulated and 3-
hydroxy-3-methylglutaryl coenzyme A reductase (HMGR). This is important since the latter 
enzyme was reported to limit artemisinin biosynthesis [7, 8].  
All known genes coding for enzymes involved in the artemisinin biosynthesis were 
significantly upregulated in glandular trichomes. These genes were amorpha-4,11-diene 
synthase which cyclises the general sesquiterpene precursor to amorpha-4,11-diene, oxidizing 
enzymes CYP71AV1, alcohol dehydrogenase 1 (ADH1), aldehyde dehydrogenase 1 (ALDH1) 
and the reductase: artemisinic aldehyde Δ 11(13) double bond reductase. The enhanced 
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expression of these genes in glandular trichomes and decreased expression in filamentous 
trichomes was as expected since A. annua plants with only filamentous trichomes lack 
artemisinin production. As all known artemisinin biosynthesis genes were so clearly 
differentially expressed in this experiment, these results show that our differential expression 
analysis of glandular and filamentous trichomes is a good base to pick up artemisinin 
biosynthesis genes.  
To find new candidates, the list of 427 upregulated contigs was screened for cytochrome 
P450, peroxidases and dioxygenases. This resulted in 5 cytochrome P450 genes significantly 
upregulated in the glandular trichomes. One cytochrome P450 from the CYP72A family 
(comp2774) in this list was very recently investigated by Misra et al. for its involvement in 
artemisinin biosynthesis but no in vitro activity was detected with dihydroartemisinic acid, 
artemisinin, artemisinic acid, arteannuinB as substrates [9]. Two other contigs: comp69 and 
comp548 were respectively annotated as CYP81B1 and CYP82. In both enzyme families, 
epoxidation reactions were reported in respectively fatty acids and terpenes. The best BLAST-
hits of comp15043 were CYP76B1 (7-ethoxycoumarin O-deethylase) and geraniol 10-
hydroxylase which hydroxylates the monoterpenoid geraniol [10]. Comp3673 was also in this 
list of significantly upregulated contigs. Three peroxidase-annotated sequences were 
upregulated in glandular trichomes: comp252, comp2084 and comp6217 and two 
dioxygenases: comp225 and comp453. To investigate in future experiments if one of these 
genes or a combination of these genes is involved in artemisinin biosynthesis, they can be 
expressed in a yeast strain which contains all artemisinin biosynthesis genes up to 
dihydroartemisinic acid and subsequently, it can be monitored if artemisinin is detected. Other 
possibilities are to make over-expression lines for these genes in A. annua plants or in vitro 
feeding experiments. 
Some genes coding for lipid biosynthesis enzymes showed also a significantly enhanced 
expression in glandular trichomes for example fatty acyl-CoA reductase. This is corroborated 
by the results from Tellez et al. who measured a higher oil content in A. annua plants with 
glandular trichomes [11]. 
Because of their interesting metabolite content as illustrated with artemisinin, a large number 
of studies have been devoted to glandular trichomes. In contrast to the extensive literature 
describing glandular trichomes, less attention has been paid to non-glandular trichomes. Non-
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glandular trichomes are assumed to form a physical barrier by steric hindrance of herbivores. 
To investigate if filamentous trichomes are involved in the production of interesting 
secondary metabolites, the contigs upregulated in filamentous trichomes were investigated 
(Part III Chapter I). Some specific genes from sesquiterpenoid and triterpenoid pathways such 
as 8-epi-cedrol synthase and an uncharacterized oxidosqualene cyclase were detected 
significantly more in filamentous than in glandular trichomes. Our results underscore the vast 
metabolic capacities of A. annua glandular trichomes but nonetheless point to the existence of 
specific terpene metabolic pathways in the filamentous trichomes. 
In the RNASeq experiment, some plants were treated with jasmonic-acid (Part III Chapter I) 
to trigger the artemisinin biosynthesis genes and to make transcriptome differences for 
artemisinin candidate genes more pronounced between glandular and filamentous trichomes. 
Unfortunately, no difference was observed if plants were treated or not. This was not expected 
since Maes et al. measured higher artemisinin levels after jasmonic-acid treatment [12]. A 
possible explanation is the use of plants in different developmental stages: Maes et al. used 
young seedlings while in our RNASeq experiment 6-months old plants with closed capitula 
were used. Some authors report highest artemisinin levels in pre-flowering stages whereas 
others report the peak during flowering [13]. Another possible explanation is that distinct 
cultivars can react differently to jasmonic-acid treatment as previously reported by Maes et al. 
[12]. The added value from this experiment was that these jasmonic-acid samples gave extra 
coverage for the de novo assembly and these 3 additional repeats also gave a statistical 
surplus. 
Another part of the RNASeq experiment (Part III Chapter II) was the comparison of apical 
versus sub-apical cells. Since Olsson et al. [14] detected transcriptional expression of ADS, 
CYP71AV1 and DBR2, three enzymes involved in artemisinin biosynthesis only in apical 
cells and not in sub-apical cells, genes with an enhanced expression in apical and not in sub-
apical cells might also be candidate genes for artemisinin biosynthesis. If the transcriptome of 
apical and sub-apical cells was compared, significantly differentially expressed genes were 
observed but these differences were not clearly linked to functional pathways and none of 
these differences was known to be involved in artemisinin biosynthesis. Olofsson et al. [1] 
also detected the expression of artemisinin biosynthesis genes in both cell types which is in 
contrast with their previous results [14]. In this PhD project, attempts were also made to 
detect artemisinin metabolites in apical and sub-apical cells with HPLC-MS/MS (Part III 
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Chapter II), but it was impossible to localize artemisinin metabolites in a specific cell-type of 
glandular trichomes since a lot of metabolites were present on the outer plant surface. 
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In ancient Chinese medicine, extracts from Artemisia annua L. were used to cure people 
suffering from malaria. The active molecule in this herbal therapeutic was characterized as 
artemisinin, a sesquiterpene with an endoperoxide bridge. Due to the emerging resistance of 
Plasmodium species against chloroquine, mefloquine and sulfadoxine-pyrimethamine, the 
World Health Organization (WHO) recommends the use of artemisinin-based combination 
therapies. Since every year around 216 million people are infected with malaria, a high supply 
of artemisinin is needed at a reduced cost. To produce artemisinin in a more cost-effective 
way, several strategies are followed. Plants of A. annua produce low amounts of artemisinin 
(0.01-0.8% of dry weight) and by crossing high-producing plants, artemisinin production is 
enhanced. Another strategy is biosynthesis of artemisinin in heterologous hosts. Despite 
attempts made for engineering E. coli and Saccharomyces cerevisiae to produce artemisinin, 
only the production of precursors from artemisinin was achieved. This is due to an incomplete 
knowledge of the biosynthetic pathway of artemisinin. Therefore, the discovery of new 
candidate genes is the focus of this PhD project.  
On leaves, stems and inflorescences of A. annua, artemisinin is produced in glandular 
trichomes which are specialized secretory hairs. Additionally, non-glandular hairs with a 
filamentous T-shape are present but these do not produce artemisinin. By comparison of gene 
expression in glandular and filamentous trichomes, new candidate genes were discovered. 
Glandular and filamentous trichomes were collected from flower heads with laser 
microdissection and laser pressure catapulting and RNA was isolated and amplified. The 
optimization of these procedures is discussed in Part II Chapter II.  
Thereafter, the transcriptome was sequenced with 2
nd
 generation sequencing. During library 
preparation, samples were prepared for cluster generation and sequencing by ligation of 
adaptors. If a group of samples e.g. glandular and filamentous trichomes is sequenced in one 
lane, library preparation includes the introduction of a barcode. These barcodes are short 
DNA fragments with a unique combination of nucleotides and they reflect which read is 
originating from which sample. In the commercially available TruSeq DNA library 
preparation kit of Illumina, barcodes are ligated before PCR amplification. Introducing 
different barcodes prior to amplification might result in amplification bias in which some 
products with one barcode might be more efficiently amplified than products with another 
barcode. To investigate if this type of bias is actually a problem and to prepare the trichome 
samples, a protocol was developed (Part II Chapter III) that adds barcodes after amplification 
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called Post Amplification Ligation-Mediated (PALM). In both the PALM and TruSeq 
protocol, the results showed virtually no bias between the different barcodes.  
Trichome samples were single-end 100 bp sequenced on the IlluminaHiSeq platform. A 
transcriptome assembly was made de novo which contains 150,288 contigs. From these 
contigs, 631 were significantly differentially expressed if glandular and filamentous trichomes 
were compared (Part III Chapter I). In filamentous trichomes, 204 contigs were significantly 
more expressed whereas 427 contigs were upregulated in glandular trichomes. In glandular 
trichomes, as expected, all known genes involved in the biosynthesis pathway of artemisinin 
were upregulated. MEP and MVA pathways that produce precursors for the artemisinin 
biosynthesis, were also significantly upregulated in glandular trichomes. In addition to this, 
other sesquiterpene biosynthesis and monoterpene pathways as well as lipid biosynthesis 
pathways were predominantly expressed in glandular trichomes. Novel cytochrome P450-, 
peroxidase- and dioxygenases-encoding genes highly expressed in glandular trichomes were 
detected and these might be potential candidate genes for the formation of the endoperoxide 
bridge in artemisinin. 
Because of their interesting metabolite content as illustrated with artemisinin, a large number 
of studies have been devoted to glandular trichomes. In contrast to the extensive literature 
describing glandular trichomes, less attention has been paid to non-glandular trichomes. Non-
glandular trichomes are assumed to form a physical barrier by steric hindrance of herbivores. 
To investigate if filamentous trichomes are involved in the production of interesting 
secondary metabolites, the contigs upregulated in filamentous trichomes were investigated 
(Part III Chapter I). Some specific genes from sesquiterpenoid and triterpenoid pathways such 
as 8-epi-cedrol synthase and oxidosqualene cyclase were detected significantly more than in 
glandular trichomes. Our results underscore the vast metabolic capacities of A. annua 
glandular trichomes but nonetheless point to the existence of specific terpene metabolic 
pathways in the filamentous trichomes. 
Glandular trichomes are composed of 10 cells from which 6 cells are surrounded by a sub-
cuticular cavity in which metabolites are secreted. The 2 secretory cells on top (apical) of the 
glandular trichome are morphologically different from the 4 secretory cells below (sub-apical) 
and might have another metabolic function. Therefore, it is possible that only one of these 
cell-types is involved in artemisinin production. To test this hypothesis, apical and sub-apical 
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cells as well as complete glandular and filamentous trichomes were collected with laser 
microdissection and laser pressure catapulting for performing metabolite analysis (Part III 
Chapter II). Also an attempt was made to collect the content of the sub-cuticular cavity with 
micropipetting. Metabolites were measured with HPLC-MS/MS. From these experiments, it 
was concluded that these methods were not suitable for detecting metabolites present in the 
cells. For both collection techniques, an aqueous preparation was made by chopping closed 
flower heads. During this procedure, metabolites from the wax layer surrounding the plant 
and metabolites from chopped cells were dispersed in this aqueous medium and caused 
contamination of the samples. This was suspected since artemisinin was detected in 
filamentous trichomes. The final proof of this contamination was obtained by adding mint 
trichomes in this aqueous medium. After collecting these trichomes with the laser microscope, 
artemisinin was detected in these mint trichomes. Therefore, it was impossible to localize 
artemisinin metabolites in a specific cell-type of glandular trichomes. 
Another attempt was made to look for differences in apical and sub-apical cells at the 
transcriptome level (Part III Chapter II). If the transcriptome of apical and sub-apical cells 
was compared, significantly differentially expressed genes were observed but these 
differences were not clearly linked to functional pathways and none of these differences was 
known to be involved in artemisinin biosynthesis. 
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De traditionele Chinese geneeskunde maakte gebruik van extracten van zoete alsem 
(Artemisia annua L.) voor de behandeling van malaria. Het actieve bestanddeel werd later 
gekarakteriseerd als artemisinine, een sesquiterpeen met endoperoxide brug. Door de opkomst 
van Plasmodium parasieten die resistent zijn aan chloroquine, mefloquine en sulfadoxine-
pyrimethamine, beveelt de wereldgezondheidsorganisatie het gebruik aan van artemisinine-
gebaseerde combinatietherapieën. Omdat elk jaar ongeveer 216 miljoen mensen geïnfecteerd 
worden met malaria is er nood aan veel artemisinine tegen een lage prijs. Om artemisinine op 
een goedkopere manier te produceren worden verschillende strategieën gebruikt. Zoete alsem 
bevat een relatief laag gehalte aan artemisinine (0.01-0.8% van het drooggewicht). Door 
planten met een hoog artemisinine gehalte te kruisen wordt een cultivar ontwikkeld die meer 
artemisinine aanmaakt. Een andere strategie die toegepast wordt is de productie van 
artemisinine in gist. Door gekende genen van de artemisinin biosynthese weg in gist tot 
expressie te brengen zijn wetenschappers erin geslaagd om precursoren van artemisinine aan 
te maken maar niet artemisinine zelf. Dit komt doordat nog niet alle enzymen gekend zijn die 
een rol spelen in de aanmaak van artemisinine. De zoektocht naar deze ontbrekende genen is 
de focus van dit doctoraatsproject. 
Op de blaadjes, stengels en bloemknoppen van zoete alsem zijn een soort microscopisch 
kleine klierachtige haartjes aanwezig die ook wel glandulaire trichomen genoemd worden. 
Deze haartjes zijn verantwoordelijk voor de productie van artemisinine. Naast glandulaire 
trichomen zijn er ook T-vormige haartjes aanwezig maar die hebben geen zichtbare 
klierfunctie en maken geen artemisinine aan. Deze haartjes worden filamenteuze trichomen 
genoemd. Door het vergelijken van genexpressie in glandulaire en filamenteuze trichomen 
worden nieuwe kandidaat genen gezocht die een rol kunnen spelen in de productie van 
artemisinine. Tijdens dit doctoraatsproject werden glandulaire en filamenteuze trichomen van 
bloemhoofdjes verzameld met behulp van een laser microscoop door laser microdissectie en 
laser katapultatie. Van deze stalen werd het RNA geïsoleerd en geamplificeerd. De 
optimalisatie van deze procedures wordt besproken Part II Chapter II. 
Vervolgens werd het transcriptoom gesequeneerd met 2
de
 generatie sequenering. Tijdens de 
library aanmaak worden de stalen voorbereid voor de sequenering door het ligeren van 
adaptoren. Als een groep stalen (vb. glandulaire en filamenteuze trichomen) wordt 
gesequeneerd in 1 laan, dan moeten barcodes toegevoegd worden tijdens de library aanmaak. 
Deze barcodes zijn korte DNA fragmentjes met een specifiek herkenbare combinatie aan 
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nucleotiden. Met behulp van die barcode kan achteraf teruggevonden worden welke data van 
welk staal afkomstig is. In de commercieel beschikbare DNA library voorbereidingskit 
TruSeq van Illumina worden barcodes geligeerd voor de PCR amplificatie stap. De 
introductie van specifieke barcodes per staal voor amplificatie zou kunnen resulteren in een 
betere amplificatie van sommige fragmenten met een bepaalde barcode en mindere 
amplificatie van fragmenten met een andere barcode. Om te onderzoeken of dit werkelijk een 
probleem geeft en om de trichoomstalen te analyseren werd een protocol ontwikkeld (Part II 
Chapter III) waarin barcodes na amplificatie worden toegevoegd. Als dit nieuw ontwikkelde 
protocol met het TruSeq protocol vergeleken werd, werd met beide methodes zo goed als 
geen afwijking waargenomen tussen de verschillende barcodes. 
Het transcriptoom van de trichoomstalen werd enkelzijdig gesequeneerd in reads van 100 bp 
op het IlluminaHiSeq platform (Part III Chapter I). De reads werden geassembleerd tot de 
novo transcriptoom fragmenten. In totaal werden er 150,288 fragmenten of contigs 
gegenereerd. Van deze contigs kwamen er 631 significant verschillend tot expressie als 
glandulaire met filamenteuze trichomen vergeleken werden. In filamenteuze trichomen 
kwamen 204 contigs significant meer tot expressie en in glandulaire trichomen waren 427 
contigs upgereguleerd. Zoals verwacht kwamen alle gekende artemisinine biosynthese genen 
meer tot expressie in glandulaire trichomen. Ook de mevalonate (MVA) en 2-C-methyl-D-
erythritol 4-phosphate (MEP) biosynthese pathways kwamen meer tot expressie in de 
glandulaire trichomen. Deze pathways maken precursoren voor de aanmaak van artemisinine. 
Daarnaast kwamen andere sesquiterpeen- en monoterpeen- alsook de lipide-biosyntheseweg 
predominant voor in glandulaire trichomen. Ook nieuwe kandidaatgenen voor de artemisinin 
biosynthese werden opgepikt. Deze genen kwamen significant meer tot expressie in 
glandulaire trichomen, behoren tot de cytochroom P450, peroxidase of dioxygenase 
coderende genen en kunnen mogelijks betrokken zijn bij de endoperoxide brug formatie in 
artemisinine. 
Veel interessante metabolieten worden geproduceerd in glandulaire trichomen en dit type 
trichomen werd dan ook uitvoerig bestudeerd in de literatuur. Aan niet glandulaire trichomen 
of filamenteuze trichomen werd minder aandacht besteed. Van niet glandulaire trichomen 
wordt aangenomen dat ze de plant beschermen door sterisch hinderen van herbivoren. Om uit 
te zoeken of filamenteuze trichomen ook specifiek interessante secundaire metabolieten 
produceren werd onderzocht welke contigs significant meer tot expressie kwamen in 
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filamenteuze trichomen (Part III Chapter I). Dit waren sommige genen van sesquiterpeen en 
triterpeen pathways zoals 8-epi-cedrol synthase en oxidosqualene cyclase. Deze resultaten 
bevestigen niet enkel het belang van glandulaire trichomen als productie plaats voor 
secundaire metabolieten maar geven ook een indicatie van de aanwezigheid van belangrijke 
specifieke terpeen biosynthese pathways in filamenteuze trichomen. 
Glandulaire trichomen zijn opgebouwd uit 10 cellen waarvan 6 cellen omgeven zijn door een 
sub-cuticulaire blaas waarin metabolieten gesecreteerd worden. De 2 secretorische cellen aan 
de top (apicaal) van de glandulaire trichoom verschillen morfologisch van de 4 secretorische 
cellen die daaronder liggen (sub-apicaal). Deze morfologische verschillen zijn een indicatie 
dat deze celtypes mogelijks verschillende functies uitoefenen. Het is mogelijk dat maar 1 van 
beide celtypes betrokken is bij de productie van artemisinine. Daarom werden zowel apicale, 
sub-apicale als volledige glandulaire en filamenteuze trichomen voor een metabolietanalyse 
verzameld met laser microdissectie en laser katapultatie (Part III Chapter II). Ook werd 
geprobeerd om de inhoud van de sub-cuticulaire holte te verzamelen met een micropipet. De 
metaboliet gehaltes werden bepaald met HPLC-MS/MS. Uit de resultaten kon geconcludeerd 
worden dat deze methode niet geschikt was om de aanwezigheid van metabolieten in de 
cellen te meten. Voor de collectie met laser katapultatie en micropipetteren werd een 
preparaat gemaakt door bloemknoppen te verhakken in water. Hierbij migreerden 
metabolieten afkomstig van de waslaag rondom de bloemknoppen en metabolieten uit de 
opengehakte cellen in het water en dit veroorzaakte contaminatie van de stalen. Dit werd 
aangetoond door munt trichomen in waswater toe te voegen: na collectie met de laser 
microscoop en analyse met HPLC-MS/MS werd artemisinine ook gedetecteerd in deze munt 
trichomen. Daaruit werd besloten dat het met deze methode niet mogelijk was om 
artemisinine te lokaliseren in een specifiek celtype van de glandulaire trichomen.  
Vervolgens werden de problemen op metaboliet niveau omzeild door op transcriptoom niveau 
te kijken naar waar de gekende artemisinine biosynthese genen tot expressie komen in de 
glandulaire trichomen (Part III Chapter II). Als het transcriptoom van apicale en sub-apicale 
cellen vergeleken werd, werden significante verschillen in expressie niveaus gedetecteerd 
maar deze verschillen konden niet gelinkt worden aan functionele pathways en daarenboven 
was geen enkel van deze verschillen een gekend artemisinine biosynthese gen. 
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List of abbreviations  
AACT: acetyl-CoA C-acetyltransferase 
ACP: acyl carrier protein 
ACT: artemisinin-based-combination therapy 
ADS: amorpha-4,11-diene synthase 
ADH1: alcohol dehydrogenase 1 
ALDH1: aldehyde dehydrogenase 1 
APS: adenosine 5’ phosphosulfate 
CASAVA: Consensus Assessment of Sequence and Variation 
CMK: 4-cytidine 5’-diphospho-2-C-methyl-D-erythritol kinase 
CNAP: Centre for Novel Agricultural Products 
CYP71AV1: amorpha-4,11-diene monooxygenase 
DBR2: artemisinic aldehyde Δ11(13) double bond reductase 
DMAPP: dimethylallyl pyrophosphate 
DXP: 1-deoxy-D-xylulose-5-phosphate 
DXS: 1-deoxy-D-xylulose-5-phosphate synthase 
DXR: 1-deoxy-D-xylulose-5-phosphate reductoisomerase 
EST: expressed sequence tags 
FDS: farnesyl diphosphate synthase 
FT: filamentous trichome 
GDP: geranyl diphosphate 
GGDP: geranylgeranyl diphosphate 
GO: gene onthology 
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GT: glandular trichome 
HDS: hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate synthase 
HDR: hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate reductase 
HMGR: 3-hydroxy-3-methyl-glutaryl coenzyme A reductase 
HMGS: 3-hydroxy-3-methyl-glutaryl coenzyme A synthase 
HPLC-ESI-Q-TOF: high pressure liquid chromatography with electrospray ionisation and 
time of flight 
HPLC-MS/MS: high pressure liquid chromatography with tandem mass spetrometry 
Hsp: high-scoring segment pairs 
IC50: half maximal inhibitory concentration 
IDI: isopentenyl diphosphate isomerase 
IPP: isopentenyl pyrophosphate 
LSU: large subunit 
JA: jasmonic acid 
KAS: β-ketoacyl-ACP synthase 
MCS: 2-C-methyl-D-erythritol-2,4-cyclodiphosphate synthase 
MCT: 2-C-methyl-D-erythritol-4-phosphate cytidylyltransferase 
MEP: 2-C-methyl-D-erythritol 4-phosphate 
MVA: mevalonate 
MVK: mevalonate kinase 
NAT: nucleic acid-based tests 
P.A.L.M.: photo ablation laser microdissection 
PALM: post amplification ligation mediated barcoding 
PCR: polymerase chain reaction 
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PGM: personal genome machine 
PMK: phosphomevalonate kinase 
PMD: diphosphomevalonate decarboxylase 
PP2AA3: protein phosphatase 2A subunit A3 
PPR: pentatricopeptide repeat superfamily protein 
RDT: rapid diagnostic test 
RED1: dihydroartemisinic aldehyde reductase 
RIN: RNA integrity number 
RNASeq: RNA sequencing 
RQI: RNA quality indicator 
RT-PCR: reverse transcriptase PCR 
RSEM: RNASeq by Expectation Maximization 
SEM: scanning electron microscopy 
SERCAs: sarco/endoplasmic reticulum Ca
2+
 ATPase 
SOLiD: sequencing by oligo ligation detection 
SMRT: single molecule real time sequencing 
SPIA: single primer isothermal amplification 
SSU: small subunit 
TFAR1: fatty acyl-CoA reductase 1 
TMM: trimmed mean of M values 
UCSC: University of California, Santa Cruz 
U_OSC: uncharacterized oxidosqualene cyclase 
WHO: World Health Organisation 
 
 189 
 
 
Part VIII. Curriculum 
vitae 
 
Curriculum vitae Part VIII 
 
191 
 
Personal Information 
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Nationality  Belgian 
 
Education and working experience 
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- Preparation of a validation-file for an in-house developed multiplex PCR for obtaining an 
extension of the Belac-accreditation and implementation in the forensic laboratory. 
 
Additional Courses and Workshops Organizer  Date 
 
Project management     Ghent University 2012 
Leading, Following and Collaborating  Ghent University 2011 
Introduction to Linux for bioinformatics   BITS (VIB)  3 and 7/10/2011 
Comparative & Regulatory Genomics in Plants Ghent University    13-15/04/2011 
qPCR experiment design and data analysis   Biogazelle   8-9/11/2010 
Introduction to Bioinformatics    BITS (VIB)  4-5/11/2010 
Advanced academic English: Writing Skills  Ghent University 2010 
 
Scientific awards 
 
2009   Presentation award Terpnet 2009 (Tokyo, Japan)  
 
Teaching experience 
 
2008-2012   Practicum Biotechnology 
2008-2012   Practicum Phytotherapy/Pharmacognosy 
 
A1 Publications (Articles in Web of Science) 
 
Filip Van Nieuwerburgh, Sandra Soetaert, Katie Podshivalova, Eileen Ay-Lin Wang, Lana 
Schaffer, Dieter Deforce, Daniel R. Salomon, Steven R. Head, Phillip Ordoukhanian: 
Quantitative Bias in Illumina TruSeq and a Novel Post Amplification Barcoding 
Strategy for Multiplexed DNA and Small RNA Deep Sequencing. PLoS ONE 2011, 6(10): 
e26969 IF: 4.411 
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Sandra SA Soetaert, Christophe MF Van Neste, Mado Vandewoestyne, Steven R Head, Alain 
Goossens, Filip CW Van Nieuwerburgh, Dieter DL Deforce: Differential transcriptome 
analysis of glandular and filamentous trichomes in Artemisia annua. Submitted to BMC 
Plant Biology. 
Bart J.G. Broeckx, Frank Coopman, Geert E.C. Verhoeven,Wim Van Haeringen, Leanne van 
de Goor, Tim Bosmans, Ingrid Gielen, Jimmy H. Saunders, Sandra S.A. Soetaert, Henri Van 
Bree, Christophe Van Neste, Filip Van Nieuwerburgh, Bernadette Van Ryssen, Elien Verelst, 
Katleen Van Steendam, Dieter Deforce: The prevalence of genetic disorders in a dog 
population from Belgium, the Netherlands and Germany. Submitted to PLoS ONE. 
Tessa Moses, Jacob Pollier, Sandra Soetaert, Marie-Laure Erffelinck, Robin Vanden Bossche, 
Johan M. Thevelein, Dieter Deforce and Alain Goossens: Reconstitution of Artemisia annua 
triterpene biosynthetic pathway in yeast and tobacco. Manuscript in preparation. 
C3 Publications and Presentations 
Poster Conference on Advances in Canine and Feline Genomics and Inherited Diseases 2012 
(Visby, Sweden): Relation between the FBN2 haplotype and phenotypical hip dysplasia. 
Broeckx B., Coopman F., Verhoeven G., Bosmans T., Criel A., Gielen I., Saunders J., 
Soetaert S., van Bree H. and Van Haeringen W., Van Nieuwerburgh F., Van Ryssen B., 
Deforce D 
Poster Terpnet 2011 (Kalmar, Sweden): Transcriptome analysis of apical and sub-apical 
cells of Artemisia annua trichomes with next-generation-sequencing. Sandra S.A. 
Soetaert, Filip C.W. Van Nieuwerburgh, Peter E. Brodelius, Alain Goossens, Dieter L.D. 
Deforce 
Oral presentation Terpnet 2009 (Tokyo, Japan): Metabolite analysis of laser captured 
apical and sub-apical cells of Artemisia annua trichomes. Sandra S.A. Soetaert, Filip C.W. 
Van Nieuwerburgh, Sofie R.F. Vande Casteele, Mikael E. Olsson, Mado Vandewoestyne, 
Peter E. Brodelius, Alain Goossens, Dieter L.D. Deforce 
Poster Terpnet 2009 (Japan): Phytohormonal regulation of gland formation and 
artemisinin biosynthesis in Artemisia annua. Filip Van Nieuwerburgh, Lies Maes, Sofie 
Vande Casteele, Sandra Soetaert, Marc Van Montagu, Dirk Inzé, Dieter L.D. Deforce, Alain 
Goossens  
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Als laatste zou ik graag iedereen bedanken die rechtstreeks of onrechtstreeks geholpen heeft 
om mijn doctoraat tot een goed einde te brengen. Een doctoraat is een project met “ups” en 
“downs”, vandaar dat steun van collega’s, vrienden en familie zo belangrijk is om de 
motivatie te vinden om door te gaan. Andere doctoraatsstudenten wil ik graag de raad geven 
om nooit op te geven, de “ups” komen meestal pas op het einde… 
Dieter, bedankt om mij als promotor onder je vleugels te nemen en mij te steunen dit 
doctoraat af te ronden. Je hebt mij de kans gegeven om heel zelfstandig te werken maar als ik 
ergens met een technisch probleem zat, dan kon ik altijd bij jou terecht en wist jij vaak heel 
creatieve oplossingen te bedenken. 
Alain, als co-promotor was jij steeds beschikbaar om mij met raad en daad bij te staan. Je 
woorden “Je ziet dat het bij de rest ook niet altijd vlot verloopt.” zullen mij bij blijven. Je 
expertise op het gebied van plantenbiotechnologie hielp ook om de zaken vanuit een ander 
perspectief te bekijken. 
Filip, als mede co-promotor wil ik je danken voor het schrijven van mijn FWO aanvraag, voor 
je hulp bij het uitwerken van het 2nd generation sequencing gedeelte en voor de begeleiding 
gedurende 4 jaar. 
Christophe, als bioinformatica buddie, heb je met mij veel mailtjes heen en weer gestuurd om 
de RNASeq analyse tot een goed eind te brengen. Jouw programmeer skills hebben dit 
onderzoek in een hogere stroomversnelling gebracht. Toch kan ik nog niet geloven dat een 
kapotte harde schijf kan gemaakt worden door die in te vriezen… Het was leuk om met jou 
samen te werken.  
Yens, jou wil ik ook graag bedankt voor de praktische hulp in het labo op het einde van mijn 
doctoraat. Op het einde was het echt rushen en ik was super blij dat ik kon rekenen op een 
extra paar handen. Jill, Liselotte, Kim en Anne-Marie, de thesisstudenten die geholpen hebben 
aan dit project, bedankt voor de assistentie! 
Sofie, bedankt voor de opleiding tot HPLS-MS analist. Technische problemen worden vlot 
door jou opgelost, vandaar je bijnaam massa fluisteraar. 
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Maarten en Katleen, de pater et mater familias van “den bokaal” waarbij we altijd terecht 
konden voor goede raad. Marlies en Trees voor de gezellige babbels en bemoedigende 
woorden. Veerle en Liesbeth, het vaak komische duo aan den overkant van den bokaal die de 
dagen opvrolijkt. Pieter, merci voor de veelal filosofische discussies over projecten en Ellen, 
jouw enthousiasme is moeilijk te evenaren. Paulien, bedankt te luisteren als mijn project eens 
wat minder vlot ging. Bart, jij wist ook vaak de sfeer erin te brengen met de 
dierengeneeskundige weetjes van de week. Bert, bedankt voor je droge humor om de sfeer er 
in te houden en om de IT helpdesk te bemannen. Mado, veel geluk met je nieuwe job. De 
collega’s van het DNA labo (David, Saskia, Sylvie, Delphine, Petra, Sabine, Eveline, Evelien, 
Leen, Astrid en Nadine), bedankt voor de aangename babbels en toffe werksfeer. Ik heb ook 
heel goede herinneringen aan mijn manama thesis bij jullie! Inge, merci voor de hulp bij het 
regelen van “van alles en nog wat”. Super vlot, altijd met een glimlach en nooit is iets te veel 
gevraagd. 
I would also like to thank the people from NXT-GNT and Mdx at the 3th Floor for the nice 
working environment and the technical support for transcriptomics analysis. 
Tessa and Jacob, thanks for the nice congress company at Terpnet in Sweden and Tokyo. I 
also liked the in depth discussions about terpenoids, that helped to put things into another 
perspective. Thanks to the other metabol group members for their amusing BBQs, seminars 
(Blankenberge) and interesting group discussions. 
Chen and Bjorn, thanks for the help with the micropipetting of the glandular cavities. This 
was a difficult piece of master work! 
Mama en papa, Brigitte en Denis, Claudia en Simon, bedankt voor de ontspannen avondjes, 
weekendjes en wandelingen. Dat was een welkome afwisseling. Bedankt ook voor het begrip 
tijdens super drukke periodes en de steun bij het zoeken van een job. 
Als laatste, bedankt Quinten om mijn steunpilaar te zijn gedurende die 4 jaar. Zonder jou zou 
ik dit niet volgehouden hebben. Je kon mij echt opbeuren als het eens wat minder ging en je 
stond steeds klaar voor een diepe wetenschappelijke discussie om een tweede opinie te geven. 
 
